Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AC008560.1 ENSG00000253251 "Uncharacterized protein FLJ26957 " Q6ZNX1 5 65624765-65630891 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA066071: , HPA068764: " "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favourable (1.17e-4)" 5.8 7.1 7.3 6.5 13.1 31.5 10.0 8.7 13.3 5.4 6.6 7.1 5.5 7.0 5.9 7.4 6.3 5.3 6.1 4.9 8.2 7.9 11.6 9.7 6.2 9.9 9.9 8.0 5.9 8.7 3.8 13.1 6.5 11.3 10.7 7.6 5.7 6.4 6.6 6.6 7.0 7.6 7.8 9.1 8.9 6.0 7.5 8.6 10.4 6.9 6.4 8.3 5.3 5.0 5.0 4.4 13.4 4.1 6.3 8.8 2.9 2.8 3.7 5.7 12.0 3.3 3.8 6.8 4.3 3.8 6.1 7.8 6.4 8.7 5.1 4.9 5.0 3.6 5.5 5.2 9.2 6.7 6.9 4.6 9.7 8.5 2.6 5.0 8.0 2.3 7.3 6.4 6.8 4.1 6.5 12.0 5.0 7.1 7.2 7.3 4.5 2.2 5.0 5.4 7.9 5.1 6.1 7.8 5.9 3.8 3.5 10.8 4.2 4.5 3.2 5.7 7.5 4.4 6.8 7.6 13.9 11.3 4.2 6.2 5.3 13.4 4.1 7.5 5.4 3.7 5.7 5.0 6.5 5.6 3.7 4.9 8.8 8.1 4.3 6.3 4.1 4.4 7.9 2.9 7.3 13.1 8.7 13.3 8.2 7.9 9.9 8.0 11.3 8.6 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866908-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 2100000 "Plasma membrane, Cytosol" Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavourable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 38.3 24.0 16.7 26.2 22.9 19.1 35.7 21.5 29.1 22.9 22.2 25.1 18.0 30.7 27.0 24.9 23.2 23.7 28.2 18.4 18.3 33.7 37.8 22.2 23.3 27.4 23.1 17.9 19.0 30.6 27.1 19.5 26.7 49.0 41.3 23.2 15.6 25.4 19.6 10.9 19.6 29.6 27.2 26.2 24.5 24.6 20.7 21.4 32.0 21.3 18.2 24.6 20.3 21.3 16.1 23.9 25.2 26.3 16.0 23.9 21.4 23.2 79.1 37.4 32.2 57.8 54.3 34.4 32.7 35.8 41.2 51.8 40.1 26.8 37.8 21.0 45.8 37.0 48.2 56.0 34.5 34.0 46.1 21.6 45.6 41.7 26.9 34.9 28.3 43.1 16.9 72.4 14.6 43.4 26.6 30.2 34.1 23.7 57.4 19.6 24.3 14.4 37.7 45.2 48.4 42.2 41.4 70.4 38.7 23.3 73.0 25.0 43.5 33.4 46.6 32.2 26.5 32.3 53.6 17.7 22.5 35.9 54.4 27.1 26.1 18.9 20.7 25.2 23.8 22.1 22.5 16.1 19.0 21.3 23.9 13.8 14.6 16.1 10.7 16.0 26.3 13.9 23.9 21.4 16.7 22.9 21.5 27.7 18.3 33.7 23.1 17.9 49.0 21.4 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell line enriched" "Detected in some" 11 "Hep G2: 21.9" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favourable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.3 0.0 0.2 0.4 0.2 0.1 0.5 0.8 21.9 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.1 0.4 1.0 0.1 0.3 0.3 0.6 0.3 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.5 0.0 0.4 0.5 0.2 0.4 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442350-134459284 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 302.2;seminal vesicle: 109.3" "Cell line enhanced" "Detected in many" "A549: 121.0;BJ hTERT+: 222.0;RPTEC TERT1: 105.0;U-87 MG: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol 1700000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: " "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavourable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (7.00e-4)" 5.9 302.2 7.5 4.7 13.7 2.5 9.5 6.9 10.9 4.4 3.9 8.2 50.4 2.7 4.6 6.1 4.2 4.6 5.2 24.2 7.3 8.4 17.7 2.5 6.9 10.0 9.5 9.0 8.2 7.2 9.4 8.0 24.8 11.9 5.5 4.1 5.8 4.4 109.3 37.6 2.8 4.8 5.6 7.9 6.7 5.0 5.2 5.9 7.3 6.0 10.3 7.6 7.1 3.7 31.4 34.8 22.5 26.0 26.3 42.7 47.2 13.3 121.0 13.6 19.3 58.9 16.0 36.3 13.0 222.0 19.1 24.8 5.6 12.3 0.0 6.0 21.7 5.7 14.8 12.9 15.2 4.8 13.6 6.8 18.2 16.4 84.4 0.0 0.0 14.9 9.7 27.3 7.3 26.9 0.0 4.5 21.1 0.2 20.0 9.2 22.7 0.1 20.9 8.7 10.1 105.0 65.4 10.2 22.7 90.9 0.1 9.5 0.0 10.2 21.2 18.9 8.8 1.7 14.1 12.5 13.7 33.8 99.9 0.0 11.3 22.5 26.0 1.2 37.9 17.0 34.0 31.4 32.4 36.7 34.8 28.5 42.7 41.1 2.1 26.3 8.9 4.9 22.0 47.2 7.5 13.7 6.9 10.9 7.3 8.4 9.5 9.0 11.9 5.9 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Group enriched" "Detected in many" 10 "ASC diff: 186.6;Hep G2: 316.4" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: " "unprognostic (1.54e-2)" "prognostic favourable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favourable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.6 0.1 25.8 186.6 22.5 0.0 0.8 5.7 0.3 0.2 0.5 0.0 0.0 0.3 5.8 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.2 316.4 1.8 0.1 0.0 11.4 1.6 2.7 1.6 0.6 5.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Group enriched" "Detected in some" 4 "A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: " "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 134.6 0.1 14.2 167.1 5.7 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 3.8 0.0 0.7 0.0 0.0 0.0 0.0 38.0 251.2 0.3 0.0 0.0 14.9 8.4 0.7 0.7 0.0 5.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.2 76.9 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.9 0.0 0.0 0.0 0.0 1.7 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell line enhanced" "Detected in many" "A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: " "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavourable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 149.2 0.1 43.6 85.8 30.9 0.0 0.0 2.1 0.0 0.1 4.4 2.5 0.0 8.1 2.0 1.2 0.1 2.9 0.0 0.3 0.0 0.2 46.2 62.6 0.4 0.0 0.0 17.1 6.1 2.0 0.0 2.8 0.9 0.0 3.9 0.3 1.0 0.2 0.0 0.4 0.3 0.9 4.4 14.7 58.9 0.0 0.3 21.4 0.0 0.0 0.0 0.0 20.8 0.5 0.4 9.0 0.3 0.0 0.0 0.0 5.0 5.9 0.4 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell line enriched" "Detected in some" 6 "HDLM-2: 11.8" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: , HPA068265: " "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0;THP-1: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.4 0.8 0.0 0.8 0.2 6.6 1.0 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 0.5 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 15.6 20.3 17.8 14.7 25.1 12.2 19.9 24.8 25.1 20.6 16.2 16.8 12.2 11.9 21.4 19.8 34.2 20.9 15.6 18.8 19.1 18.5 21.4 16.8 16.6 20.8 16.2 22.1 18.1 16.7 26.6 14.9 9.6 17.6 21.8 18.9 16.4 19.7 21.3 29.7 16.0 13.3 24.0 17.1 16.8 14.9 36.3 16.3 25.8 23.2 24.5 22.2 19.2 22.5 14.9 17.7 17.6 15.1 20.1 22.4 12.5 18.3 25.3 18.6 15.8 19.5 9.9 10.6 12.9 11.8 23.9 16.6 25.8 11.8 29.4 13.2 17.3 18.7 27.6 17.7 24.4 15.6 22.3 26.0 18.8 21.3 14.2 23.2 12.3 10.7 12.8 20.7 13.8 23.1 40.7 6.0 18.7 19.7 35.1 17.3 16.1 22.1 27.2 18.4 35.0 16.2 23.6 24.2 13.9 20.2 15.9 21.2 33.7 21.1 14.5 14.3 13.4 12.7 15.2 10.6 21.7 39.6 15.9 19.9 16.5 14.3 10.5 17.6 17.2 15.1 20.2 13.3 18.5 16.5 17.7 14.9 15.5 16.5 8.3 20.1 13.1 9.7 22.4 12.5 17.8 25.1 24.8 25.1 19.1 18.5 16.2 22.1 17.6 16.3 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell line enhanced" "Detected in many" "HL-60: 16.9;THP-1: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA046346: , HPA046695: , HPA049923: , HPA051288: " "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.6 3.6 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 2.0 0.0 0.9 3.5 3.3 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.9 0.4 0.0 2.3 0.0 3.1 0.0 1.6 0.4 0.3 4.3 0.1 0.8 3.7 2.1 0.0 6.4 6.4 2.1 1.9 1.5 3.0 2.3 0.5 0.1 2.5 8.0 4.4 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Cell line enhanced" "Detected in many" "NB-4: 20.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA046346: , HPA046695: , HPA049923: , HPA051288: " "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.4 8.4 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.5 0.2 0.2 0.4 0.2 1.7 4.5 1.6 2.8 0.1 4.5 8.1 9.8 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.5 3.8 4.4 2.1 2.6 1.2 0.2 20.5 7.2 3.7 0.0 10.3 1.5 1.2 1.8 0.2 7.2 3.4 0.3 0.5 5.9 10.0 3.8 1.7 7.5 3.4 2.9 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39053910 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA073637 Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favourable (8.28e-4)" 6.9 9.0 1.9 7.9 2.3 2.5 3.1 0.7 2.0 9.6 5.4 3.9 14.5 3.1 8.2 5.6 5.6 8.1 3.1 6.7 2.4 1.7 5.9 4.5 5.4 13.1 1.8 1.2 14.1 5.5 3.9 4.9 1.7 2.6 6.4 2.4 6.6 6.4 16.3 3.2 1.6 5.0 3.9 3.6 14.3 4.3 11.9 1.9 7.3 4.2 2.5 15.9 5.4 4.5 23.2 4.3 5.9 9.1 9.3 6.9 4.7 4.4 3.5 1.4 5.4 4.0 6.0 1.9 3.3 6.2 8.0 12.7 3.0 7.9 10.5 3.5 7.0 5.6 1.3 5.3 3.1 9.8 4.4 14.1 0.0 1.5 8.0 1.5 5.9 7.9 2.3 4.1 1.4 7.3 1.0 17.4 3.9 3.1 3.1 1.9 0.6 0.5 5.3 0.5 2.3 6.6 5.8 0.7 1.1 4.1 1.0 2.2 4.2 1.2 1.9 1.7 4.6 0.2 1.5 3.0 1.5 0.5 4.8 1.4 2.6 1.4 3.3 5.9 6.1 6.6 6.9 16.4 4.0 6.2 4.3 23.2 2.5 3.9 1.5 9.3 9.1 3.7 5.4 4.7 1.9 2.3 0.7 2.0 2.4 1.7 1.8 1.2 2.6 1.9 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077005-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.4" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 14.6;Daudi: 19.7;HDLM-2: 16.4;Karpas-707: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favourable (4.78e-4)" "prognostic favourable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favourable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavourable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favourable (6.30e-4)" 6.0 6.1 1.9 8.0 2.2 4.8 3.8 1.4 1.8 6.4 4.2 2.8 8.0 1.7 6.1 4.3 3.7 8.8 7.2 4.6 2.4 1.7 4.1 4.1 5.1 16.0 2.5 1.3 12.4 0.9 2.0 3.4 3.4 2.5 5.0 3.3 4.8 3.8 28.0 3.3 1.2 5.6 3.6 3.1 18.9 3.5 15.6 1.4 6.5 3.8 2.6 15.2 7.4 6.0 16.1 8.6 5.9 17.5 35.5 64.4 39.1 1.9 0.0 0.0 0.0 2.4 4.8 0.1 0.4 8.1 9.4 14.6 0.7 11.7 19.7 0.2 3.3 0.0 0.1 0.6 2.8 16.4 0.0 10.1 0.0 0.1 10.9 3.3 4.8 7.3 0.2 5.1 1.1 1.3 0.9 22.6 1.4 0.0 3.7 3.4 0.3 0.7 7.6 0.0 12.5 0.0 8.7 0.0 0.0 0.2 0.0 1.0 0.0 6.4 0.0 1.4 0.1 0.0 0.0 0.0 1.8 0.2 1.7 3.0 2.5 4.0 6.8 4.5 64.4 15.1 37.7 16.1 20.2 49.8 8.6 11.6 6.9 30.3 5.9 35.5 17.5 5.5 15.8 39.1 1.9 2.2 1.4 1.8 2.4 1.7 2.5 1.3 2.5 1.4 ARSJ FLJ23548 ENSG00000180801 "Arylsulfatase family member J" Q5FYB0 4 113900284-113979727 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.0;HUVEC TERT2: 18.0;LHCN-M2: 18.3;TIME: 23.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 15.4" "HPA036481, HPA036482" Uncertain Supported "Actin filaments" "Secreted in other tissues" "Actin filaments" "HPA036481: , HPA036482: AB_10672356" "unprognostic (1.98e-1)" "unprognostic (1.55e-2)" "unprognostic (4.23e-1)" "unprognostic (5.31e-1)" "unprognostic (6.23e-2)" "prognostic unfavourable (6.08e-4)" "unprognostic (2.54e-2)" "unprognostic (2.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-1)" "unprognostic (5.31e-2)" "unprognostic (2.20e-1)" "prognostic favourable (2.97e-6)" "unprognostic (2.26e-1)" "unprognostic (8.37e-2)" "unprognostic (1.30e-1)" "unprognostic (2.07e-2)" 3.5 2.2 2.6 2.0 2.7 0.0 2.6 10.3 3.4 7.9 4.7 0.9 4.1 1.0 4.8 2.2 9.1 4.6 6.0 5.2 1.5 1.2 9.4 3.4 6.9 3.5 1.8 3.6 4.7 2.6 13.3 1.8 6.7 4.2 7.2 5.4 1.8 9.1 3.9 0.8 1.7 1.7 10.5 2.9 0.5 5.8 0.9 2.0 0.6 1.9 3.6 1.7 7.5 18.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 2.4 0.2 0.0 4.4 9.1 0.0 20.0 15.2 12.6 4.9 0.5 1.4 0.0 2.5 9.5 2.1 0.1 4.9 15.8 0.0 0.9 0.0 1.9 0.0 13.6 0.0 0.0 5.6 5.0 8.5 17.5 18.0 0.0 0.0 18.3 0.1 0.0 0.0 0.6 3.6 0.0 2.2 0.0 16.5 0.0 0.0 0.7 1.3 0.2 0.9 0.1 0.0 23.0 14.5 4.0 2.1 9.4 0.0 0.0 0.0 7.1 0.0 4.4 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 10.3 3.4 1.5 1.2 1.8 3.6 4.2 2.0 ASNS ENSG00000070669 "Asparagine synthetase (glutamine-hydrolyzing)" P08243 7 97852118-97872542 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" Ligase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 68.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;T-cells: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004924, HPA029318, HPA064737" Approved Enhanced Cytosol Cytosol "HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341" "unprognostic (3.93e-2)" "unprognostic (2.51e-1)" "unprognostic (6.70e-2)" "prognostic unfavourable (4.24e-4)" "unprognostic (3.64e-1)" "prognostic unfavourable (8.79e-5)" "prognostic unfavourable (9.42e-6)" "unprognostic (2.28e-2)" "unprognostic (9.08e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-3)" "prognostic unfavourable (6.21e-7)" "unprognostic (5.33e-1)" "unprognostic (2.15e-1)" "unprognostic (6.21e-2)" "unprognostic (1.33e-1)" 6.5 7.5 15.9 10.9 21.4 7.6 9.9 31.7 32.3 5.7 10.1 9.4 5.6 6.5 10.0 19.9 10.2 6.9 6.8 9.2 24.5 20.4 6.5 5.9 9.6 16.0 16.3 13.4 19.2 68.0 16.7 16.7 3.2 35.9 9.2 12.7 4.4 49.9 9.3 3.5 13.6 7.8 11.3 20.6 11.0 20.8 16.9 9.2 3.6 16.7 8.2 15.0 9.6 6.6 8.6 1.4 1.5 1.2 2.2 13.2 3.2 18.8 7.2 7.3 59.3 5.8 8.2 17.9 13.9 8.9 6.7 19.9 9.3 7.6 14.8 7.0 28.3 8.6 18.9 22.0 15.9 18.5 14.0 4.7 3.6 6.9 53.7 30.2 13.3 16.1 74.0 8.7 53.8 5.4 26.5 52.6 10.4 39.9 0.8 8.0 10.0 19.7 2.3 1.3 38.8 4.3 3.7 31.9 24.0 3.6 19.3 75.0 8.2 21.2 1.4 3.3 21.8 8.7 6.5 62.4 31.1 56.4 41.2 13.8 31.7 1.5 0.3 0.5 3.8 1.2 4.9 8.6 7.4 3.4 1.4 6.2 10.2 5.5 1.5 2.2 0.8 0.1 13.2 3.2 15.9 21.4 31.7 32.3 24.5 20.4 16.3 13.4 35.9 9.2 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.6 1.1 1.3 2.2 8.8 22.5 4.2 13.9 86.6 2.7 8.4 4.9 3.2 0.0 9.4 28.6 82.0 5.7 0.5 1.9 2.0 2.6 0.0 1.8 12.7 30.7 1.7 0.1 14.8 79.7 4.4 8.0 0.1 0.4 51.7 2.7 57.6 0.6 24.3 1.8 2.5 0.1 1.5 132.8 7.6 5.8 33.4 0.5 49.5 52.2 3.9 35.8 99.5 0.0 1.1 6.9 0.2 1.2 8.6 8.2 2.9 21.8 12.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell line enhanced" "Detected in many" "BEWO: 43.4;HDLM-2: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA001562 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.6 0.4 13.4 2.8 1.3 3.4 43.4 4.8 3.9 4.1 9.9 8.9 5.0 0.1 2.2 0.3 3.7 8.0 1.3 6.8 31.7 7.7 0.5 3.9 3.1 24.6 2.8 7.5 6.0 21.6 11.5 26.9 0.8 3.1 25.3 0.6 0.8 8.5 1.8 9.6 2.8 2.5 8.9 5.7 0.5 0.9 6.0 6.1 6.2 11.2 18.8 6.5 2.0 0.8 1.2 6.4 4.0 2.1 20.0 8.4 2.2 4.0 1.5 3.5 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587746-114598373 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli 150000 Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: " "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favourable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 34.8 66.4 41.5 36.7 38.0 56.6 56.6 37.5 49.4 45.2 34.2 23.4 42.3 26.7 43.7 91.0 57.5 32.3 39.2 45.4 40.8 52.5 84.9 65.9 45.3 50.0 52.2 39.5 49.2 55.9 39.5 79.4 77.8 44.7 65.3 33.2 49.2 63.2 45.1 54.9 40.8 33.2 31.7 35.6 66.5 52.7 58.3 25.6 51.7 65.2 53.5 53.4 45.8 40.1 99.9 81.6 96.6 67.9 50.0 85.1 121.6 17.9 17.3 35.7 8.7 29.6 21.5 33.1 28.1 22.3 23.3 16.7 23.2 21.7 17.4 24.6 20.0 40.8 26.6 21.2 19.6 13.8 18.3 16.7 21.9 33.7 41.5 37.2 31.0 27.4 57.1 18.6 23.2 22.0 32.0 37.0 31.8 39.0 35.9 23.5 42.2 32.7 34.9 22.9 27.9 47.6 30.9 26.9 34.4 37.8 66.1 99.7 53.6 44.2 29.3 19.0 15.1 29.5 31.4 49.9 97.9 30.4 24.5 22.4 26.0 78.3 67.9 96.6 46.7 63.9 57.9 99.9 65.6 56.0 50.9 94.2 85.1 67.1 87.3 50.0 65.8 81.6 76.5 121.6 41.5 38.0 37.5 49.4 40.8 52.5 52.2 39.5 44.7 25.6 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: " "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.3 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.6 2.2 2.6 2.1 2.1 0.1 5.0 7.1 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.6 3.1 5.5 3.7 4.4 4.7 4.0 4.6 0.0 4.1 1.9 1.7 0.2 3.6 0.7 3.3 0.2 4.5 3.0 3.1 5.8 0.2 1.9 3.4 4.3 7.0 2.8 5.4 7.0 3.2 4.9 3.7 3.3 24.1 13.8 0.1 2.0 3.2 7.7 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 BACH1 "BACH-1, BTBD24" ENSG00000156273 "BTB domain and CNC homolog 1" O14867 21 29194071-29630751 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.7" "Group enriched" "Detected in all" 4 "granulocytes: 46.7;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034949 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034949: " "unprognostic (1.57e-1)" "unprognostic (8.08e-3)" "unprognostic (2.64e-1)" "unprognostic (2.33e-2)" "unprognostic (6.00e-2)" "unprognostic (2.99e-1)" "unprognostic (9.84e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "unprognostic (5.79e-3)" "prognostic unfavourable (3.11e-5)" "unprognostic (5.63e-2)" "prognostic unfavourable (7.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.60e-1)" "unprognostic (4.19e-2)" "unprognostic (8.70e-2)" 23.3 7.8 7.9 15.5 13.1 44.7 10.3 4.7 8.8 13.5 12.8 9.6 6.7 9.9 16.0 10.0 18.6 8.9 15.6 10.7 8.0 5.8 11.7 17.6 25.2 21.9 10.8 5.5 9.5 12.5 5.3 9.2 28.8 11.1 14.9 7.8 9.2 12.2 5.3 30.7 22.9 17.9 15.9 16.0 22.9 9.5 20.6 11.1 14.3 11.3 12.6 14.0 19.4 15.8 4.0 7.6 46.7 15.2 2.1 4.4 4.0 7.4 3.0 9.5 2.4 7.5 21.8 5.9 8.2 19.7 8.0 9.0 6.3 10.4 8.9 6.6 7.5 3.9 5.7 11.0 14.2 7.4 4.7 27.5 6.4 6.5 10.0 7.9 10.3 11.2 16.9 15.6 23.3 4.2 13.9 47.2 10.9 2.6 6.7 4.6 14.7 3.1 6.9 22.6 11.5 4.2 5.9 3.9 4.6 4.5 8.5 10.4 6.2 9.6 10.5 7.8 10.9 8.5 4.1 27.4 17.5 9.6 6.4 9.8 23.4 17.9 15.2 11.3 1.6 12.4 1.3 3.2 2.7 1.4 7.6 4.0 3.9 1.9 46.7 2.1 13.3 1.8 4.4 4.0 7.9 13.1 4.7 8.8 8.0 5.8 10.8 5.5 11.1 11.1 BCL9 ENSG00000116128 "B cell CLL/lymphoma 9" O00512 1 147541412-147626216 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020274 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA020274: " "unprognostic (2.31e-1)" "unprognostic (1.52e-2)" "unprognostic (5.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (6.74e-4)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.29e-1)" "unprognostic (4.78e-3)" "unprognostic (3.92e-2)" "unprognostic (1.64e-3)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" 4.5 7.8 10.2 5.9 9.2 3.1 4.8 22.3 12.6 18.2 9.4 8.1 10.9 5.3 23.9 15.9 6.8 18.9 5.2 8.3 8.0 7.4 9.6 4.3 5.0 4.0 5.9 8.7 17.0 6.1 14.6 10.6 4.5 6.8 10.5 7.9 11.8 8.1 13.2 7.9 7.8 5.5 15.7 5.4 3.8 7.6 6.1 6.5 22.4 7.8 8.0 6.0 9.6 8.0 0.4 0.0 0.6 0.3 0.1 2.6 1.0 3.0 2.9 20.9 15.5 2.4 2.8 4.1 2.5 3.9 2.7 2.6 3.8 4.5 2.9 5.5 2.3 2.4 13.2 4.5 2.6 6.8 3.7 1.4 3.2 2.5 2.0 0.8 4.1 2.8 3.8 3.2 2.3 4.2 2.7 4.7 2.4 6.8 7.1 0.7 24.6 6.5 7.6 5.2 5.5 10.6 3.4 5.7 12.3 2.8 5.1 4.8 6.5 1.4 3.0 1.9 9.1 5.4 3.9 21.1 5.3 5.4 4.8 0.8 9.2 0.0 0.3 0.6 1.0 0.0 0.9 0.2 1.2 1.2 0.0 0.4 2.6 1.6 0.2 0.1 0.1 0.0 0.9 1.0 10.2 9.2 22.3 12.6 8.0 7.4 5.9 8.7 6.8 6.5 BFSP1 "CP115, CP94, filensin, LIFL-H" ENSG00000125864 "Beaded filament structural protein 1" Q12934 20 17493905-17569220 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.3;SK-BR-3: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.1" "Group enriched" "Detected in many" 5 "NK-cells: 1.5;T-cells: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040748, HPA042038" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA040748: AB_10963786, HPA042038: AB_10964054" "unprognostic (2.24e-3)" "unprognostic (1.99e-1)" "unprognostic (1.63e-1)" "prognostic favourable (1.39e-4)" "unprognostic (1.07e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-6)" "unprognostic (5.11e-2)" "unprognostic (5.53e-1)" "unprognostic (2.10e-4)" "unprognostic (1.75e-1)" "unprognostic (8.81e-2)" "unprognostic (3.35e-4)" "unprognostic (4.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.78e-2)" "unprognostic (7.50e-2)" 2.5 1.8 3.5 2.5 5.6 0.8 2.6 2.8 4.4 3.5 1.8 0.9 5.5 0.8 10.7 5.4 5.1 2.2 4.8 2.4 3.2 3.7 6.1 1.1 4.1 0.6 3.3 1.7 5.3 2.7 4.8 1.3 4.5 3.0 3.3 1.2 2.3 2.0 4.0 3.0 1.8 0.9 2.7 6.9 0.8 1.1 8.0 0.7 0.6 5.3 2.3 1.5 5.1 1.1 0.0 0.0 0.7 0.0 1.5 6.1 0.5 0.7 7.5 2.4 0.3 0.6 2.5 0.4 1.9 8.7 1.2 1.2 3.3 6.4 0.0 1.5 1.0 1.1 2.6 1.5 1.0 1.6 2.0 0.5 1.1 1.0 1.4 0.4 0.8 3.0 4.6 0.7 2.1 5.2 0.2 0.4 3.9 1.4 0.0 1.0 5.7 2.1 0.0 1.7 0.4 18.3 1.3 2.5 0.3 2.2 9.9 3.8 4.8 1.6 5.9 0.3 0.6 0.6 1.8 0.0 0.1 0.0 1.3 0.0 1.5 0.1 0.0 0.0 6.1 0.0 0.2 0.0 1.7 1.0 0.0 0.0 0.1 0.5 0.7 1.5 0.0 0.0 0.0 0.5 3.5 5.6 2.8 4.4 3.2 3.7 3.3 1.7 3.0 0.7 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.1;pancreas: 54.1" "Cell line enhanced" "Detected in some" "A-431: 6.3;BEWO: 11.3;CAPAN-2: 10.4;HaCaT: 16.2;MCF7: 15.7;RT4: 7.4;SK-BR-3: 8.1;T-47d: 10.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "eosinophil: 2.6;neutrophil: 3.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favourable (9.04e-4)" 0.4 0.0 0.4 2.5 0.4 0.0 2.9 0.4 0.4 6.2 7.9 0.4 8.3 5.7 1.0 2.0 31.1 2.2 11.0 0.4 0.4 0.0 1.2 0.4 5.3 0.4 0.4 0.4 0.9 54.1 3.6 0.9 0.5 0.4 5.1 3.5 0.4 13.9 8.3 1.1 13.7 6.9 1.0 0.4 0.4 10.2 0.5 0.4 0.4 2.3 8.6 12.4 6.1 12.0 0.1 0.1 3.5 0.0 0.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.8 10.4 0.0 0.0 0.0 16.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 7.4 0.1 0.0 0.0 8.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.1 16.1 15.6 10.8 10.7 11.5 7.5 9.5 5.9 15.0 13.0 23.6 3.0 30.3 17.0 7.6 7.1 33.7 13.0 12.7 8.0 26.5 18.6 14.5 20.0 15.6 33.8 11.5 13.5 0.9 11.7 6.8 22.0 39.6 12.4 6.2 7.7 41.8 24.7 14.9 7.5 36.3 40.5 20.0 12.0 9.1 36.0 12.9 8.4 16.4 10.3 11.2 17.5 14.0 9.3 18.7 4.1 16.8 15.0 30.8 40.9 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favourable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.3 19.7 4.9 16.4 25.2 21.1 12.9 3.4 23.4 4.2 11.5 24.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.2 4.0 6.7 18.1 15.2 15.2 16.9 15.7 6.6 10.6 38.1 9.3 5.2 9.6 5.7 46.4 7.8 6.5 11.8 11.1 4.0 3.9 6.1 6.3 8.4 15.9 10.9 3.8 16.9 33.7 16.5 45.7 8.3 7.1 3.1 3.5 19.9 3.0 26.2 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Cell line enhanced" "Detected in some" "ASC diff: 11.3;fHDF/TERT166: 7.5;HEK 293: 7.8;NTERA-2: 4.8;SK-BR-3: 6.7;U-2 OS: 6.6" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favourable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.8 1.8 11.3 0.2 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.1 0.9 7.5 2.9 2.4 0.0 0.0 0.0 7.8 0.4 0.0 0.0 0.8 0.0 0.2 0.8 0.1 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.7 0.7 3.1 0.2 0.1 1.8 6.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.8 10.4 14.5 8.8 10.7 9.2 14.1 13.0 11.3 18.5 17.6 9.9 8.2 18.8 9.3 6.6 9.9 20.1 7.5 21.7 6.8 13.7 17.3 11.0 11.5 9.3 18.1 10.2 7.1 9.4 12.3 10.2 15.8 18.6 11.3 12.3 5.6 21.0 8.6 11.5 11.3 12.7 39.9 9.6 9.6 7.5 17.8 16.0 6.9 12.7 15.1 13.9 11.5 8.6 19.4 17.9 6.2 12.3 12.8 15.2 18.1 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell line enhanced" "Detected in all" "HMC-1: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favourable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.3 2.5 3.5 7.1 4.5 1.9 2.2 5.1 4.5 5.1 4.3 4.0 3.5 5.1 13.4 3.5 7.6 4.3 2.2 2.0 8.0 3.6 20.0 3.2 2.9 6.0 5.7 29.2 2.2 4.5 9.5 3.5 3.2 8.3 9.1 4.7 8.9 6.4 13.8 1.3 6.8 4.1 3.1 5.8 5.0 2.1 10.7 6.1 2.1 11.5 3.2 20.2 7.7 3.8 4.7 1.6 5.6 8.9 4.0 2.4 2.0 2.9 9.9 5.2 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 22.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.2;SiHa: 4.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Uncertain "Nuclear bodies" "Nuclear bodies" "HPA052136: , HPA056962: " "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 1.0 0.5 0.1 0.4 0.5 0.2 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.6 22.3 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.0 0.3 0.3 1.0 0.0 0.6 0.1 1.5 1.6 2.3 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 2.1 0.8 2.0 0.0 0.5 0.0 0.0 0.0 1.4 0.4 3.0 1.2 1.5 0.0 1.7 1.3 0.0 0.0 0.2 0.0 0.2 1.2 2.1 0.1 0.3 0.0 0.8 0.4 0.0 1.2 1.3 0.5 0.0 1.5 6.2 1.1 4.4 1.1 0.6 1.0 1.1 2.7 1.4 2.0 0.9 1.0 0.4 0.0 1.9 0.5 0.3 2.0 0.0 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 40.6" "Cell line enhanced" "Detected in many" "SK-MEL-30: 42.2;U-266/70: 61.0" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 4.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nucleoplasm, Nuclear bodies" "HPA073649: " "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favourable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 12.0 2.9 22.3 1.6 31.5 1.8 40.6 8.6 23.4 4.7 4.1 3.0 0.0 6.0 7.7 2.7 5.6 9.2 4.2 3.2 13.9 11.9 10.8 8.0 17.0 2.0 17.2 12.9 3.3 2.0 31.3 2.6 8.4 13.6 2.8 4.2 17.1 17.0 3.9 1.1 13.5 5.1 5.7 3.8 2.6 11.6 2.8 9.2 0.3 12.2 0.2 1.8 5.4 7.1 0.3 0.5 0.0 0.2 4.2 0.4 0.0 3.5 3.9 3.3 0.2 2.0 0.1 5.7 0.8 4.8 1.1 0.7 2.6 6.3 0.1 3.7 4.0 3.1 2.5 0.6 0.9 0.1 5.4 0.2 10.8 10.0 1.7 0.6 0.2 1.2 0.5 1.4 1.7 13.1 0.1 4.5 3.2 8.1 0.0 2.3 2.1 13.0 0.8 11.8 13.4 5.9 8.6 3.1 2.3 7.2 9.1 42.2 14.6 1.9 21.8 13.6 0.1 0.4 1.0 61.0 23.2 7.4 0.0 5.2 4.6 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.3 0.3 0.0 0.4 0.0 4.2 0.2 0.5 0.1 0.0 22.3 31.5 8.6 23.4 13.9 11.9 17.2 12.9 13.6 9.2 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.6;NTERA-2: 29.6;U-2197: 15.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.9 21.6 3.2 8.6 3.0 0.0 3.0 4.0 5.1 4.9 12.5 0.1 0.0 8.9 4.9 1.6 12.0 2.5 5.2 2.3 6.5 4.5 1.3 0.0 0.0 1.9 0.0 2.6 1.8 0.6 3.3 2.8 0.0 0.0 0.0 0.3 0.3 0.0 29.6 2.2 2.3 2.2 0.0 0.0 0.6 0.5 11.3 6.6 0.0 2.6 0.8 0.3 1.9 0.5 3.8 15.2 2.7 0.0 0.0 0.0 0.4 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;TIME: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022996, HPA047220, HPA047851" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: , HPA047851: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.5 3.8 0.9 2.4 3.4 10.9 0.4 0.2 0.0 0.2 0.2 4.8 0.1 0.5 3.3 6.7 5.9 4.9 0.3 0.3 3.4 0.3 0.5 0.5 0.3 0.2 0.7 3.1 2.0 0.1 2.3 0.2 0.1 0.5 0.3 2.2 0.2 0.1 1.2 0.8 0.4 1.5 0.2 0.1 0.1 4.6 1.2 1.3 0.7 0.2 1.4 4.0 0.2 9.3 0.8 0.5 5.2 1.5 6.6 6.8 0.2 0.4 6.8 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047777, HPA051965" Approved Approved "Nucleoli,Intermediate filaments,Mitochondria" Mitochondria "Nucleoli, Intermediate filaments" "HPA047777: AB_2680152, HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favourable (7.29e-4)" 9.5 13.3 8.7 6.8 8.1 7.1 9.2 6.9 12.6 8.2 13.3 7.1 12.4 10.6 7.3 12.4 14.0 5.8 7.7 12.4 7.2 7.0 21.9 23.3 5.4 10.0 8.6 5.3 8.8 9.3 3.1 7.7 6.7 8.5 8.2 14.4 6.5 7.2 6.9 35.2 6.9 10.2 6.3 7.2 8.6 9.1 8.7 9.3 5.5 8.8 24.5 9.6 8.7 7.1 13.9 18.3 1.7 10.2 11.4 16.1 4.6 34.5 11.0 21.0 13.4 7.8 11.0 27.0 13.3 14.4 32.2 31.8 30.9 17.6 25.4 23.0 10.1 24.2 34.0 22.7 38.7 8.7 12.0 29.9 7.8 37.4 13.1 44.4 10.7 9.0 11.8 19.7 21.7 14.8 33.8 11.1 16.9 17.2 28.3 31.8 40.2 20.8 18.8 24.9 31.2 22.2 18.4 21.2 10.4 15.4 16.4 36.9 16.3 29.3 8.5 18.1 23.2 7.6 26.4 8.8 11.7 54.8 20.6 21.6 15.9 0.4 5.0 1.7 10.2 10.2 12.0 13.9 13.6 13.4 10.3 13.5 16.1 14.9 0.9 11.4 8.5 18.3 10.5 4.6 8.7 8.1 6.9 12.6 7.2 7.0 8.6 5.3 8.5 9.3 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavourable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavourable (9.17e-5)" "prognostic unfavourable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavourable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.1 9.9 27.3 11.6 1.4 3.8 22.3 26.6 11.7 35.5 26.4 21.6 23.7 35.1 7.2 14.0 12.9 34.3 15.7 29.2 16.8 15.8 28.2 13.2 21.0 0.3 42.4 20.0 0.9 1.2 14.6 8.8 21.2 40.0 35.3 28.1 13.7 54.0 24.6 21.5 11.1 24.8 52.8 17.1 10.0 7.6 11.6 12.3 14.0 17.1 7.4 14.3 18.0 12.4 16.6 25.2 17.5 25.4 22.4 23.7 40.2 9.5 43.2 18.4 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell line enriched" "Detected in some" 6 "MOLT-4: 23.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: " "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favourable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 23.7 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 1.7 3.6 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.7;Karpas-707: 72.4;U-266/84: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 52.9;neutrophil: 59.9" "Group enriched" "Detected in all" 7 "granulocytes: 59.9;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: , HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavourable (5.07e-4)" "prognostic unfavourable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 22.4 20.3 21.1 11.2 34.8 29.5 20.2 27.6 27.7 32.1 16.0 9.9 28.2 11.9 16.0 19.4 12.7 11.7 26.6 29.7 21.2 26.1 27.5 56.2 23.3 19.8 21.8 18.5 17.4 41.6 37.7 56.3 13.4 21.7 21.0 16.5 13.5 33.1 27.4 44.2 7.8 16.9 16.7 23.2 19.5 22.2 13.8 19.7 5.2 41.9 12.9 11.3 20.0 16.7 3.7 5.5 59.9 15.4 4.9 5.6 5.6 2.8 10.4 2.3 5.2 38.3 13.0 3.3 6.2 11.9 3.7 5.7 3.0 5.0 4.3 21.5 20.6 3.9 2.0 5.3 3.1 11.4 3.1 5.8 13.2 2.7 49.7 8.0 18.1 10.9 12.8 7.8 7.6 13.6 9.7 72.4 11.7 3.9 0.0 4.0 1.4 2.7 1.3 3.7 17.2 7.8 2.1 3.0 4.6 7.4 4.1 31.6 6.6 17.7 13.7 11.0 2.4 8.3 4.2 14.0 51.1 2.7 20.7 16.1 8.7 34.6 11.5 52.9 5.6 10.1 4.8 3.7 3.6 4.3 5.5 2.8 3.1 4.3 59.9 4.9 15.4 0.9 4.4 5.6 21.1 34.8 27.6 27.7 21.2 26.1 21.8 18.5 21.7 19.7 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: , HPA055288: " "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavourable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 51.7 25.3 35.3 23.0 1.2 3.1 33.9 24.0 21.6 70.1 37.4 39.6 43.2 30.0 14.1 22.0 36.5 38.6 45.8 58.5 23.5 28.5 43.9 25.0 24.5 0.3 30.6 16.0 1.0 2.1 48.6 44.1 29.7 19.8 20.6 31.7 20.0 29.4 18.8 44.7 34.1 42.8 48.5 19.0 17.1 13.8 20.9 10.3 42.5 28.7 13.3 20.1 38.8 15.4 21.0 49.2 23.3 74.5 15.9 14.0 31.1 15.0 38.2 31.2 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: , HPA065070: " "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.0 17.3 21.0 14.9 1.1 2.3 19.1 27.3 8.2 23.9 29.0 19.6 11.2 20.2 17.1 5.8 36.4 18.1 12.4 23.8 10.7 14.2 16.4 20.7 17.6 0.7 22.4 10.1 0.5 0.9 27.7 16.7 7.2 29.9 19.0 11.6 13.1 32.5 5.4 17.2 6.4 24.0 51.0 19.1 4.0 28.2 14.4 12.9 24.8 85.2 8.4 17.3 19.4 6.0 17.3 24.7 28.3 32.3 7.9 17.2 39.0 15.0 14.8 18.9 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favourable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavourable (1.10e-6)" "prognostic unfavourable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.2 18.4 48.9 19.3 3.2 4.9 20.1 36.5 26.6 44.5 42.9 43.0 42.7 44.2 14.2 10.0 30.0 33.2 21.2 46.4 31.4 24.2 23.2 18.1 24.9 0.5 35.5 24.0 0.9 2.1 28.8 28.1 26.7 35.3 54.5 49.5 12.8 44.6 25.5 21.5 38.7 38.8 45.5 21.7 17.0 16.0 22.9 20.1 24.5 37.3 18.9 40.2 21.8 11.0 19.0 40.6 20.0 49.8 21.4 34.3 39.9 16.4 39.8 23.6 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400560 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 43.7;TIME: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 16.3 9.1 20.6 13.9 47.0 31.5 14.7 17.8 35.7 11.8 12.9 23.6 3.4 9.2 20.7 7.5 11.7 10.9 12.9 9.4 25.3 17.3 9.2 12.4 15.9 15.2 23.8 21.0 12.9 8.0 9.9 7.3 24.3 14.8 11.4 9.8 5.7 7.5 9.3 7.3 9.1 9.3 23.4 19.6 15.8 7.9 19.9 28.0 29.6 9.4 6.1 16.6 11.0 10.7 9.6 5.3 29.1 4.7 16.5 14.8 8.6 4.8 4.1 10.8 2.9 5.3 14.0 7.7 10.9 15.4 9.6 9.1 2.4 2.8 7.2 7.6 7.9 4.4 6.4 6.7 13.2 7.6 4.9 10.4 2.8 3.4 11.5 5.5 6.0 10.2 7.0 14.2 25.7 43.7 7.6 5.9 21.7 3.0 5.2 8.7 4.7 7.2 9.1 5.8 6.2 11.4 4.1 5.6 3.8 6.4 6.0 7.9 4.6 5.0 52.4 8.6 3.3 4.6 5.9 8.3 6.3 7.8 3.2 2.4 6.3 29.1 3.4 8.9 12.7 4.7 13.7 9.6 10.4 14.4 5.3 8.8 14.8 12.6 12.8 16.5 4.6 3.9 8.1 8.6 20.6 47.0 17.8 24.6 25.3 17.3 23.8 21.0 14.8 28.0 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687339 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 97.4;HSkMC: 71.6;hTCEpi: 92.6;LHCN-M2: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 21.0;non-classical monocyte: 27.7" "Group enriched" "Detected in many" 8 "B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: " "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favourable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favourable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 81.2 27.0 8.2 21.9 29.8 22.0 38.0 4.8 13.7 25.2 60.8 13.9 10.2 39.8 17.5 17.7 63.5 49.4 47.3 35.9 22.2 8.4 29.1 102.2 55.8 6.3 16.6 4.9 59.1 45.5 12.8 22.8 38.6 44.1 42.0 40.7 8.8 18.0 11.4 98.6 43.5 144.9 40.2 29.6 13.6 25.2 25.3 10.3 6.6 22.7 42.2 27.4 50.5 44.4 8.8 8.5 1.8 27.7 0.2 1.1 13.3 3.0 12.4 9.6 0.2 33.8 60.5 17.6 50.3 40.8 6.2 24.5 1.1 2.9 2.0 1.8 31.5 6.9 0.4 55.5 10.1 4.0 2.5 0.3 10.3 15.4 97.4 0.0 15.1 71.6 92.6 57.1 18.0 32.4 0.5 14.2 72.2 6.4 0.4 1.2 1.2 1.8 6.1 7.9 3.5 11.0 23.1 4.3 4.2 11.6 1.0 2.3 3.8 12.6 17.9 10.9 10.3 0.7 4.1 23.9 4.6 6.1 14.1 1.1 30.3 0.0 9.3 0.2 0.2 21.0 0.3 8.8 0.4 0.3 8.0 5.7 0.1 0.1 1.8 0.2 27.7 8.5 1.1 13.3 8.2 29.8 4.8 13.7 22.2 8.4 16.6 4.9 44.1 10.3 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: , HPA076524: " "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavourable (2.43e-4)" "prognostic favourable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favourable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.1 30.4 17.8 23.6 21.7 18.2 9.5 14.2 19.1 12.1 12.9 5.9 10.3 34.3 10.8 20.9 16.5 33.4 15.0 15.2 17.4 19.4 16.6 39.4 0.7 11.6 4.7 32.7 24.0 8.0 16.2 10.9 22.3 11.1 0.5 11.2 12.0 13.1 5.5 2.8 11.2 38.4 21.7 5.2 12.0 29.7 12.1 16.4 35.3 13.8 6.9 15.8 7.8 27.9 26.2 20.6 6.3 20.4 2.5 0.4 19.4 13.3 13.5 22.3 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3;lymphoid tissue: 49.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008410, HPA027821" Enhanced Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavourable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavourable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 4.6 9.2 7.1 12.1 12.2 42.3 4.4 16.4 9.9 4.3 6.7 1.9 2.3 9.0 4.2 5.2 14.7 3.0 4.1 5.3 5.8 7.8 5.0 3.2 5.0 13.5 5.9 5.8 3.5 2.4 3.4 10.9 10.2 16.1 4.6 7.4 1.4 6.7 3.6 5.8 10.4 7.0 6.5 5.5 12.4 4.2 22.1 5.2 49.2 5.0 10.3 14.8 8.1 6.6 15.2 16.1 30.4 12.8 2.5 15.7 4.2 19.2 10.4 41.8 20.6 5.4 5.4 10.5 31.7 18.7 37.0 23.9 15.0 24.4 36.9 5.1 23.6 22.6 28.8 16.1 51.7 25.0 23.7 33.3 11.7 10.6 2.3 33.1 13.6 3.9 6.7 17.3 22.8 22.4 14.0 15.3 40.8 9.0 22.7 16.3 24.7 11.0 21.9 23.9 16.1 11.3 10.5 12.8 16.7 17.9 13.2 9.8 14.5 15.9 14.7 10.7 16.6 16.7 31.7 9.0 13.3 45.6 7.5 17.3 28.2 30.4 7.2 10.4 5.4 10.4 4.8 12.2 8.2 6.4 7.5 15.2 6.5 5.5 2.2 2.5 12.8 16.1 15.7 4.2 7.1 12.2 16.4 9.9 5.8 7.8 5.9 5.8 16.1 5.2 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637805 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Cytosol" Microtubules "CAB017840: , HPA031707: , HPA031708: , HPA032045: " "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 22.6 44.7 43.0 31.3 37.3 27.8 36.4 24.5 45.6 30.0 31.9 41.8 26.2 22.1 29.3 47.4 41.5 34.5 29.9 33.2 37.2 39.5 26.8 90.9 20.8 41.2 45.3 31.2 49.2 44.9 26.5 28.9 29.0 38.5 28.7 35.7 29.6 28.2 27.4 43.1 24.4 26.3 26.1 48.5 32.5 28.5 21.7 31.7 47.0 40.5 36.8 45.1 31.9 28.8 33.4 45.9 12.8 34.1 31.8 32.7 30.6 24.4 24.1 40.3 29.9 30.2 43.4 16.3 21.6 33.4 35.3 31.9 58.9 35.1 55.3 36.0 26.3 29.8 48.7 44.9 43.3 30.9 29.7 54.3 30.4 33.9 25.4 80.2 25.2 34.8 52.5 31.1 59.1 40.0 71.2 17.1 34.6 36.4 52.7 65.4 38.0 45.3 28.5 78.4 59.3 25.5 34.4 41.1 46.8 29.1 33.1 20.0 44.9 35.1 26.3 26.4 32.3 51.4 20.8 34.4 47.9 59.3 10.4 30.2 21.1 12.8 33.1 12.2 21.0 34.1 24.0 32.1 26.8 23.1 45.9 33.4 32.7 27.5 2.3 31.8 28.7 28.2 23.0 30.6 43.0 37.3 24.5 45.6 37.2 39.5 45.3 31.2 38.5 31.7 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Cell line enhanced" "Detected in many" "Karpas-707: 15.8;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059056 Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA059056: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favourable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favourable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.1 0.3 0.4 2.6 0.7 0.7 1.1 1.1 0.8 1.6 1.3 0.8 2.6 1.4 1.3 0.5 3.3 1.1 0.9 0.9 1.6 1.4 1.8 1.8 0.9 2.0 0.9 1.9 0.6 2.0 1.0 3.1 1.5 1.3 15.8 0.6 0.9 1.2 1.0 0.2 1.2 1.5 2.3 2.7 1.6 0.5 2.0 0.6 1.0 3.0 1.9 3.8 2.0 1.2 0.8 0.8 0.6 1.0 8.8 2.3 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.1;LHCN-M2: 7.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: " "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.6 1.7 0.0 0.4 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.6 0.9 0.7 1.0 1.7 0.0 1.5 2.6 2.2 2.2 3.5 4.6 0.8 0.3 0.0 3.7 1.1 0.3 1.5 7.1 1.7 1.3 1.5 7.9 0.4 1.9 2.7 1.7 1.3 0.0 4.0 0.6 1.3 1.3 1.8 0.7 0.8 0.4 1.1 1.3 1.9 3.5 0.0 2.4 0.9 0.0 1.9 1.4 3.1 1.2 5.8 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909541 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11.8;testis: 34.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042923 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA042923: " "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavourable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavourable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavourable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 1.1 1.2 1.4 5.9 2.0 1.8 3.0 1.9 1.9 1.4 2.1 0.0 0.6 1.2 1.2 1.4 1.7 1.1 1.5 1.0 1.5 1.4 1.2 1.1 2.4 5.0 1.3 1.0 3.4 1.3 1.2 1.8 1.4 0.8 1.2 1.2 0.0 1.2 1.1 1.9 1.3 1.5 0.9 1.2 4.6 1.1 34.2 0.7 11.8 1.4 1.9 2.7 1.6 1.1 1.3 0.9 4.0 0.4 0.9 1.6 0.5 1.3 1.4 2.9 3.8 0.7 0.6 0.9 1.4 0.3 1.5 2.9 2.2 0.9 3.1 1.1 0.8 1.3 3.0 0.8 1.6 2.2 2.0 1.9 1.7 0.5 0.2 2.4 1.6 0.7 0.8 1.7 1.6 1.3 1.7 6.4 2.0 2.3 4.1 2.9 3.0 2.8 1.1 4.6 3.6 1.2 0.2 4.3 2.8 1.9 3.2 1.5 1.3 2.5 0.5 1.8 2.1 4.6 3.0 3.7 7.6 3.0 1.2 4.3 3.8 4.0 0.4 0.4 1.2 0.3 0.3 0.8 1.1 0.6 0.2 1.3 1.1 1.3 1.1 0.9 0.4 0.9 1.6 0.5 1.4 2.0 1.9 1.9 1.5 1.4 1.3 1.0 0.8 0.7 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262531 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favourable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavourable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 26.6 28.7 26.3 21.6 29.5 21.2 26.4 37.6 38.3 22.2 28.0 39.6 31.6 25.0 28.7 38.2 24.6 27.6 29.0 35.8 25.9 20.0 25.6 42.2 23.0 25.5 30.1 29.2 29.8 34.6 45.3 33.1 21.5 31.7 23.8 19.0 29.3 29.0 44.9 86.4 28.8 26.1 26.8 23.8 28.6 28.6 20.8 32.5 25.7 36.9 27.2 22.7 28.0 21.6 26.6 17.8 22.4 21.6 24.9 26.6 14.4 16.8 21.2 24.0 21.6 30.2 22.9 20.9 20.0 28.4 16.8 15.1 22.2 29.3 18.6 37.7 22.7 20.9 11.6 18.9 10.6 42.7 22.8 20.7 29.6 17.5 24.6 17.4 26.6 27.1 20.0 15.0 21.8 25.9 18.7 34.4 15.5 16.0 22.3 17.3 17.2 21.1 21.9 14.2 36.5 19.3 30.1 16.3 15.7 33.6 37.6 22.5 35.3 26.3 31.1 20.7 10.7 12.7 18.5 56.6 38.6 30.4 23.1 16.3 16.9 22.4 17.5 18.1 26.6 16.9 26.1 23.7 23.6 25.0 14.8 26.6 26.2 23.8 19.9 24.9 21.6 17.8 24.3 14.4 26.3 29.5 37.6 38.3 25.9 20.0 30.1 29.2 31.7 32.5 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: " "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.4 50.5 47.2 25.9 55.6 47.2 28.8 33.1 46.6 34.0 27.4 51.9 30.6 0.5 23.7 37.1 30.7 57.7 46.6 56.7 26.9 45.0 28.9 50.3 31.2 28.9 54.1 52.0 34.1 33.1 57.3 55.4 53.3 53.0 28.6 31.6 34.4 34.1 16.9 45.4 20.4 40.0 50.3 37.0 32.0 61.2 32.3 48.9 75.0 38.5 39.7 34.6 36.8 48.1 35.1 37.6 37.5 39.3 33.4 39.6 44.9 35.4 32.8 33.2 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 DDX3Y DBY ENSG00000067048 "DEAD-box helicase 3, Y-linked" O15523 Y 12904108-12920478 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 40.6;HEL: 41.4;U-266/84: 34.4;U-698: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059583" Enhanced Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: " "unprognostic (3.89e-2)" "unprognostic (1.70e-1)" "prognostic favourable (4.70e-5)" "unprognostic (6.50e-2)" "unprognostic (4.74e-2)" "unprognostic (2.22e-2)" "unprognostic (4.17e-2)" "unprognostic (3.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (7.87e-2)" 12.0 10.5 4.9 29.5 14.1 46.1 8.7 17.0 16.3 0.4 24.4 12.6 31.5 7.6 0.4 29.7 12.2 0.4 14.2 10.8 5.6 7.1 8.9 26.5 20.0 17.7 5.7 0.0 0.4 14.5 0.4 12.2 14.0 20.2 26.7 15.8 15.1 20.4 32.6 17.7 8.4 16.0 40.7 6.2 34.3 8.9 41.9 0.0 26.9 10.8 21.4 19.3 14.4 0.0 6.1 8.8 6.5 7.1 6.5 8.4 3.8 0.1 7.5 0.0 0.0 0.0 0.0 5.5 18.6 13.3 9.8 12.1 0.0 0.0 40.6 0.0 18.3 0.0 0.0 0.0 17.3 10.2 0.0 41.4 0.0 12.2 9.7 0.0 0.0 10.3 11.6 0.0 0.0 0.0 0.0 0.0 11.6 0.0 16.0 0.0 7.4 0.0 0.0 4.9 7.4 10.5 11.2 12.2 0.0 0.0 0.0 13.6 0.0 9.7 13.3 15.3 0.0 0.0 12.2 21.9 34.4 30.2 1.8 0.0 0.0 1.6 6.2 5.7 8.4 7.1 7.7 6.1 6.4 7.1 8.8 5.9 7.8 6.5 6.5 6.5 4.6 2.5 5.7 3.8 4.9 14.1 17.0 16.3 5.6 7.1 5.7 0.0 20.2 0.0 DDX60 FLJ20035 ENSG00000137628 "DExD/H-box helicase 60" Q8IY21 4 168216293-168318807 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 22.5;BJ hTERT+ SV40 Large T+ RasG12V: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA046952 Approved Supported "Intermediate filaments,Cytosol" Cytosol "Intermediate filaments" "HPA046952: AB_10963572" "unprognostic (4.05e-2)" "unprognostic (2.87e-1)" "unprognostic (7.22e-3)" "unprognostic (7.71e-2)" "unprognostic (2.30e-1)" "unprognostic (2.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.15e-2)" "unprognostic (3.06e-1)" "unprognostic (8.69e-3)" "prognostic unfavourable (3.35e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (2.48e-1)" "unprognostic (3.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.44e-1)" 18.0 8.3 4.1 18.5 5.0 4.4 9.0 1.3 3.8 11.4 14.8 4.3 5.1 8.8 10.8 15.2 10.7 8.1 11.5 8.5 3.7 3.5 10.0 8.8 21.6 18.7 4.2 3.2 20.3 5.5 8.8 6.7 25.5 5.6 11.6 14.3 9.0 15.6 6.2 5.6 7.9 16.7 11.2 6.1 18.9 29.2 5.7 3.9 23.2 14.5 6.0 9.3 8.2 7.2 4.1 2.5 3.2 6.3 7.6 10.0 3.5 5.5 1.2 2.8 1.1 2.1 7.7 3.1 1.8 13.5 22.5 21.8 0.0 12.2 0.0 1.1 3.0 4.6 0.3 4.5 6.5 4.3 0.5 8.7 4.8 0.0 10.1 3.2 2.2 6.9 1.9 5.7 1.3 8.4 0.0 1.6 2.8 0.3 4.9 2.4 0.5 1.6 3.3 1.4 0.1 6.6 3.4 0.6 0.6 3.5 0.9 13.6 0.9 4.1 5.6 1.4 1.4 0.5 1.4 1.0 0.2 0.0 4.3 3.8 3.9 3.2 2.8 2.6 8.5 5.1 10.0 4.1 6.7 8.0 2.5 3.3 6.8 8.5 2.8 7.6 6.3 0.2 5.5 3.5 4.1 5.0 1.3 3.8 3.7 3.5 4.2 3.2 5.6 3.9 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavourable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favourable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favourable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.3 5.9 17.4 19.7 12.2 19.9 3.7 9.1 15.7 5.9 9.3 2.3 10.3 7.9 7.2 10.9 7.8 6.4 9.2 9.9 11.9 0.7 19.0 5.3 9.4 15.3 4.1 3.9 15.7 7.1 4.7 8.0 17.7 19.7 15.7 28.5 11.9 11.8 6.1 1.1 17.8 10.0 4.6 14.1 29.2 26.0 0.7 6.6 13.8 129.9 10.9 16.6 10.7 15.9 10.1 4.8 13.3 5.4 7.9 6.0 9.3 9.6 9.4 12.8 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.0;CAPAN-2: 59.3;SK-BR-3: 31.8;WM-115: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favourable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 5.1 29.0 0.0 12.8 16.8 1.4 3.3 1.7 0.0 0.0 0.1 3.4 59.3 0.0 1.4 17.0 23.4 6.2 3.2 0.0 0.0 10.4 4.5 3.0 16.1 2.5 0.0 0.0 8.5 3.9 0.1 0.1 5.4 6.8 0.0 0.1 0.9 1.2 0.2 1.9 11.7 0.1 0.0 5.9 0.0 9.9 0.3 0.5 9.8 31.8 1.8 3.1 1.2 3.9 0.1 0.6 8.9 0.1 0.9 0.0 0.0 6.7 0.4 55.1 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031121 Approved Approved Nucleoplasm,Mitochondria 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803" "prognostic favourable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favourable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 51.8 15.7 9.1 19.9 47.0 18.4 11.5 16.7 43.2 6.1 13.6 8.6 35.1 5.4 10.1 15.6 22.4 11.8 23.6 8.9 37.7 11.0 13.3 7.7 14.2 24.7 15.8 0.4 13.6 28.3 9.7 32.8 11.7 4.0 11.7 15.3 15.6 9.2 15.1 4.3 15.9 9.5 12.2 6.3 27.3 17.7 19.5 24.4 17.0 25.7 37.1 18.0 7.0 8.2 30.5 10.3 8.3 9.6 4.2 1.9 9.6 16.6 15.3 20.8 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.52e-6)" "prognostic unfavourable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavourable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.0 14.7 38.8 17.4 0.9 3.9 12.0 21.5 14.2 31.9 30.4 12.0 20.5 21.6 11.9 12.5 23.1 24.8 17.3 41.9 25.9 12.2 22.1 13.8 10.3 0.1 21.6 13.6 0.7 0.6 14.9 7.2 35.1 17.9 21.6 29.6 17.8 27.3 11.1 20.0 15.4 21.3 37.5 9.9 10.4 12.1 19.8 11.1 22.9 8.6 8.5 19.3 8.1 13.6 14.3 37.4 13.8 24.7 5.3 11.5 28.6 10.0 15.4 22.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" 19 55158661-55166722 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 12 "fallopian tube: 29.7;testis: 60.1" "Cell line enhanced" "Detected in many" "HEK 293: 16.9;HEL: 19.7;K-562: 15.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA056220 Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA056220: " "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavourable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.2 1.0 0.7 0.1 1.7 0.0 0.4 0.1 0.5 1.9 0.3 2.5 1.8 0.0 0.9 3.8 0.3 29.7 0.6 2.9 1.2 1.5 2.5 1.7 3.3 0.1 0.5 0.1 3.1 0.8 1.0 0.3 0.1 2.7 0.2 0.0 0.4 0.8 0.6 0.2 0.3 0.1 0.1 0.2 0.2 0.2 60.1 0.8 0.2 1.5 0.1 0.4 0.1 0.1 0.0 0.9 0.5 0.4 0.0 0.0 1.6 5.4 4.5 0.4 4.4 0.0 0.0 0.5 0.1 0.0 0.6 0.5 0.2 2.6 6.6 1.6 0.2 6.5 0.9 1.9 0.2 0.0 16.9 19.7 0.2 0.3 0.1 8.4 2.0 0.1 2.7 1.1 1.4 0.3 15.4 9.0 0.2 3.5 0.2 0.2 0.3 9.8 10.2 0.6 2.0 3.4 0.1 0.6 1.7 0.7 0.7 1.0 5.5 0.3 0.6 0.5 2.6 2.5 0.1 0.2 1.5 0.3 3.1 11.2 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.7 1.7 0.1 0.5 1.2 1.5 0.5 0.1 2.7 0.8 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Enhanced Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA066767: , HPA068706: " "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favourable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favourable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.1 6.8 10.0 20.1 10.6 9.2 10.7 17.4 13.2 9.8 15.0 8.1 2.8 5.7 15.5 36.4 9.2 13.4 6.8 4.7 8.1 3.5 13.1 10.8 20.3 3.8 6.3 14.6 12.4 14.2 7.8 12.8 8.5 4.5 14.2 25.2 3.1 3.2 8.7 11.9 3.1 9.0 11.1 11.8 7.7 6.2 7.0 14.2 11.7 6.3 20.5 5.0 10.6 11.9 4.3 14.9 8.8 4.3 10.7 2.8 11.2 3.5 9.0 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favourable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavourable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 16.8 24.1 8.2 8.1 15.3 16.3 15.7 11.9 11.8 19.3 18.0 25.5 10.1 16.3 15.5 13.7 17.8 13.5 16.5 13.1 14.4 36.9 7.1 12.8 14.2 16.6 6.5 11.4 18.1 14.7 19.3 16.3 18.4 12.5 6.4 11.2 19.0 17.3 11.0 6.1 17.7 18.6 19.9 30.2 11.5 9.9 4.7 13.3 11.8 7.0 14.6 13.9 9.9 13.8 9.3 8.9 10.9 19.5 7.3 8.9 9.2 13.4 11.9 17.1 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: " "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favourable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favourable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.4 25.0 0.0 0.0 0.0 0.1 5.1 13.3 11.3 11.5 4.3 13.6 4.5 7.9 11.1 5.2 0.0 0.6 8.0 11.3 1.5 2.6 13.0 4.5 19.3 0.0 0.0 9.5 6.3 8.6 0.1 12.6 0.0 15.4 8.6 7.0 13.7 0.1 19.7 0.7 0.0 20.9 0.2 1.0 8.4 18.2 28.8 4.0 1.2 2.4 14.4 6.9 0.0 14.8 5.9 6.8 7.3 25.2 18.9 0.0 9.5 0.0 7.7 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA006465: " "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 23.2 22.3 22.2 22.4 23.8 34.8 23.2 34.7 27.0 20.4 18.6 21.8 20.0 15.6 23.7 20.9 21.2 17.0 20.6 18.8 17.9 16.9 22.4 23.6 17.7 21.4 23.4 16.7 24.1 21.1 32.5 32.1 23.4 25.5 21.8 18.1 16.7 21.4 21.3 19.9 23.3 16.8 19.9 19.4 20.5 18.5 25.4 23.1 32.7 24.2 18.7 22.4 22.1 20.7 20.4 16.8 23.3 26.3 25.4 27.2 15.7 18.5 13.4 15.2 23.1 14.0 13.9 12.5 14.5 22.8 23.7 27.8 24.3 19.5 14.6 14.3 14.1 15.6 16.2 17.2 24.4 11.8 15.8 18.4 11.0 17.3 21.2 21.9 12.3 15.5 14.4 19.9 25.0 25.2 19.0 10.2 22.3 15.7 19.6 12.2 15.6 38.8 14.6 16.9 7.9 19.0 13.8 6.7 12.6 13.1 29.9 18.6 17.1 10.6 15.5 10.3 20.9 11.1 16.6 11.9 8.1 24.9 19.3 18.4 8.8 15.0 19.3 20.9 21.8 20.5 23.2 20.4 20.6 21.4 16.8 18.6 27.2 19.4 23.3 25.4 26.3 11.5 19.7 15.7 22.2 23.8 34.7 27.0 17.9 16.9 23.4 16.7 25.5 23.1 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036363: , HPA053261: " "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavourable (6.82e-6)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavourable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.0 32.9 25.9 13.4 2.7 5.6 13.0 20.4 16.8 30.7 29.8 18.2 48.9 11.4 31.1 11.9 20.3 20.9 13.1 42.0 16.3 11.5 7.1 18.0 9.3 1.1 11.0 8.3 1.8 2.2 18.2 18.7 13.2 7.4 16.8 24.2 16.3 11.2 8.3 21.2 17.9 8.1 25.5 14.7 23.3 10.8 17.4 11.1 25.8 29.4 10.4 48.9 8.2 11.4 14.9 14.3 20.0 42.4 8.3 11.1 21.6 13.2 9.7 19.4 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 EFNA2 "ELF-1, EPLG6, LERK6" ENSG00000099617 "Ephrin A2" O43921 19 1286154-1300237 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.0;intestine: 30.3;liver: 14.2" "Cell line enhanced" "Detected in some" "AF22: 4.8;BEWO: 4.9;Hep G2: 9.3;NTERA-2: 5.4;REH: 7.1;SH-SY5Y: 16.8;U-2 OS: 5.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067567 Approved Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA067567: " "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (2.87e-3)" "unprognostic (1.96e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-1)" "unprognostic (7.19e-2)" "unprognostic (2.34e-3)" "unprognostic (3.58e-2)" "unprognostic (6.82e-2)" "unprognostic (8.48e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-4)" "unprognostic (1.94e-1)" 0.2 0.1 1.5 3.4 2.2 0.2 0.1 1.5 2.0 0.1 10.7 2.0 0.0 12.0 0.2 0.1 0.4 0.1 10.0 0.1 1.0 1.6 0.3 14.2 0.1 0.1 1.2 0.5 0.1 0.1 0.1 0.3 0.2 1.1 0.1 2.3 1.9 0.1 0.2 0.2 0.1 30.3 0.2 0.9 0.2 0.6 0.6 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 1.7 0.0 0.0 4.9 0.2 0.0 0.0 0.0 3.5 0.0 0.0 2.3 0.0 0.0 2.2 0.0 0.0 0.1 2.1 0.0 0.0 9.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 5.4 0.0 7.1 0.6 0.0 0.0 0.1 0.0 16.8 0.2 0.0 0.1 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 1.5 2.0 1.0 1.6 1.2 0.5 1.1 0.7 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030341-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7;salivary gland: 109.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavourable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 17.7 3.4 2.5 4.9 3.6 9.2 21.7 1.8 3.2 5.5 15.4 2.0 7.7 6.2 5.3 2.1 22.2 5.0 7.0 9.4 2.2 1.8 6.0 39.6 6.9 7.4 4.3 1.4 9.3 94.7 1.7 2.2 8.7 2.8 7.4 4.6 2.8 109.8 8.0 38.4 4.9 9.0 7.1 4.2 9.3 10.6 3.0 2.7 2.7 3.7 12.6 9.2 11.3 11.1 16.3 41.3 31.3 53.5 4.0 7.6 28.0 20.4 10.6 3.1 18.4 4.0 3.5 13.6 22.7 10.6 12.3 19.7 7.0 5.3 8.0 15.9 11.3 10.9 10.3 18.5 7.3 6.1 33.5 46.8 4.7 9.6 41.8 15.1 7.5 9.8 30.2 13.6 25.5 19.7 25.5 21.4 5.1 12.8 13.2 36.8 22.9 42.7 11.6 13.0 28.2 4.6 2.0 43.2 32.8 4.6 7.5 53.4 10.0 17.8 18.5 7.4 24.3 21.9 17.2 30.8 16.7 9.2 17.3 26.8 16.0 5.1 53.5 31.3 3.9 41.2 3.5 16.3 4.5 4.0 41.3 13.5 3.6 3.6 4.7 4.0 31.4 31.3 7.6 28.0 2.5 3.6 1.8 3.2 2.2 1.8 4.3 1.4 2.8 2.7 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847678 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Group enriched" "Detected in some" 10 "midbrain: 11.4;pons and medulla: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "midbrain: 5.9" "Region enriched" "Detected in some" 5 "midbrain: 23.9" "CAB014884, HPA073141" Enhanced Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB014884: , HPA073141: " "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 5.6 0.1 0.0 0.1 0.4 0.0 2.7 0.9 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 11.4 0.0 0.1 0.0 0.1 0.0 0.0 8.8 0.1 0.1 0.2 0.7 0.1 20.1 10.0 0.1 0.1 2.7 0.1 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.2 14.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.4 0.5 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 8.6 0.8 9.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.2 0.1 11.4 0.0 8.8 0.1 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099881 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favourable (5.27e-4)" "unprognostic (1.33e-1)" 28.2 21.8 30.4 22.1 31.9 30.8 27.9 58.8 34.7 24.8 22.0 31.9 22.4 18.5 27.0 22.9 27.6 22.7 18.3 18.3 27.8 16.2 22.4 18.2 20.8 26.0 31.5 26.3 31.2 24.2 23.1 32.1 23.5 24.3 22.1 25.9 20.4 24.6 20.5 27.3 33.2 22.7 25.6 23.2 26.0 25.2 20.3 32.7 28.2 20.8 12.5 29.9 23.6 24.6 21.0 21.6 24.8 26.4 27.5 25.9 22.3 23.1 14.8 31.1 12.0 16.6 18.4 17.8 22.9 16.9 40.4 36.8 21.8 33.9 23.4 14.9 21.7 23.1 34.3 25.5 37.2 26.2 34.4 34.0 29.1 22.2 16.3 27.6 27.1 14.4 22.1 39.6 23.4 25.1 35.6 21.6 22.2 13.1 27.1 25.5 20.6 17.8 28.0 26.5 20.4 23.7 11.9 20.1 19.6 24.7 21.4 27.4 18.7 25.5 22.7 21.6 22.5 19.3 26.8 13.1 20.5 46.3 22.0 41.2 25.8 24.8 18.2 14.6 22.2 23.4 25.9 21.0 23.1 22.1 21.6 19.9 19.8 22.0 3.6 27.5 26.4 11.0 21.8 22.3 30.4 31.9 58.8 34.7 27.8 16.2 31.5 26.3 24.3 32.7 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128116 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 453.2;liver: 370.7" "Group enriched" "Detected in some" 7 "CACO-2: 25.6;Hep G2: 81.3" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol 32000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 0.4 0.1 0.4 33.9 0.4 0.0 0.4 0.4 0.5 0.4 153.5 0.4 0.4 137.9 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.2 57.6 370.7 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 97.7 0.4 0.5 0.4 0.4 0.1 453.2 6.7 0.4 0.4 0.2 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 25.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 81.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.0 1.4 7.5 0.0 0.1 0.8 5.6 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.4 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.0 6.2 9.3 0.1 1.0 1.8 0.1 18.3 9.2 10.9 16.2 13.1 9.6 30.0 12.4 5.3 18.7 13.5 12.3 19.5 15.6 3.3 3.2 11.8 5.7 0.0 0.1 3.9 0.4 0.4 10.5 0.8 5.8 0.9 28.3 12.8 9.1 18.9 0.2 0.1 7.3 20.0 13.8 11.7 5.8 20.8 1.8 5.9 15.1 17.5 3.0 19.4 1.7 3.2 8.5 18.5 25.5 16.6 21.8 15.7 0.2 12.3 0.1 12.1 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 FAM122A "C9orf42, MGC17347" ENSG00000187866 "Family with sequence similarity 122A" Q96E09 9 68780034-68784608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056646 Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA056646: " "unprognostic (1.88e-2)" "unprognostic (7.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.16e-1)" "unprognostic (9.79e-2)" "unprognostic (1.45e-2)" "unprognostic (4.18e-1)" "unprognostic (8.49e-3)" "unprognostic (1.45e-2)" "unprognostic (4.58e-3)" "prognostic favourable (1.34e-5)" "unprognostic (9.35e-2)" "unprognostic (3.02e-2)" "unprognostic (2.72e-1)" "unprognostic (6.89e-2)" 21.0 21.3 13.9 12.0 20.2 9.8 21.4 22.5 24.6 23.1 15.5 17.0 12.4 10.0 20.3 15.6 17.6 19.7 14.4 24.2 13.8 14.3 21.5 21.2 14.1 14.7 16.8 14.2 24.2 17.9 25.3 20.8 21.8 18.0 20.6 14.9 22.4 17.0 19.8 20.0 15.1 15.0 17.6 13.9 17.7 15.0 16.2 14.6 18.1 19.1 14.8 15.4 15.7 16.5 5.8 6.7 4.3 5.1 4.5 9.8 2.5 5.3 3.6 5.0 4.4 17.5 11.4 6.9 7.7 7.3 6.8 5.5 1.3 2.7 11.3 3.9 8.1 10.1 5.6 5.2 8.5 12.2 6.0 6.2 6.0 4.5 10.8 11.3 4.5 9.2 11.9 6.2 4.9 6.7 6.6 12.9 7.3 2.9 6.3 3.0 6.4 6.6 7.7 7.0 3.5 6.1 4.4 8.1 3.7 5.7 4.8 3.9 2.9 5.0 8.4 6.4 4.5 11.8 5.6 15.2 6.1 4.7 6.8 7.2 7.1 4.3 5.1 3.7 4.5 4.9 4.0 3.6 4.5 4.9 5.7 5.8 9.8 5.5 2.9 4.5 4.8 6.7 4.9 2.5 13.9 20.2 22.5 24.6 13.8 14.3 16.8 14.2 18.0 14.6 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Cell line enhanced" "Detected in some" "Karpas-707: 21.8;U-2197: 11.3;U-266/70: 17.0;U-266/84: 37.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA066175: , HPA069513: " "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 21.8 0.0 0.0 0.0 0.0 0.5 5.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.5 11.3 0.4 17.0 37.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560793-92590394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA066175: , HPA069513: " "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 10.5 11.7 18.5 11.1 23.6 32.1 15.1 25.7 23.3 13.6 10.4 8.2 12.0 11.9 13.0 22.5 11.4 10.4 9.2 9.2 13.8 9.1 11.2 14.3 11.2 14.1 15.3 13.2 15.1 13.6 13.4 21.3 12.9 18.0 12.0 11.7 7.5 11.4 10.5 17.1 12.8 10.8 15.7 18.5 12.1 10.6 7.3 17.3 15.9 12.5 7.5 12.8 10.6 12.0 22.5 23.2 9.8 11.7 10.7 17.0 5.9 12.8 6.7 18.8 28.8 11.0 11.8 11.3 14.6 15.8 14.3 17.5 10.7 14.4 21.1 14.2 9.9 10.4 14.8 9.2 22.0 11.8 19.4 17.1 9.8 21.4 11.6 18.8 14.8 7.8 9.8 11.0 13.7 8.4 22.4 26.8 15.3 15.7 29.5 29.3 25.7 8.6 21.4 18.9 17.5 14.3 13.8 18.3 17.7 12.6 16.0 17.0 14.9 13.8 9.7 16.5 26.2 19.2 16.3 7.0 7.4 37.8 9.9 24.8 21.2 9.5 11.7 9.8 10.7 10.5 13.9 22.5 13.6 13.2 9.6 18.8 17.0 14.4 4.9 10.7 7.8 23.2 14.3 5.9 18.5 23.6 25.7 23.3 13.8 9.1 15.3 13.2 18.0 17.3 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074513: " "prognostic unfavourable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.0 7.9 7.5 8.7 6.6 2.7 11.3 5.7 6.0 4.7 8.4 12.1 9.4 20.3 8.0 5.5 12.1 10.3 9.8 15.6 7.4 7.8 27.3 6.3 5.9 12.0 9.4 6.1 11.4 9.9 3.4 11.6 10.9 9.6 17.0 6.8 5.9 10.7 4.8 9.7 8.2 5.5 8.3 15.4 9.6 6.3 6.3 39.7 14.0 6.3 14.3 12.6 6.4 12.9 7.6 7.8 8.2 6.5 7.2 10.5 8.1 13.8 5.2 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.1;HEK 293: 25.1;HUVEC TERT2: 31.2;REH: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046812, HPA054443" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA046812: , HPA054443: " "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favourable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.3 9.4 9.2 0.0 0.0 8.4 0.3 0.0 0.3 0.4 9.5 1.5 0.8 28.1 0.0 2.9 4.8 0.1 0.0 1.3 25.1 5.3 0.4 0.3 0.1 0.8 2.8 0.1 0.0 0.1 0.0 31.2 6.2 0.9 0.0 4.1 3.6 8.4 14.5 2.1 20.0 0.2 9.4 0.5 1.0 16.0 17.3 0.4 1.8 7.0 5.2 4.9 16.0 0.8 7.0 1.3 0.5 5.5 0.5 2.4 0.6 0.8 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725979-27763122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: " "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favourable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 22.1 8.6 10.6 12.2 17.2 14.3 14.1 17.9 18.3 14.7 12.8 17.4 8.4 10.2 15.9 16.6 13.9 13.8 15.3 13.8 11.3 11.4 13.7 13.8 13.1 11.3 9.5 16.1 14.6 14.4 11.7 19.5 12.8 14.3 12.9 16.2 15.7 12.4 16.8 39.7 15.4 12.1 17.8 11.9 12.1 13.8 28.5 10.9 13.6 18.7 17.8 13.8 14.0 14.1 13.6 14.6 13.7 12.2 12.0 16.0 6.4 8.6 7.0 8.0 8.2 10.1 8.8 14.4 8.1 8.6 12.1 11.9 8.0 11.7 15.9 5.3 9.0 11.5 10.0 9.0 9.4 8.2 7.6 4.9 9.9 9.4 8.1 7.8 7.7 9.0 9.8 13.2 13.3 6.0 9.3 15.0 8.6 8.4 18.4 7.2 12.6 7.0 11.2 9.5 9.0 9.6 12.5 11.6 5.2 9.3 10.1 9.7 7.3 3.1 6.4 14.3 6.2 16.5 5.6 13.7 14.9 13.0 8.9 10.2 6.1 10.0 12.2 13.7 14.7 12.1 15.6 12.2 15.3 14.0 10.4 13.6 14.5 16.0 8.3 12.0 12.1 14.6 11.3 6.4 10.6 17.2 17.9 18.3 11.3 11.4 9.5 16.1 14.3 10.9 FAM96A "CIA2A, FLJ22875" ENSG00000166797 "Family with sequence similarity 96 member A" Q9H5X1 15 64072559-64094018 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: " "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 13.6 32.3 11.2 19.1 12.8 17.0 13.9 9.0 10.3 8.5 24.3 13.6 17.7 31.3 8.1 14.9 13.6 8.3 14.0 20.6 11.2 10.8 39.4 89.7 18.1 22.7 15.2 8.0 7.8 27.0 10.6 15.4 25.2 11.2 17.2 20.2 10.7 16.5 15.7 28.2 7.6 45.5 6.4 14.9 25.2 17.9 8.9 13.8 20.5 30.1 18.3 19.3 14.6 9.0 51.8 63.7 23.7 48.6 11.8 21.3 38.2 19.5 28.7 17.6 10.9 14.9 18.3 11.6 15.4 17.2 20.6 21.8 28.3 31.7 32.5 27.1 9.7 21.6 34.3 15.1 17.5 26.5 18.5 26.5 26.0 26.6 11.8 42.9 22.9 14.4 15.2 13.4 12.0 20.8 36.2 25.2 14.5 33.1 16.3 37.1 25.4 15.2 26.2 23.2 72.0 26.5 23.0 18.8 14.2 12.3 28.1 29.8 20.6 44.8 12.5 16.3 23.2 18.6 33.1 24.4 57.5 29.2 19.8 77.6 15.5 16.2 48.6 16.9 10.1 44.1 12.4 51.8 15.3 13.5 42.6 48.8 12.3 11.6 23.7 11.8 36.7 63.7 21.3 38.2 11.2 12.8 9.0 10.3 11.2 10.8 15.2 8.0 11.2 13.8 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513798 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036049: " "unprognostic (2.86e-3)" "prognostic unfavourable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 6.4 6.2 11.0 7.2 15.0 8.5 3.7 10.8 17.7 3.0 4.6 8.1 4.3 5.6 5.1 3.4 6.1 4.4 3.3 5.0 10.2 8.0 4.3 3.6 4.4 5.7 6.6 12.3 4.3 8.0 6.2 4.8 4.2 7.6 5.0 3.2 5.6 5.3 3.8 10.8 10.2 5.0 4.3 5.4 5.4 4.6 5.7 7.7 4.3 4.8 2.8 5.6 4.8 3.2 3.4 2.5 8.9 4.0 3.9 2.7 1.8 9.2 12.2 3.5 7.4 3.2 3.4 6.0 5.5 2.9 3.4 3.7 9.2 5.9 4.2 6.7 2.7 14.6 4.0 9.7 2.6 3.2 5.1 2.2 9.2 3.0 2.3 4.7 3.6 2.8 5.2 5.3 2.5 4.1 6.7 3.8 2.3 9.7 2.5 3.0 11.2 10.1 6.2 6.7 2.3 2.2 4.8 7.5 10.5 8.6 14.6 2.9 14.3 2.9 9.3 11.3 16.2 8.3 8.4 5.0 6.2 3.2 5.8 5.8 13.4 7.9 3.5 1.3 2.7 3.2 2.7 2.1 1.7 2.5 2.5 3.4 1.9 2.4 8.9 3.9 4.0 2.5 2.0 1.8 11.0 15.0 10.8 17.7 10.2 8.0 6.6 12.3 7.6 7.7 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol 2000000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 21.0 57.8 19.3 17.6 26.5 16.5 19.8 12.8 32.2 19.0 25.0 22.6 14.5 45.9 18.0 21.7 41.4 16.7 18.8 19.6 18.6 23.4 23.7 100.8 25.7 19.2 19.5 24.3 15.2 27.5 15.6 12.3 20.2 47.3 16.5 29.7 20.5 29.2 12.9 15.7 29.3 32.3 18.9 23.0 17.7 23.4 15.1 16.5 25.1 19.5 41.7 27.3 13.7 20.8 41.1 39.7 49.4 37.1 45.3 45.5 48.3 35.6 19.4 71.3 25.7 16.7 61.3 25.4 17.0 33.7 27.2 44.3 31.4 84.9 27.2 41.4 14.9 39.8 42.4 147.8 25.5 14.8 30.4 15.8 34.6 37.8 27.5 25.5 18.1 43.6 23.4 43.2 21.7 47.3 28.1 73.3 28.3 38.3 32.6 24.8 42.8 28.4 28.2 30.9 75.4 71.6 23.8 27.7 23.7 17.5 31.9 29.4 23.0 69.4 34.4 15.2 18.7 9.4 31.1 31.1 23.9 48.5 14.8 27.2 23.9 30.5 36.0 49.4 39.4 37.1 35.0 41.1 34.8 39.8 39.7 34.2 31.5 39.3 16.5 45.3 27.2 31.4 45.5 48.3 19.3 26.5 12.8 32.2 18.6 23.4 19.5 24.3 47.3 16.5 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Group enriched" "Detected in some" 10 "NTERA-2: 57.4;SCLC-21H: 25.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in single" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064639: , HPA073693: " "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 57.4 1.0 0.0 0.0 0.0 0.0 0.1 25.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 FP565260.1 ENSG00000275464 21 5130871-5154734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 17.2" "Cell line enhanced" "Detected in many" "HEL: 37.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA024573 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 3.0 3.0 1.1 3.0 2.2 3.3 1.4 1.1 6.8 1.7 1.9 7.2 1.1 2.8 1.6 2.6 1.9 2.4 4.8 2.9 3.2 1.8 1.1 1.8 4.2 2.4 1.1 1.9 2.0 2.5 1.1 2.3 2.9 1.8 2.7 1.1 1.7 1.1 6.8 1.8 2.2 3.4 1.1 2.8 1.4 1.4 1.1 1.1 1.7 1.1 2.3 2.4 1.1 8.9 6.6 5.0 12.9 7.4 17.2 7.5 11.6 8.7 5.9 9.1 2.6 1.9 3.5 0.0 0.0 0.0 0.0 0.0 7.5 0.0 5.4 3.9 7.7 16.4 7.2 0.0 2.5 5.3 37.5 4.6 4.5 4.1 17.2 11.2 7.1 8.8 10.1 7.9 7.7 20.9 4.1 2.5 10.3 12.6 11.8 23.3 11.0 19.8 5.5 10.3 5.3 9.3 5.7 10.3 9.6 14.6 5.5 12.2 9.3 3.7 4.5 11.4 0.1 12.1 4.9 5.3 23.6 8.0 22.7 6.2 2.6 5.5 5.0 15.0 9.7 17.2 8.7 9.1 11.0 6.6 8.9 9.2 12.6 3.3 7.4 12.9 4.4 6.0 7.5 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavourable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavourable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 196.0 345.9 99.8 155.5 97.4 160.6 217.5 149.0 212.2 218.1 227.7 244.1 134.6 229.2 29.5 175.6 111.7 92.7 345.6 151.4 201.0 100.7 126.8 217.1 207.3 131.3 204.9 102.1 134.3 112.9 214.3 242.1 240.0 68.1 48.3 247.7 391.1 233.5 107.9 368.8 115.3 189.9 177.7 109.1 248.1 239.9 70.7 113.5 131.5 343.1 197.9 53.6 144.8 149.7 170.2 205.7 87.8 257.4 109.8 79.8 295.4 360.8 129.9 266.3 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496842-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 60.9" "Cell line enhanced" "Detected in some" "HEL: 12.4;Hep G2: 19.0;HUVEC TERT2: 6.1;TIME: 3.7" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA064305" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "CAB034098: AB_2247323, HPA064305: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.2 2.0 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.3 0.4 0.0 3.9 0.5 0.1 0.0 0.2 60.9 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.5 3.1 0.9 0.2 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.8 2.6 1.2 1.7 0.9 0.7 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.6 0.2 0.2 0.0 0.0 0.1 0.0 12.4 0.5 19.0 0.8 0.1 0.4 0.3 0.9 0.5 0.1 6.1 0.0 0.2 0.2 0.1 0.1 0.7 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.5 0.1 3.7 0.1 0.3 0.6 0.2 0.3 0.1 0.2 1.1 0.1 0.2 2.6 1.2 0.3 0.6 1.0 0.6 0.8 0.4 0.4 0.1 2.4 0.9 0.8 2.1 1.7 0.3 0.8 0.1 0.7 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.4;HMC-1: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.2 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 9.9 10.4 0.7 6.5 2.0 3.1 0.4 0.7 3.7 18.4 3.8 3.8 1.5 5.2 28.5 0.6 2.5 0.9 2.7 5.6 0.5 0.9 0.8 2.3 1.2 3.2 1.0 2.1 4.0 1.3 5.1 0.3 1.4 3.4 0.6 2.4 0.4 2.3 0.6 0.5 7.5 0.9 2.0 2.1 3.3 8.3 4.7 11.9 0.8 3.1 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 GRASP Tamalin ENSG00000161835 "General receptor for phosphoinositides 1 associated scaffold protein" Q7Z6J2 12 52006940-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 20.1;TIME: 14.5;WM-115: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 6 "amygdala: 31.9;basal ganglia: 22.2;cerebral cortex: 27.5;hippocampal formation: 25.8;olfactory region: 21.0" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: " "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 29.3 5.1 6.4 9.9 16.4 28.6 17.3 2.1 21.0 17.8 7.3 6.3 5.2 3.8 16.2 7.8 6.8 14.5 17.2 10.8 5.2 3.9 8.7 6.9 38.1 6.3 5.3 9.1 12.1 8.4 3.5 4.5 13.0 8.0 8.9 4.0 14.7 4.7 12.8 16.3 7.1 6.8 9.9 4.5 16.9 6.0 2.8 4.5 3.5 11.3 13.5 6.6 9.0 26.3 0.3 0.8 0.0 0.1 0.1 1.2 0.0 0.0 0.0 2.6 0.1 1.2 2.1 0.6 0.1 0.7 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.1 0.8 0.0 0.2 0.1 0.7 0.2 0.0 3.6 4.5 0.2 2.0 4.4 0.0 0.2 0.0 20.1 0.9 0.0 0.5 0.1 1.8 4.9 2.3 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.1 3.4 0.0 0.2 14.5 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.4 0.0 26.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.3 0.8 0.1 0.2 0.2 0.0 0.1 0.1 0.8 1.2 0.0 6.4 16.4 2.1 20.9 5.2 3.9 5.3 9.1 8.0 4.5 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell line enhanced" "Detected in many" "AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA000750 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favourable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.4 0.3 0.0 22.4 0.4 0.5 0.9 3.1 1.8 4.6 4.8 9.6 0.0 0.0 5.1 7.8 9.4 0.0 9.9 2.1 0.0 0.8 0.3 12.6 1.5 33.0 0.0 3.6 13.6 1.6 13.1 2.7 3.6 0.0 0.0 2.7 0.1 0.0 0.0 0.1 4.7 0.0 16.7 0.0 10.1 0.0 0.4 9.4 3.1 0.0 22.8 25.2 0.3 12.2 3.8 2.5 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 HDDC3 MGC45386 ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929964-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 14.3 18.8 16.3 8.9 17.1 10.7 11.3 10.3 17.6 8.2 13.1 9.3 12.6 12.4 5.4 12.8 7.7 12.7 7.1 15.2 12.9 12.3 14.7 18.3 7.8 9.0 14.6 12.5 10.3 30.3 15.1 10.4 10.4 11.0 8.7 11.1 9.7 24.8 14.0 14.2 9.3 17.1 6.1 11.4 13.1 11.2 4.5 8.2 11.8 12.0 10.1 10.7 7.5 7.5 19.9 25.3 5.6 15.6 16.4 21.5 14.3 6.9 8.5 3.0 3.6 6.9 7.0 5.0 4.6 6.4 4.4 6.5 4.3 14.4 13.0 4.9 3.9 10.8 6.3 10.9 3.7 16.5 13.2 16.5 3.3 9.6 14.1 6.2 8.1 6.1 17.2 8.0 14.4 9.6 13.1 11.8 3.9 10.1 8.5 5.4 2.4 8.8 7.2 1.1 20.8 9.0 7.3 7.6 4.9 3.9 11.0 11.7 16.6 17.0 5.5 2.7 6.1 4.6 6.0 19.4 21.7 9.0 10.1 12.3 8.1 5.6 11.8 4.7 14.0 15.6 18.4 19.9 18.4 16.2 15.9 17.5 21.5 15.7 2.8 16.4 14.2 25.3 17.4 14.3 16.3 17.1 10.3 17.6 12.9 12.3 14.6 12.5 11.0 8.2 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: " "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavourable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.7 11.1 10.2 16.2 6.4 8.6 11.0 13.2 8.7 13.2 5.3 13.5 8.2 20.4 9.6 12.5 13.0 12.3 9.8 15.4 5.2 13.3 10.1 7.7 17.1 9.1 17.4 20.5 6.7 6.8 9.3 5.7 10.6 12.8 3.5 12.9 6.6 13.3 21.8 12.1 11.5 14.8 13.9 16.5 7.3 8.9 13.3 7.0 12.7 16.6 8.3 7.5 12.8 13.8 10.6 7.2 8.1 10.0 8.7 6.8 18.3 10.5 17.6 10.4 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.1;HHSteC: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved Vesicles "Intracellular and membrane" 360000000 Vesicles "HPA010952: , HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavourable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavourable (1.16e-4)" 23.6 8.2 5.8 12.1 8.4 0.7 16.4 2.6 8.9 12.2 9.6 14.7 8.0 3.9 12.0 7.3 9.0 11.4 29.6 36.3 6.9 5.5 8.9 5.5 42.4 7.7 9.7 4.7 8.1 16.6 14.2 4.0 17.4 11.6 7.2 6.5 26.2 7.1 7.4 6.2 4.3 7.9 14.4 11.9 11.5 7.5 11.3 6.5 3.0 29.1 10.8 8.7 13.0 15.6 1.0 0.9 1.2 3.9 7.3 4.0 1.1 2.0 2.1 14.7 1.2 18.2 16.2 5.5 17.3 22.6 19.2 21.1 15.0 0.2 0.6 11.8 46.1 3.6 2.2 8.4 23.2 1.6 1.1 0.3 11.1 1.8 56.0 0.4 22.4 19.7 2.4 25.0 5.9 18.7 0.0 0.2 5.8 0.3 0.9 0.0 2.5 1.3 1.3 11.1 0.0 3.3 0.3 0.2 1.3 38.3 2.6 1.5 6.2 0.9 28.9 10.8 12.1 38.9 7.3 1.5 4.7 0.0 20.4 1.6 21.1 1.2 0.3 0.0 4.0 3.6 2.7 0.9 1.6 3.6 0.7 1.0 2.4 1.5 0.0 7.3 3.9 0.9 0.5 1.1 5.8 8.4 2.6 8.9 6.9 5.5 9.7 4.7 11.6 6.5 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli" Mitochondria "HPA008436: AB_1850757, HPA027261: " "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (3.37e-5)" "prognostic unfavourable (2.46e-4)" "prognostic unfavourable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavourable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.0 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.6 5.3 2.9 10.1 19.9 18.0 13.2 24.4 12.5 6.7 20.5 18.5 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 11.4 17.4 13.3 33.6 17.2 23.7 18.6 19.2 16.0 18.3 33.8 9.4 9.4 10.3 13.0 8.1 14.7 11.2 10.5 8.4 13.1 8.3 19.8 21.5 14.5 27.6 12.7 10.0 21.4 11.8 12.5 49.2 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43289395-43313512 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 117.0" "Cell line enhanced" "Detected in all" "AF22: 123.5;HBEC3-KT: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 310000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: , HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favourable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 6.0 16.5 13.3 8.1 24.4 4.3 12.8 8.4 38.2 16.9 15.5 16.9 9.5 27.8 6.8 11.5 53.0 4.1 7.5 5.1 19.4 18.8 10.5 117.0 26.9 6.2 10.4 20.7 15.4 8.4 10.8 5.0 6.9 59.3 12.9 14.2 13.0 18.5 7.7 5.0 25.2 17.1 6.3 25.8 4.4 13.4 9.8 8.1 3.3 7.5 58.1 23.3 6.1 21.4 9.3 7.8 6.9 7.7 6.7 7.9 3.3 15.3 7.4 123.5 14.2 7.2 28.7 8.4 2.4 9.7 3.5 7.0 12.8 22.2 16.3 5.5 3.5 12.1 30.7 71.2 3.7 3.4 36.9 6.0 6.8 17.3 11.3 13.1 4.3 15.6 8.6 18.5 7.4 3.6 10.7 44.6 2.9 7.1 11.8 16.0 22.1 3.9 8.5 17.3 18.0 54.7 23.8 10.6 5.1 12.6 6.3 3.7 9.9 17.5 4.3 2.6 13.3 2.8 2.3 6.0 9.1 22.2 2.3 15.8 2.3 5.5 4.0 3.7 5.6 7.4 5.6 9.3 6.2 7.9 7.8 7.5 5.3 7.3 6.9 6.7 7.7 6.5 5.7 3.3 13.3 24.4 8.4 32.1 19.4 18.8 10.4 20.7 59.3 8.1 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200106 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 48.5;prostate: 25.1" "Cell line enhanced" "Detected in many" "HAP1: 15.2;HEK 293: 21.1;PC-3: 10.5;RT4: 23.5;THP-1: 10.0;U-937: 11.2" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA069061 Supported "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 48.5 6.9 0.0 7.1 0.0 5.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 16.5 0.0 25.1 8.6 0.0 0.1 17.9 1.2 0.4 0.1 15.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 12.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 1.4 0.1 0.0 0.0 7.4 8.2 2.9 1.9 1.5 0.1 0.0 0.9 3.5 0.0 15.2 0.0 2.5 0.0 21.1 1.0 4.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 10.5 1.5 0.3 0.0 0.0 23.5 0.4 0.0 1.8 0.0 0.1 0.0 10.0 0.0 0.2 2.7 0.1 0.1 0.0 0.0 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 HS1BP3 "FLJ14249, HS1-BP3" ENSG00000118960 "HCLS1 binding protein 3" Q53T59 2 20560448-20651089 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035050 Approved Approved Nucleoli,Cytosol 32000 Nucleoli Cytosol "HPA035050: AB_10601816" "unprognostic (4.52e-2)" "unprognostic (5.93e-2)" "unprognostic (2.67e-1)" "unprognostic (4.39e-1)" "unprognostic (4.61e-2)" "unprognostic (1.45e-3)" "prognostic unfavourable (2.97e-5)" "unprognostic (2.06e-3)" "unprognostic (1.88e-2)" "unprognostic (2.16e-1)" "unprognostic (9.53e-2)" "unprognostic (8.00e-2)" "prognostic favourable (2.30e-4)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-1)" 17.9 23.1 10.4 8.8 15.7 10.7 11.8 6.7 17.6 17.6 22.6 21.3 14.3 11.7 17.6 18.6 22.6 13.9 28.4 17.5 11.0 9.1 18.5 47.8 14.2 11.7 16.7 9.4 14.8 13.9 10.6 14.3 22.3 13.5 20.3 11.7 17.0 12.9 17.3 9.6 17.0 16.0 27.3 13.8 14.5 16.4 9.7 14.1 6.6 18.5 8.0 9.9 20.8 17.1 6.0 8.0 14.6 13.3 2.9 5.3 6.1 8.8 10.3 5.2 6.3 27.7 18.6 10.4 3.4 15.7 8.0 10.6 8.0 10.7 5.9 2.7 4.9 5.6 10.3 10.6 3.9 7.6 8.5 3.2 5.2 26.7 26.1 2.3 13.9 19.7 24.9 9.1 16.9 15.2 2.0 12.8 9.1 7.6 1.0 4.0 4.3 7.5 5.7 10.6 5.8 17.8 10.7 4.9 7.6 2.4 10.5 20.1 6.6 4.9 9.8 8.0 8.6 12.2 5.1 9.2 10.2 5.4 17.2 11.3 8.4 11.4 11.3 11.0 5.3 11.2 3.7 6.0 3.2 4.0 8.0 4.0 2.7 2.8 14.6 2.9 13.3 3.0 2.9 6.1 10.4 15.7 6.7 17.6 11.0 9.1 16.7 9.4 13.5 14.1 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell line enriched" "Detected in some" 10 "HEK 293: 302.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: " "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 30.5 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.7 0.0 0.0 2.3 0.0 0.2 302.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Group enriched" "Detected in some" 4 "A549: 23.9;Karpas-707: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: " "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 23.9 0.1 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.5 1.3 1.0 0.0 0.0 0.0 0.5 7.4 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 71.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.4 0.0 0.0 0.1 5.0 0.0 0.1 11.6 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815065 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "testis: 29.1;vagina: 17.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.7;U-266/70: 2.8;U-266/84: 2.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles 49000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: " "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favourable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favourable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 0.4 0.5 1.8 0.5 2.2 0.5 1.2 1.4 3.1 0.5 0.7 1.5 0.0 0.3 0.8 3.0 0.8 1.5 0.3 0.5 2.0 1.1 0.9 0.7 1.7 0.7 4.5 0.8 1.1 1.5 0.3 0.7 1.0 2.6 1.2 0.6 0.2 0.4 1.5 3.9 0.6 0.8 0.5 4.6 1.1 0.8 29.1 3.2 0.0 2.0 0.0 0.7 0.5 17.0 0.3 0.0 0.4 0.1 0.0 1.7 1.1 0.0 1.7 0.0 0.0 1.9 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.9 0.0 0.0 6.7 0.0 0.0 0.2 0.2 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 2.8 2.4 0.0 1.7 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 1.3 0.0 0.3 1.5 1.6 0.3 0.0 0.0 0.0 1.7 1.1 1.8 2.2 1.4 3.1 2.0 1.1 4.5 0.8 2.6 3.2 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Cell line enhanced" "Detected in many" "A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: " "prognostic favourable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.6 24.6 3.8 0.0 2.7 0.2 38.4 13.9 32.8 5.6 9.2 0.9 17.4 2.4 5.6 15.1 11.0 0.0 0.7 3.4 1.3 1.9 0.0 1.4 0.0 2.7 0.0 3.3 1.2 0.5 0.8 0.0 0.3 0.0 2.0 2.7 4.3 0.1 0.1 2.8 3.0 1.9 0.0 0.0 8.6 1.5 34.1 1.9 0.6 1.2 0.0 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.5 0.0 0.0 3.1 0.0 3.7 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526910 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;vagina: 99.8" "Cell line enriched" "Detected in some" 7 "Karpas-707: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 67.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 67.6" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: " "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavourable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 6.8 11.9 9.4 10.3 12.4 3.5 43.0 3.5 6.0 1.4 1.9 2.2 1.7 1.9 2.2 1.3 3.2 1.1 9.6 4.5 4.5 9.3 3.1 14.6 13.5 2.1 13.7 1.3 9.3 5.4 0.9 5.4 20.8 5.7 3.3 1.9 1.7 2.9 5.8 1.4 4.4 1.7 4.2 13.2 11.2 3.6 1.4 5.0 1.3 5.8 1.8 2.8 3.1 99.8 0.0 2.5 67.6 9.0 1.6 1.4 2.1 0.5 0.9 0.0 0.2 0.0 0.8 0.7 0.4 0.3 0.1 0.3 0.3 0.5 0.1 1.5 0.1 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.9 0.0 0.0 0.1 2.2 0.1 0.7 0.3 0.0 0.0 0.4 33.3 0.0 0.0 0.1 0.8 0.0 3.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 1.9 0.2 0.4 0.1 0.1 0.3 0.2 2.2 4.5 0.2 0.0 0.8 0.8 1.5 0.8 7.5 2.7 1.4 9.0 0.2 0.0 0.1 0.7 2.5 0.0 0.0 0.3 67.6 1.6 7.3 0.0 0.0 2.1 9.4 12.4 3.5 6.0 4.5 9.3 13.7 1.3 5.7 5.0 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles 210000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: " "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favourable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favourable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 70.0 96.8 93.7 78.1 102.8 58.1 73.8 119.5 125.1 52.8 64.1 72.0 77.3 77.7 59.9 98.3 83.4 76.2 76.7 106.4 83.1 102.4 128.6 114.2 68.9 93.3 105.7 72.4 66.7 191.1 97.2 98.3 71.6 169.2 65.3 81.0 53.1 62.4 69.9 224.6 31.2 74.4 75.4 91.8 79.7 92.7 58.3 98.1 92.9 90.9 98.3 124.4 76.1 123.2 77.4 47.5 41.1 84.2 76.1 124.3 200.0 82.8 125.6 83.4 72.0 77.2 82.8 110.5 164.7 91.3 201.5 121.3 188.4 109.0 134.9 104.0 91.6 112.9 238.2 59.7 201.2 116.6 36.2 146.4 59.0 91.8 21.1 142.2 112.5 44.1 96.6 61.9 19.3 107.8 158.4 70.2 161.4 73.8 147.8 105.6 131.9 111.9 133.4 59.5 76.3 104.4 60.6 85.6 64.9 120.0 130.3 45.4 113.6 55.7 105.9 101.2 81.3 87.0 145.9 47.4 116.9 115.8 112.8 203.3 122.1 30.3 41.5 41.1 96.5 82.9 115.9 77.4 113.4 105.2 47.5 53.7 109.6 105.1 14.9 76.1 84.2 34.4 124.3 200.0 93.7 102.8 119.5 125.1 83.1 102.4 105.7 72.4 169.2 98.1 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.90e-4)" "prognostic unfavourable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 14.5 27.8 23.0 2.2 22.1 12.6 15.3 25.2 22.4 39.2 18.3 32.7 22.6 37.7 15.8 17.5 28.2 88.5 22.4 50.6 29.5 11.1 32.7 15.4 28.8 7.3 22.6 26.1 7.9 51.8 26.1 15.0 22.6 27.3 6.0 27.4 19.8 32.4 25.9 32.7 20.8 25.6 18.8 12.5 29.5 17.7 23.8 19.8 22.9 22.6 11.6 7.5 22.0 13.7 13.5 17.2 19.4 27.8 4.7 15.4 32.3 11.2 27.5 22.5 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell line enriched" "Detected in some" 7 "EFO-21: 35.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favourable (5.27e-4)" "prognostic favourable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.4 2.5 0.1 0.3 0.0 35.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 6.9 0.5 2.4 0.1 16.8 55.6 0.0 14.8 39.7 41.7 55.5 0.0 8.9 40.9 12.8 9.0 20.3 0.3 15.0 16.7 12.6 0.1 10.5 3.1 0.0 31.4 3.6 0.7 52.3 26.9 21.3 30.4 43.8 0.2 30.0 23.1 0.0 48.0 3.3 6.4 5.4 22.7 15.4 47.2 5.8 2.6 1.1 0.0 19.4 0.1 42.1 0.0 4.2 24.7 10.7 5.1 30.2 6.2 28.0 13.1 38.4 30.8 11.8 25.8 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Supported Nucleoplasm,Nucleoli,Mitochondria 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavourable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavourable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.4 37.0 60.0 54.9 13.0 17.9 34.9 29.1 24.7 48.9 38.3 42.4 26.4 56.8 29.0 26.1 40.8 64.8 39.3 44.1 36.3 57.7 73.7 32.7 39.5 18.7 53.0 36.8 16.9 17.6 38.8 43.5 41.7 62.9 44.7 28.4 37.4 87.9 85.3 72.0 40.7 64.8 57.2 39.3 19.4 48.3 66.3 48.2 37.5 29.8 21.6 25.2 34.1 33.4 40.1 38.2 41.5 57.4 38.4 52.4 69.0 22.4 56.7 43.2 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 41.6" "Cell line enhanced" "Detected in many" "Daudi: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: " "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favourable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 1.7 2.2 5.5 3.5 6.3 0.5 2.5 10.1 7.2 2.3 2.2 3.1 1.0 7.0 3.3 1.6 3.1 2.0 4.5 3.9 4.9 2.1 2.3 2.6 2.7 5.0 5.1 3.0 5.5 2.2 0.9 4.4 1.6 5.9 2.7 0.3 1.7 3.6 1.5 6.1 5.0 4.9 1.2 4.1 4.3 3.1 41.6 3.6 0.5 5.2 1.3 0.4 2.8 9.4 1.5 1.3 0.7 4.4 0.3 2.4 0.6 3.9 4.5 3.2 3.0 2.2 0.9 3.8 4.3 0.4 1.1 1.2 3.2 4.7 18.8 2.9 1.1 11.2 0.5 0.2 0.7 7.8 4.8 4.0 5.4 2.1 1.5 0.6 10.0 1.2 0.0 0.6 0.3 0.4 5.1 8.9 0.8 2.0 5.7 1.3 1.4 1.2 7.0 1.6 1.7 0.8 1.2 9.6 2.9 2.1 2.7 2.5 5.6 0.9 8.6 4.0 1.5 3.9 3.2 1.5 0.7 0.9 4.0 10.0 2.0 0.5 2.4 0.0 0.8 4.4 2.0 1.5 1.2 1.7 0.9 1.0 2.4 1.9 0.7 0.3 3.4 1.3 0.7 0.6 5.5 6.3 10.1 7.2 4.9 2.1 5.1 3.0 5.9 3.6 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010500-154019980 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: " "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavourable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavourable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 22.3 23.7 12.1 25.0 11.4 48.3 38.5 7.7 14.8 11.1 24.8 10.8 13.4 29.9 13.2 12.4 25.5 12.2 23.1 14.1 9.9 12.3 23.7 46.9 18.5 37.5 12.6 7.9 15.1 34.6 8.1 15.2 14.3 11.9 18.0 11.0 10.1 31.9 15.9 32.6 15.9 34.6 11.5 12.7 34.0 19.3 14.3 9.8 17.0 12.6 20.4 26.7 17.2 15.3 10.0 13.0 6.7 10.6 6.3 6.7 3.4 76.3 29.7 4.2 34.3 8.4 6.7 18.3 11.4 10.8 17.6 16.4 23.5 34.0 32.6 64.3 12.2 20.9 9.7 18.6 6.9 25.6 29.0 11.9 26.7 14.0 19.4 28.1 20.5 9.3 16.4 16.8 18.6 10.5 20.9 37.8 12.3 28.1 11.5 25.1 10.4 59.3 30.0 21.3 54.8 11.7 14.5 23.6 17.0 13.6 15.2 22.5 5.9 29.9 14.3 21.4 33.9 48.9 70.7 47.6 30.4 59.8 31.3 33.8 22.2 1.3 8.7 6.7 6.7 10.6 5.9 7.5 5.3 5.3 5.4 10.0 3.1 6.1 5.9 6.3 8.1 13.0 2.5 3.4 12.1 11.4 7.7 14.8 9.9 12.3 12.6 7.9 11.9 9.8 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell line enriched" "Detected in some" 12 "REH: 57.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA065938: " "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.1 0.9 1.8 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 57.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29927035 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA043524: " "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavourable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favourable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 5.7 5.4 20.4 12.3 28.4 9.5 5.6 11.4 26.0 6.0 6.6 16.0 6.2 11.5 7.2 13.2 5.8 6.3 13.1 3.8 24.4 11.4 6.1 4.2 4.3 13.5 15.7 14.7 8.0 5.7 9.2 11.9 5.3 10.5 7.4 10.6 6.1 6.9 9.6 3.1 15.1 9.9 4.3 9.7 9.7 9.2 33.9 15.7 6.4 10.5 3.6 11.0 5.6 5.7 3.9 2.5 8.8 2.8 2.9 5.7 1.6 5.9 10.8 3.4 7.3 1.8 2.7 7.8 3.1 0.6 0.9 3.1 4.7 11.3 11.9 3.9 2.7 10.0 3.2 3.4 2.2 5.0 7.3 2.7 7.6 2.5 0.8 4.2 6.7 4.2 5.5 6.1 1.4 2.2 5.7 6.4 4.0 6.8 5.2 4.9 4.1 2.4 9.4 3.6 3.2 2.4 6.6 9.3 3.1 3.4 4.9 8.5 5.1 2.6 5.3 4.4 3.3 8.6 4.9 6.1 2.3 4.6 3.5 8.0 6.2 4.9 2.8 7.4 3.0 2.3 3.5 2.2 5.7 4.6 2.5 3.9 5.0 4.0 8.8 2.9 2.7 2.1 4.0 1.6 20.4 28.4 11.4 26.0 24.4 11.4 15.7 14.7 10.5 15.7 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: , HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favourable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favourable (5.45e-4)" "prognostic unfavourable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavourable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.2 17.3 28.9 25.6 10.9 15.4 23.6 18.5 15.3 20.2 25.6 18.6 18.9 42.8 20.4 16.3 11.0 21.9 14.9 27.0 42.9 15.3 43.0 16.2 10.1 12.9 23.4 16.4 12.7 9.8 19.6 17.8 18.4 30.4 26.1 16.8 13.0 39.1 11.6 16.8 10.9 28.9 22.9 23.6 9.0 21.0 25.9 21.5 25.1 10.6 13.0 13.8 13.2 15.9 12.0 19.9 13.9 18.4 24.7 35.6 45.2 13.9 28.2 14.7 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 LGALS1 GBP ENSG00000100097 "Galectin 1" P09382 22 37675608-37679806 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000646, HPA000687, HPA001130, CAB002157" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" 19000000 Cytosol Nucleoplasm "CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311" "unprognostic (1.65e-1)" "unprognostic (8.13e-2)" "unprognostic (5.13e-2)" "prognostic favourable (2.36e-5)" "unprognostic (6.38e-2)" "unprognostic (2.67e-3)" "prognostic unfavourable (3.06e-4)" "unprognostic (3.22e-3)" "unprognostic (4.91e-3)" "unprognostic (2.51e-1)" "unprognostic (6.16e-3)" "unprognostic (8.06e-2)" "prognostic unfavourable (1.18e-10)" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.47e-2)" "prognostic unfavourable (5.10e-4)" 167.5 49.3 23.0 56.0 22.9 29.8 213.7 7.6 30.9 158.6 94.5 20.1 44.2 22.0 150.9 80.3 74.0 66.8 78.8 108.6 18.9 29.3 24.0 20.8 55.8 45.4 41.4 28.9 105.1 18.2 5.1 17.5 80.1 53.6 85.9 23.4 35.7 34.9 89.6 117.1 29.2 29.2 145.8 88.3 40.3 40.0 42.4 20.5 16.7 19.6 59.1 20.4 99.8 81.7 29.0 185.2 44.0 149.1 19.6 73.1 180.2 93.4 55.1 1.2 49.0 114.7 225.4 1.1 217.4 255.3 161.1 160.6 6.1 12.4 0.1 22.4 219.6 10.0 1.9 143.0 56.3 96.0 1.0 8.2 57.9 25.3 74.9 4.7 109.7 139.5 9.7 128.5 55.0 176.9 5.9 39.6 124.6 41.7 0.1 66.6 0.4 131.0 0.1 82.1 25.7 66.3 0.2 0.1 29.0 43.4 7.6 54.3 40.4 56.3 239.1 215.3 107.7 95.5 111.0 24.3 16.2 0.3 252.9 24.9 85.7 44.0 149.1 5.3 40.8 114.2 6.1 29.0 38.0 39.8 185.2 10.8 6.6 26.8 6.3 19.6 120.0 45.7 73.1 180.2 23.0 22.9 7.6 30.9 18.9 29.3 41.4 28.9 53.6 20.5 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.3;U-266/70: 7.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA071806: " "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 7.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell line enhanced" "Detected in many" "HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavourable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.6 2.8 2.1 20.7 11.7 2.9 12.1 6.2 6.7 16.5 12.2 3.7 0.0 1.4 14.0 0.2 1.6 3.1 2.7 5.0 1.1 3.6 1.1 2.4 29.8 0.0 0.3 41.7 0.0 30.6 0.2 3.2 0.0 0.0 8.6 2.1 0.0 0.0 5.4 0.7 0.0 9.2 0.0 6.1 1.1 0.1 6.9 2.0 10.1 6.3 13.2 0.0 1.5 6.7 13.5 27.0 8.1 1.6 1.9 0.8 1.3 0.9 8.7 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 29.0 20.6 15.4 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 12.7 42.3 57.8 7.3 15.3 18.0 21.7 28.3 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 11.1 45.7 9.0 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.0;lymphoid tissue: 75.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favourable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 16.3 5.6 5.1 34.2 4.7 4.2 5.1 3.5 4.9 4.4 6.7 9.0 4.1 5.1 6.5 5.9 3.8 4.7 7.2 3.9 5.2 5.1 6.3 7.1 19.7 37.2 6.3 2.5 6.6 5.6 3.9 4.8 2.6 5.0 5.7 9.6 6.2 7.6 5.1 2.1 3.7 16.0 4.7 11.4 32.2 5.7 5.9 4.9 75.1 6.8 4.4 52.9 11.2 3.9 19.9 36.5 3.8 19.1 20.1 42.0 20.9 0.3 0.4 0.4 0.7 1.5 1.9 0.2 9.8 39.3 2.4 4.4 0.0 1.0 28.7 0.4 11.9 0.3 0.3 26.7 10.3 12.4 0.1 1.3 0.2 0.1 2.6 7.7 65.8 1.4 0.6 33.9 4.4 15.8 0.3 56.4 19.9 0.2 27.1 9.7 0.3 8.9 0.4 0.5 24.7 1.6 13.7 0.2 0.3 0.4 0.6 3.9 0.5 2.2 15.4 6.2 1.8 39.6 8.8 3.6 3.5 28.2 14.3 7.0 14.0 1.7 19.1 3.1 28.2 11.0 42.0 19.9 29.0 32.4 36.5 11.5 22.6 26.8 3.8 20.1 5.6 33.1 38.7 20.9 5.1 4.7 3.5 4.9 5.2 5.1 6.3 2.5 5.0 4.9 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Group enriched" "Detected in some" 5 "AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA047619: " "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 12.8 0.0 0.0 0.0 6.7 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672693 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 31.8;HUVEC TERT2: 69.1;MCF7: 37.6;RT4: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Approved Approved Nucleoplasm,Cytosol 4200000 "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 32.3 31.5 2.8 13.6 3.3 9.4 35.8 11.7 3.5 11.8 20.9 1.2 12.7 12.4 9.8 17.7 14.0 15.2 17.2 24.4 5.7 3.6 13.6 4.0 16.9 17.8 3.0 2.1 37.1 15.0 7.9 20.6 15.5 4.4 34.0 18.6 11.1 29.3 11.3 7.8 4.8 24.1 22.8 2.6 10.0 7.0 8.5 1.3 12.4 15.8 6.6 7.3 29.3 31.5 5.9 4.5 22.2 3.6 5.2 17.0 4.2 0.0 9.4 0.7 0.1 4.1 14.2 0.8 7.2 18.7 1.8 3.6 0.0 21.3 0.0 6.7 2.0 3.3 1.9 2.9 2.7 0.0 9.3 4.4 8.2 0.1 4.7 1.1 0.1 31.8 0.5 3.4 0.5 69.1 0.0 0.2 0.0 37.6 0.4 0.0 0.8 2.4 1.2 0.0 9.0 6.4 26.1 1.2 0.0 0.0 10.0 2.4 0.0 0.0 9.9 0.1 0.0 10.0 0.0 0.1 0.0 0.0 3.5 0.3 0.1 13.8 3.6 5.0 3.7 3.4 3.6 5.9 7.6 5.9 4.3 4.1 8.5 4.7 22.2 5.2 2.1 4.5 17.0 4.2 2.8 3.3 11.7 3.5 5.7 3.6 3.0 2.1 4.4 1.3 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell line enhanced" "Detected in some" "A-431: 5.8;BEWO: 9.0;HaCaT: 9.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: " "unprognostic (4.27e-3)" "prognostic favourable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.8 0.0 0.3 0.0 0.1 0.0 9.0 0.4 0.0 0.8 1.0 0.6 2.0 0.3 1.1 0.7 9.3 0.0 1.0 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.8 2.6 0.4 1.1 0.3 0.1 0.3 0.0 0.3 0.2 0.1 0.6 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 30.7;SK-MEL-30: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "CAB025341: , HPA055371: " "prognostic favourable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.3 1.2 1.7 2.6 2.7 8.5 7.7 15.0 20.8 7.7 8.3 2.2 6.1 0.2 1.4 6.4 5.0 0.4 6.0 13.0 1.4 0.2 0.8 0.7 1.9 7.1 0.5 2.7 3.7 10.0 30.7 17.1 16.1 1.4 7.2 5.9 1.7 0.3 1.9 1.2 6.1 0.5 1.4 1.5 7.7 11.4 0.9 1.3 2.2 6.0 36.5 1.3 0.5 20.9 9.7 7.2 7.1 5.0 2.7 2.8 0.3 14.7 0.6 6.1 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Cell line enhanced" "Detected in some" "K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 15.1 28.5 0.0 20.4 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAPKAPK5 PRAK ENSG00000089022 "Mitogen-activated protein kinase-activated protein kinase 5" Q8IW41 12 111841978-111902238 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavourable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 20.7 26.2 21.4 17.5 26.4 24.1 21.7 23.7 28.3 17.3 28.8 26.1 21.9 26.3 25.8 22.8 20.8 17.5 22.7 20.7 17.7 15.2 21.7 21.5 18.9 19.4 22.3 20.4 21.3 24.5 19.8 20.4 21.0 17.3 18.7 32.9 23.6 23.3 20.5 33.2 23.0 28.4 21.1 18.0 18.4 19.8 16.7 22.0 19.3 20.5 15.1 19.3 19.9 16.5 4.9 4.1 3.2 11.4 3.9 6.8 2.5 15.1 20.2 19.5 16.4 14.1 14.3 29.7 15.2 18.4 23.4 16.2 26.0 12.5 22.9 11.3 17.9 15.2 25.6 15.9 22.0 15.2 14.0 20.4 14.0 20.8 17.1 25.6 14.5 15.1 22.9 22.3 26.6 17.1 28.1 9.1 17.0 17.0 25.4 40.5 27.7 14.2 25.2 14.2 22.0 18.6 22.0 24.1 20.4 17.3 29.5 21.1 23.8 29.3 14.9 13.3 13.4 13.6 19.0 18.6 22.7 27.1 16.2 18.7 18.8 1.3 4.8 3.2 6.5 3.5 3.5 4.9 4.3 4.7 3.3 4.0 6.8 5.1 2.5 3.9 11.4 4.1 6.6 2.5 21.4 26.4 23.7 28.3 17.7 15.2 22.3 20.4 17.3 22.0 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030832: AB_10601869, HPA030833: " "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favourable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.0 6.6 7.8 7.7 4.7 7.0 17.5 6.3 4.7 5.1 1.8 1.2 5.8 5.6 11.8 6.8 19.4 4.6 4.4 2.0 4.9 8.0 1.7 3.3 3.1 10.2 3.9 15.6 10.0 18.3 9.2 3.0 2.3 8.9 1.0 2.6 2.8 0.8 5.3 2.8 5.0 0.5 3.7 5.5 7.9 4.5 4.1 4.1 3.0 4.9 2.5 7.3 9.1 4.4 8.8 6.8 5.1 8.4 2.9 6.1 4.3 7.6 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA057997: , HPA071835: " "unprognostic (2.02e-2)" "prognostic favourable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavourable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.5 3.3 7.1 4.3 3.4 9.6 5.3 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 6.9 5.1 5.4 4.0 10.7 10.4 5.7 3.3 4.2 4.2 6.5 5.5 4.0 5.3 4.9 5.2 3.1 9.4 17.7 3.6 9.1 6.8 6.1 7.8 11.5 7.2 5.0 15.9 3.4 3.6 8.7 4.6 4.6 4.6 5.3 3.3 8.6 3.7 7.4 5.9 8.9 7.1 12.4 10.0 11.8 5.2 8.6 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 METTL22 "C16orf68, FLJ12433, MGC2654" ENSG00000067365 "Methyltransferase like 22" Q9BUU2 16 8621683-8649654 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040803, HPA059882, HPA074173" Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA040803: AB_10795479, HPA059882: , HPA074173: " "unprognostic (1.74e-1)" "unprognostic (6.50e-2)" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (7.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-3)" "unprognostic (3.82e-2)" "prognostic unfavourable (2.79e-8)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" "unprognostic (1.15e-2)" "unprognostic (8.90e-2)" 8.4 10.6 5.4 10.5 8.8 12.5 8.0 17.1 10.2 9.6 10.9 10.9 13.6 9.2 13.0 12.2 7.6 8.6 9.8 15.0 7.0 7.3 7.1 9.5 6.5 10.8 7.9 6.8 10.8 10.6 7.3 7.6 9.4 9.3 10.5 7.9 10.2 9.5 15.6 45.2 15.7 6.4 11.4 6.3 8.1 9.8 27.8 9.3 10.4 10.1 10.0 9.1 9.7 9.9 1.1 2.8 12.6 3.0 1.8 1.6 1.4 3.7 7.7 8.8 8.4 3.3 8.5 7.6 6.4 3.4 7.7 8.7 7.5 8.7 5.8 5.8 5.6 7.1 5.5 10.2 5.1 8.5 7.5 6.0 13.5 21.2 10.0 6.1 4.6 8.5 7.4 8.4 9.3 6.1 8.1 6.0 5.8 13.3 6.3 14.8 4.7 7.6 9.6 6.6 12.1 3.8 4.0 10.8 7.2 5.6 6.6 4.2 7.2 5.1 4.7 9.1 8.0 7.4 2.9 8.1 4.3 9.1 3.3 8.2 4.2 1.4 3.0 2.4 1.3 2.3 1.2 1.1 1.1 1.3 2.8 1.1 1.5 0.7 12.6 1.8 2.5 1.6 1.6 1.4 5.4 8.8 17.1 10.2 7.0 7.3 7.9 6.8 9.3 9.3 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046141 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 15.6;testis: 33.3" "Cell line enhanced" "Detected in many" "AN3-CA: 32.7;HEL: 24.0;SH-SY5Y: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.0 0.6 1.5 1.8 1.6 2.0 1.6 3.8 4.5 15.6 2.8 1.6 2.5 0.8 7.9 0.6 1.1 1.2 2.8 2.0 2.0 1.4 1.0 1.0 1.4 2.8 2.2 3.3 6.8 0.7 0.2 0.9 3.3 1.0 3.7 0.9 1.2 3.0 3.8 1.6 1.1 1.1 4.0 1.0 1.2 1.0 33.3 0.7 8.4 1.0 1.8 1.2 3.1 4.2 0.0 1.3 0.0 0.1 0.4 0.1 0.0 0.1 1.2 8.6 32.7 0.7 1.0 2.5 1.0 0.5 1.8 1.6 0.2 0.1 1.5 0.6 1.9 0.2 4.1 0.1 1.3 0.3 2.7 24.0 1.4 1.0 1.4 0.2 7.6 0.5 0.6 1.0 2.0 3.7 1.1 0.0 3.1 0.8 3.9 2.0 11.2 0.3 5.5 5.2 0.8 0.0 0.0 6.9 13.4 1.7 0.3 1.1 0.1 0.4 3.4 4.5 5.3 2.5 1.5 3.1 1.6 1.8 1.4 2.4 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 1.6 3.8 4.5 2.0 1.4 2.2 3.3 1.0 0.7 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB000058: AB_2142367, CAB068198: , HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavourable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavourable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 47.3 24.1 25.1 17.8 1.0 2.1 7.8 18.0 13.3 17.1 15.3 19.7 19.7 35.7 5.2 12.3 28.9 26.3 13.5 25.8 37.6 12.7 30.6 17.8 12.3 0.0 43.0 16.6 0.5 0.6 17.6 18.0 16.7 14.0 34.4 16.9 18.8 25.6 13.1 10.0 11.0 19.1 32.9 4.7 6.2 13.3 8.7 9.5 25.5 9.2 4.4 7.5 9.2 15.4 9.1 18.2 12.8 48.6 15.7 12.4 43.3 7.5 19.7 7.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 MKL1 "BSAC, KIAA1438, MAL, MKL, MRTF-A" ENSG00000196588 "Megakaryoblastic leukemia (translocation) 1" Q969V6 22 40410281-40636702 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Actin-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 50.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030782 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030782: AB_10600930" "unprognostic (7.90e-3)" "unprognostic (4.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (9.37e-2)" "unprognostic (4.38e-3)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-2)" "prognostic unfavourable (1.58e-7)" "unprognostic (9.05e-2)" "unprognostic (8.15e-2)" "unprognostic (1.30e-2)" "unprognostic (3.98e-1)" 18.1 11.1 15.4 25.4 19.1 69.2 15.8 16.2 26.1 17.6 14.2 13.5 10.1 11.3 27.6 12.9 12.3 17.5 13.2 16.3 14.2 11.1 11.3 8.9 17.4 25.6 11.8 16.6 16.9 14.5 10.2 10.5 18.9 12.6 14.2 9.4 13.3 16.9 15.7 14.3 18.0 13.6 15.7 11.0 23.9 14.3 25.4 10.8 28.2 17.3 9.0 25.5 15.5 14.6 4.9 26.4 50.9 15.0 3.8 5.6 7.5 10.7 14.6 6.3 7.5 8.0 6.1 12.4 10.5 6.8 9.7 9.4 6.8 3.3 11.5 4.3 11.0 14.2 5.3 12.9 6.3 12.7 9.3 19.0 16.3 10.1 7.9 22.0 37.5 6.6 15.6 9.4 6.5 7.1 5.3 5.2 4.6 10.5 8.6 24.7 5.0 5.1 14.0 7.1 5.8 7.7 8.1 3.5 3.8 17.2 8.7 6.3 5.8 24.9 11.6 6.6 17.7 8.7 9.0 7.0 6.2 16.5 5.4 11.1 12.7 12.0 15.0 50.9 4.4 11.6 4.1 3.2 4.0 3.4 17.8 4.9 5.6 4.7 14.5 3.8 15.0 26.4 5.2 7.5 15.4 19.1 16.2 26.1 14.2 11.1 11.8 16.6 12.6 10.8 MLLT11 AF1Q ENSG00000213190 "MLLT11, transcription factor 7 cofactor" Q13015 1 151057758-151068497 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1" "Cell line enhanced" "Detected in many" "AF22: 38.4;EFO-21: 29.2;SH-SY5Y: 42.1;U-698: 35.8" "Cancer enhanced" "Detected in all" "glioma: 29.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000540: " "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 1.9 7.5 13.6 3.4 9.1 1.1 1.2 16.3 42.1 1.9 2.1 5.1 1.2 0.8 3.7 1.2 1.3 0.8 11.1 11.8 11.3 16.4 1.2 1.2 5.3 2.3 10.3 1.2 4.2 1.3 8.4 1.8 1.2 3.2 1.3 1.1 1.2 1.5 1.2 2.6 1.0 2.0 4.2 5.8 2.1 0.9 1.2 1.2 2.0 1.2 1.2 2.6 3.2 1.2 2.4 1.0 6.5 1.0 4.2 9.2 2.8 1.2 5.2 38.4 6.0 0.6 1.0 0.6 2.4 2.6 2.3 4.2 0.5 2.5 1.9 29.2 1.8 1.5 9.2 2.2 1.3 11.2 2.5 5.0 3.8 0.1 1.2 0.3 0.8 1.7 0.3 12.7 0.5 16.9 5.3 0.9 7.4 0.4 17.6 3.3 16.7 0.8 16.8 5.1 0.1 4.3 1.1 23.1 42.1 0.2 0.4 1.2 1.4 0.6 11.8 5.0 5.5 1.8 4.3 0.9 0.8 35.8 12.4 0.3 9.3 1.6 0.6 1.6 5.9 0.7 2.7 2.4 3.9 6.0 0.8 2.1 5.3 9.2 6.5 4.2 1.0 1.0 3.6 2.8 13.6 9.1 16.3 21.0 11.3 16.4 10.3 1.2 3.2 1.2 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836557-22849027 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 98.0;HHSteC: 92.7;HSkMC: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" 570000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: " "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 60.9 10.5 2.4 16.6 4.7 0.2 64.2 2.2 3.2 56.3 35.0 8.2 12.7 12.0 53.1 24.1 47.0 21.9 39.6 17.5 3.4 1.8 16.8 9.0 29.8 16.9 5.8 2.9 39.3 11.2 34.4 4.7 73.5 16.4 39.1 11.3 27.1 24.4 16.7 20.4 37.0 22.9 28.5 20.7 22.5 18.2 26.3 4.6 5.4 22.3 14.6 16.7 52.5 53.9 0.1 0.7 0.0 0.7 0.0 0.0 0.1 7.9 0.1 2.4 0.1 98.0 62.3 45.0 25.1 50.6 7.6 13.6 2.3 29.9 0.1 14.0 26.4 20.3 0.0 26.1 9.8 0.1 0.1 3.7 0.1 0.5 92.7 0.0 0.1 94.2 15.8 31.7 27.2 46.0 0.1 0.2 17.9 0.1 0.0 9.0 1.5 4.3 0.3 8.6 0.0 6.9 13.7 0.0 0.0 16.4 0.0 54.4 0.1 8.1 40.7 61.9 5.3 18.0 28.6 0.1 0.1 0.1 37.7 0.0 35.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 4.7 2.2 3.2 3.4 1.8 5.8 2.9 16.4 4.6 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: " "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 5.9 8.1 6.5 11.2 3.4 2.5 4.6 4.5 5.4 4.7 4.8 7.4 8.0 3.7 10.0 4.1 4.6 3.8 6.5 0.8 9.7 5.0 3.8 6.0 11.1 4.4 2.9 14.9 7.2 5.6 4.0 2.4 8.0 9.0 7.7 4.8 17.6 8.3 22.6 5.9 12.2 7.7 6.7 8.9 7.4 8.9 3.6 21.3 8.5 13.1 4.5 8.0 8.8 9.1 9.2 14.4 18.9 4.3 6.0 5.7 2.5 9.1 33.1 11.2 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170226 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavourable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favourable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 13.7 15.5 32.0 17.5 25.1 12.3 54.1 37.1 32.6 18.5 16.0 9.3 7.0 9.9 18.9 17.1 26.5 11.9 12.3 9.4 25.4 22.2 12.0 11.5 13.6 16.1 17.5 21.9 10.4 7.2 13.6 43.5 17.4 24.0 11.3 18.7 10.8 18.1 10.3 15.4 28.4 11.0 16.8 31.7 12.7 11.2 9.9 17.9 10.8 8.7 12.9 18.2 19.6 18.5 18.6 24.6 19.4 25.2 17.1 28.3 15.6 19.3 10.6 23.7 11.6 11.6 16.3 13.1 20.9 25.1 18.3 8.9 17.0 11.4 16.0 12.7 11.4 20.4 22.6 21.7 24.6 11.8 14.8 12.8 8.8 30.6 11.5 31.9 19.9 10.3 19.5 10.8 31.3 20.9 30.1 4.5 27.8 15.7 24.5 37.7 21.7 14.7 30.4 11.0 10.5 16.5 20.4 16.3 7.0 35.2 15.7 15.0 27.5 19.9 16.4 17.2 17.1 15.1 14.8 6.7 16.2 63.5 15.5 26.2 21.7 13.0 22.0 19.4 22.3 25.2 28.3 18.6 23.1 23.2 24.6 14.6 24.8 23.6 2.7 17.1 17.4 14.7 23.0 15.6 32.0 25.1 37.1 32.6 25.4 22.2 17.5 21.9 24.0 17.9 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105037983-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Enhanced Mitochondria Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 13.9 25.0 14.1 16.9 18.5 13.3 15.4 13.2 20.6 13.7 18.9 15.9 14.3 19.0 17.6 13.2 16.7 16.2 8.9 39.1 14.4 15.3 24.5 23.5 10.0 14.5 18.1 15.7 21.0 17.3 22.0 23.9 8.4 25.2 15.8 22.0 10.9 15.3 16.4 56.8 14.0 17.0 16.6 15.0 14.0 17.4 20.6 16.6 20.7 15.6 28.7 16.8 15.2 12.4 22.1 20.4 7.1 17.2 20.0 22.8 14.5 22.0 9.5 20.1 18.5 10.6 11.0 23.6 14.2 13.6 22.5 20.3 50.8 15.5 23.0 14.1 11.1 20.0 39.4 20.6 24.0 14.2 25.9 22.7 14.1 30.6 17.7 16.8 10.2 13.1 14.0 18.5 15.5 17.2 32.4 12.1 15.3 17.7 22.6 22.1 31.8 21.0 28.9 17.3 32.0 28.2 15.5 17.5 10.5 16.4 24.1 19.1 19.8 17.1 11.2 13.3 26.9 13.2 15.2 11.1 13.1 18.4 11.5 25.8 11.1 7.1 11.6 4.6 19.9 14.6 22.0 22.1 22.0 20.9 20.4 16.5 22.3 21.9 1.3 20.0 17.2 15.2 22.8 14.5 14.1 18.5 13.2 20.6 14.4 15.3 18.1 15.7 25.2 16.6 MVB12A "FAM125A, FLJ32495" ENSG00000141971 "Multivesicular body subunit 12A" Q96EY5 19 17405722-17433724 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041885, HPA042231" Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA041885: AB_10964218, HPA042231: AB_10961043" "unprognostic (1.34e-2)" "prognostic favourable (3.26e-4)" "unprognostic (1.48e-1)" "unprognostic (2.35e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (5.96e-3)" "unprognostic (8.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.77e-1)" "unprognostic (9.93e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" 18.4 24.6 9.4 16.2 9.8 14.1 21.1 10.1 12.3 13.4 16.3 13.3 22.2 19.0 16.4 15.2 24.0 16.8 17.1 10.4 8.2 6.1 17.4 16.6 12.4 21.1 11.8 7.1 33.8 16.8 9.6 7.2 15.1 8.8 12.5 9.5 15.6 17.0 17.3 11.4 20.0 20.4 9.0 9.2 17.7 14.2 10.7 11.3 19.6 29.5 12.4 22.8 15.6 15.3 13.8 28.2 24.6 30.6 17.7 26.3 17.4 16.3 9.2 4.3 12.9 6.0 9.6 23.7 5.1 10.2 13.8 17.1 8.5 24.4 13.1 17.0 11.2 7.9 8.4 12.6 3.7 13.9 23.4 2.9 19.1 19.8 18.6 5.2 12.6 10.6 9.7 10.7 6.7 15.2 9.2 25.6 5.5 12.3 9.3 8.1 6.2 26.0 11.8 4.7 19.2 11.4 9.1 8.2 12.2 7.4 11.1 26.5 14.6 10.9 7.4 10.5 5.5 11.2 6.1 18.2 22.6 14.3 10.9 18.4 12.8 24.6 30.1 19.2 17.3 30.6 16.2 11.9 17.5 16.3 28.2 13.8 14.7 14.4 17.6 17.7 23.8 25.5 26.3 17.4 9.4 9.8 10.1 12.3 8.2 6.1 11.8 7.1 8.8 11.3 MYH9 "DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA" ENSG00000100345 "Myosin heavy chain 9" P35579 22 36281277-36388067 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001644, CAB015386, HPA064783" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" 3100000000 "Plasma membrane, Actin filaments" Cytosol "CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721" "unprognostic (1.38e-1)" "unprognostic (9.12e-2)" "unprognostic (4.21e-2)" "unprognostic (6.34e-2)" "unprognostic (1.49e-1)" "unprognostic (3.90e-2)" "unprognostic (9.56e-2)" "unprognostic (8.28e-2)" "unprognostic (5.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (9.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.62e-1)" "unprognostic (2.59e-2)" 115.5 26.1 11.9 43.7 12.9 55.6 59.0 9.3 16.8 67.1 44.6 18.0 26.4 26.9 120.8 39.7 48.3 45.6 66.9 39.2 11.0 8.1 45.0 42.8 74.4 57.7 15.1 9.2 56.4 43.9 19.0 15.4 65.7 17.9 47.6 23.6 32.4 66.2 27.2 36.9 40.3 49.8 46.7 13.5 91.5 37.1 25.8 11.9 76.0 42.5 38.4 65.0 56.0 53.7 6.9 8.2 28.5 11.5 4.2 16.6 19.3 60.6 28.2 9.0 7.6 16.8 21.1 45.7 40.7 52.7 58.2 43.7 30.4 17.5 15.7 24.2 68.1 42.1 13.1 79.7 60.0 35.4 12.4 30.3 30.3 25.9 51.5 34.4 48.6 24.9 24.6 78.6 66.8 47.9 6.6 21.3 46.5 16.1 12.2 20.3 5.3 17.4 23.3 27.9 14.6 32.9 59.1 13.5 5.5 57.2 22.5 26.2 16.8 17.8 137.0 129.1 39.2 24.7 73.5 14.1 11.1 13.3 48.9 17.4 37.4 26.8 10.4 28.5 16.6 9.6 14.7 6.9 12.0 13.2 8.2 6.4 9.6 10.1 19.7 4.2 11.5 3.8 12.6 19.3 11.9 12.9 9.3 16.8 11.0 8.1 15.1 9.2 17.9 11.9 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavourable (9.53e-6)" "prognostic unfavourable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 30.9 11.8 29.9 15.5 1.1 1.6 19.8 14.7 10.3 28.4 30.0 21.8 17.4 28.9 10.4 6.4 14.0 25.6 10.0 30.5 25.4 17.0 29.8 12.3 19.6 0.2 27.5 25.5 0.5 1.1 22.0 9.3 11.2 20.6 21.5 13.4 14.6 40.4 28.7 21.4 14.9 31.4 27.2 23.5 5.6 12.0 17.8 13.6 8.5 12.0 5.2 8.8 20.4 6.5 21.0 32.1 19.6 23.7 11.5 16.3 30.8 9.1 27.6 23.7 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: , HPA070520: " "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.6 4.9 8.7 4.5 9.6 8.8 13.3 3.5 7.1 4.5 4.0 4.6 2.8 4.8 1.5 6.4 1.6 5.2 3.0 4.9 22.8 7.5 17.2 2.0 1.9 6.0 7.9 14.4 14.0 4.6 4.3 3.5 4.5 10.4 8.0 6.8 4.4 7.0 2.8 4.1 3.3 5.5 40.1 2.4 4.9 9.0 8.0 6.3 8.2 5.0 3.6 6.0 4.0 4.9 7.5 5.9 5.1 3.5 9.3 8.0 8.4 4.3 5.0 3.7 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412551-5458463 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA020068: " "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavourable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 19.4 4.8 14.2 25.8 16.7 15.0 39.8 11.8 15.2 30.2 39.3 21.0 32.1 24.1 19.4 25.7 38.2 20.7 25.9 8.4 16.5 12.7 21.3 19.0 9.5 10.5 19.0 9.4 15.2 19.4 2.9 6.6 51.8 20.8 23.0 38.9 20.3 43.0 23.2 16.7 21.8 54.7 33.4 19.9 3.9 33.5 11.8 10.9 14.8 18.1 26.8 20.2 28.0 31.8 1.8 5.9 2.7 1.2 1.0 11.5 2.4 27.9 16.6 11.6 12.9 6.8 3.1 63.7 16.9 9.3 13.7 13.1 9.1 53.3 10.3 7.1 10.3 45.8 14.0 25.6 16.5 9.6 10.1 18.6 5.6 20.3 1.8 5.3 8.1 4.6 15.3 13.5 3.2 7.9 32.8 16.3 7.5 13.3 17.9 7.4 15.6 12.7 11.3 21.4 8.0 8.4 14.0 9.9 5.5 14.9 27.7 5.0 9.2 15.9 7.2 5.2 8.2 8.0 13.7 10.0 5.4 13.5 4.7 8.1 10.8 2.7 0.8 1.8 0.9 1.2 0.0 1.8 1.6 0.5 5.9 0.9 11.5 2.1 0.1 1.0 0.6 2.5 5.1 2.4 14.2 16.7 11.8 15.2 16.5 12.7 19.0 9.4 20.8 10.9 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.7;BJ hTERT+: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: " "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavourable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavourable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 9.0 11.3 4.3 5.5 6.7 0.4 10.9 4.2 5.1 28.2 14.0 3.3 8.9 3.4 19.0 11.4 9.1 13.8 21.6 7.8 4.9 1.3 6.4 0.9 5.6 3.3 8.0 4.1 33.1 2.7 8.4 8.6 14.0 6.3 14.8 3.9 9.3 4.0 13.5 4.6 6.9 5.9 20.9 2.8 4.2 7.7 9.6 3.1 1.5 11.0 5.9 5.8 22.3 14.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 13.4 19.7 0.0 8.8 25.4 12.0 10.5 0.0 7.4 7.4 0.2 12.6 0.0 3.6 0.1 7.3 0.0 0.3 5.7 9.2 0.0 6.5 0.0 0.0 14.2 0.1 7.2 0.0 9.3 1.8 0.0 2.3 0.4 0.0 0.8 1.1 0.0 0.5 0.8 1.0 0.0 0.1 1.5 6.3 0.0 1.7 2.9 5.3 2.3 5.3 11.2 2.3 10.5 0.0 5.4 0.7 5.2 2.3 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 6.7 4.2 5.1 4.9 1.3 8.0 4.1 6.3 3.1 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 10.7 21.5 16.4 15.4 16.0 11.6 21.7 14.4 15.0 30.7 24.9 21.1 19.9 26.9 10.6 13.1 18.8 32.5 17.8 36.2 17.8 17.2 24.1 13.1 65.4 21.8 31.8 17.2 14.5 22.6 24.2 28.8 15.5 26.6 19.2 15.0 25.7 23.6 24.0 20.8 29.0 19.4 19.7 13.7 19.6 20.6 16.8 19.1 17.0 20.4 23.5 12.6 20.4 11.7 14.5 17.2 13.6 20.8 24.1 41.7 39.0 6.2 16.3 15.5 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA055238: " "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 NOL3 "ARC, CARD2, MYP, NOP30" ENSG00000140939 "Nucleolar protein 3" O60936 16 67170154-67175735 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.1" "Cell line enhanced" "Detected in many" "T-47d: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009208 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009208: AB_634091" "unprognostic (2.83e-2)" "unprognostic (1.63e-2)" "unprognostic (3.34e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-3)" "unprognostic (2.83e-1)" "prognostic unfavourable (6.43e-5)" "unprognostic (5.74e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (2.15e-1)" "unprognostic (8.08e-3)" "prognostic unfavourable (2.41e-4)" "unprognostic (1.39e-2)" "unprognostic (3.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.48e-2)" 16.3 22.6 13.0 3.2 19.6 1.3 9.4 7.3 14.1 8.4 7.1 10.8 19.7 5.3 7.5 10.5 15.4 7.8 15.7 29.1 11.1 8.3 10.1 12.8 10.1 2.6 15.9 12.3 6.8 12.3 22.8 14.8 8.6 12.7 19.8 6.1 13.8 18.0 13.3 76.1 39.7 5.2 10.6 11.6 3.7 11.1 2.7 15.8 0.6 9.6 27.7 6.3 9.4 9.2 0.0 2.1 1.5 6.8 0.7 3.4 2.5 6.1 10.1 1.7 9.5 8.5 6.5 9.5 5.0 5.3 5.4 3.2 2.1 16.3 0.1 16.6 5.8 10.3 2.3 7.7 1.3 5.5 3.5 0.2 8.0 3.2 5.3 0.5 1.2 3.9 14.4 4.3 3.0 2.3 2.2 6.6 10.2 16.1 0.1 0.8 1.6 24.9 5.5 3.5 12.3 9.2 1.9 13.5 7.2 21.0 15.2 2.2 32.5 1.7 5.2 7.2 6.2 7.0 4.3 9.6 3.0 1.7 20.4 1.5 2.4 0.0 6.8 0.0 0.3 0.6 0.1 0.0 3.4 0.3 2.1 0.0 0.0 0.5 1.5 0.7 0.2 2.1 0.0 2.5 13.0 19.6 7.3 14.1 11.1 8.3 15.9 12.3 12.7 15.8 NPM1 "B23, NPM" ENSG00000181163 "Nucleophosmin 1" P06748 5 171387116-171411137 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011384, CAB012983" Supported Enhanced Nucleoplasm,Nucleoli 810000 Nucleoli Nucleoplasm "CAB012983: AB_2533084, HPA011384: AB_1854692" "unprognostic (1.84e-3)" "unprognostic (2.59e-1)" "unprognostic (2.23e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (7.48e-4)" "prognostic unfavourable (4.82e-6)" "unprognostic (1.86e-2)" "unprognostic (5.25e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-3)" "unprognostic (1.27e-1)" "prognostic unfavourable (2.89e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.24e-2)" 56.8 44.7 29.9 61.1 33.6 76.0 67.0 37.7 34.6 113.5 57.8 24.8 39.3 36.7 78.2 50.5 81.6 65.0 44.0 48.5 28.8 31.6 64.9 78.8 59.5 128.1 36.1 27.9 177.4 102.0 27.1 57.9 65.2 36.1 87.2 49.3 29.5 47.3 48.2 67.9 42.7 52.8 92.4 43.2 85.9 54.0 56.7 31.3 111.3 112.6 66.5 82.1 116.8 65.7 85.3 54.1 12.3 29.1 59.0 126.6 91.4 118.4 80.2 97.5 138.1 59.6 108.9 145.4 107.8 98.5 146.1 131.6 191.5 83.7 317.2 85.7 62.3 69.5 135.3 245.1 190.4 98.7 107.3 111.9 78.7 141.0 88.4 225.3 92.8 96.0 86.4 99.1 195.6 109.0 136.0 73.0 106.0 147.1 147.0 160.3 122.0 98.6 132.0 107.6 162.6 124.6 83.6 76.9 61.8 64.4 105.4 195.1 129.3 100.0 68.0 48.9 107.8 56.2 181.5 58.5 106.3 190.8 73.9 183.5 97.4 12.3 26.9 8.4 45.7 29.1 84.6 85.3 85.1 66.2 54.1 62.8 126.6 99.0 4.0 59.0 23.1 48.7 73.2 91.4 29.9 33.6 37.7 34.6 28.8 31.6 36.1 27.9 36.1 31.3 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavourable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.0 20.5 1.5 0.0 13.5 15.1 1.8 15.8 18.9 13.6 15.8 1.5 13.5 8.9 7.2 23.1 9.6 0.1 12.4 16.9 5.0 7.0 2.3 27.8 4.4 12.7 9.2 7.1 10.9 16.1 22.4 21.9 5.1 3.3 34.0 12.0 3.6 5.4 6.6 4.1 4.3 1.9 14.3 18.9 4.0 0.7 2.7 2.1 27.6 4.0 6.6 1.8 13.3 12.1 33.2 6.6 15.8 11.9 6.9 6.2 14.0 17.4 9.5 11.5 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.2;HUVEC TERT2: 30.0;TIME: 28.6;U-251 MG: 58.5;U-87 MG: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Supported "Vesicles,Plasma membrane" "Secreted in other tissues" 15000000 "Vesicles, Plasma membrane" "HPA039980: AB_10795517, HPA054974: " "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavourable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavourable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.6 14.1 9.0 0.0 8.2 2.6 2.6 2.2 4.3 2.8 2.7 13.3 34.2 0.0 3.4 7.1 5.4 0.4 4.3 4.6 0.0 1.9 0.1 0.6 0.1 22.2 0.0 0.5 19.5 3.3 3.9 3.5 30.0 0.0 0.0 1.9 0.0 0.0 0.0 11.3 2.5 0.0 0.5 3.1 5.7 0.0 8.1 0.3 0.3 0.0 20.2 0.0 0.1 28.6 12.4 0.1 3.2 58.5 0.0 0.0 0.8 27.6 0.0 25.9 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favourable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.6 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 8.9 8.9 10.9 9.0 7.7 15.8 6.6 17.7 6.4 3.3 7.6 13.3 5.5 5.8 12.0 4.9 12.0 8.5 13.6 10.2 10.4 9.1 0.1 12.2 1.9 7.6 0.1 3.5 7.7 9.5 10.2 7.2 10.3 13.8 11.8 9.8 6.5 16.3 6.8 8.1 5.2 8.0 13.8 11.9 10.1 4.5 9.7 12.8 7.3 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56810479 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 27.7;retina: 78.2" "Group enriched" "Detected in some" 545 "HAP1: 62.7;NTERA-2: 52.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;pons and medulla: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.2 0.2 0.0 0.2 0.3 0.2 0.2 20.4 0.3 0.2 0.2 3.7 0.0 0.2 0.2 1.0 0.2 0.2 0.2 0.2 1.8 2.7 0.2 0.2 0.2 0.5 4.7 0.0 0.5 0.2 0.2 2.8 0.2 27.7 0.3 0.2 78.2 0.2 1.3 0.2 0.5 0.2 0.2 0.2 0.4 0.2 3.1 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.4 0.3 1.8 2.7 4.7 0.0 27.7 2.3 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132191838-132295315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 61.3;U-87 MG: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "CAB062557: , HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavourable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavourable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (3.12e-4)" 10.2 5.6 7.1 6.5 5.4 0.8 12.2 9.5 7.8 14.4 12.5 4.6 6.1 9.8 20.0 35.3 11.6 13.7 9.7 26.1 6.6 7.0 34.4 6.3 16.0 4.3 6.3 4.2 6.7 42.5 6.7 15.8 15.1 9.5 9.3 14.6 15.1 21.1 8.4 7.1 9.3 17.1 23.3 5.1 6.3 12.6 5.1 4.4 4.1 12.2 10.8 5.4 11.3 34.5 0.2 1.0 3.1 1.3 2.6 2.6 0.7 10.1 6.2 2.0 9.9 27.9 33.3 11.3 47.5 40.6 20.2 50.0 14.0 8.9 0.2 14.0 50.8 12.8 6.2 24.8 32.0 7.5 2.1 0.0 9.1 8.4 61.3 0.0 6.1 20.1 36.7 23.9 22.0 10.6 3.6 0.6 24.7 4.0 0.0 0.0 0.5 5.1 0.1 0.6 1.5 5.6 1.9 1.0 2.8 12.1 4.0 8.0 5.0 0.7 16.3 30.7 12.0 9.3 10.2 4.3 4.6 2.0 59.2 0.0 8.5 0.0 1.3 0.0 2.6 1.1 2.4 0.0 1.4 0.4 0.6 0.2 0.0 0.4 3.1 2.6 0.2 1.0 0.0 0.7 7.1 5.4 9.5 7.8 6.6 7.0 6.3 4.2 9.5 4.4 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720452 "Enzymes, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.3;eosinophil: 62.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA049781: " "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favourable (9.14e-4)" "prognostic favourable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 13.5 7.4 24.3 14.4 28.5 11.1 25.2 16.4 32.2 26.6 10.0 45.0 9.4 7.9 25.1 22.8 18.3 24.9 13.3 7.7 31.3 23.9 16.7 5.1 22.0 14.7 29.7 21.9 15.6 24.6 15.6 15.5 8.5 38.2 21.7 12.7 9.5 32.2 14.0 3.3 24.5 8.5 17.0 59.9 9.6 30.4 8.1 25.5 14.7 10.3 11.0 24.6 16.5 13.7 8.5 9.2 62.2 10.2 4.6 6.8 5.8 10.5 9.6 16.3 20.4 20.2 25.5 13.1 13.4 25.4 13.2 17.7 14.7 15.3 16.5 8.6 24.7 13.3 15.4 26.6 17.0 38.7 11.7 19.2 20.9 32.9 11.1 29.1 33.3 21.1 13.8 15.2 12.5 29.2 4.2 32.1 36.9 16.1 23.4 9.0 17.5 10.7 19.7 25.9 4.7 19.8 14.7 18.6 26.9 13.9 21.1 16.4 12.5 4.5 17.2 16.5 17.0 11.0 11.3 25.8 17.1 15.4 20.1 22.3 25.9 50.3 8.9 62.2 3.0 9.6 3.5 8.5 4.0 3.4 9.2 4.1 2.5 2.9 9.4 4.6 10.2 1.8 6.8 5.8 24.3 28.5 16.4 32.2 31.3 23.9 29.7 21.9 38.2 25.5 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Cell line enhanced" "Detected in many" "A-431: 19.3;BEWO: 16.4;RPTEC TERT1: 16.9;RT4: 18.1;SK-BR-3: 16.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Enhanced "Cell Junctions,Centriolar satellite" "Cell Junctions, Centriolar satellite" "HPA066352: , HPA066960: , HPA069079: " "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favourable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.3 3.9 1.3 1.7 0.7 1.9 16.4 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 6.0 1.7 0.0 0.1 0.7 10.9 2.0 4.6 0.6 0.0 0.0 1.0 6.8 0.0 0.0 6.7 1.0 0.0 1.5 2.7 16.9 18.1 3.4 1.1 4.9 16.1 4.2 12.8 0.2 0.1 1.0 2.5 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA057849: " "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favourable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favourable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 18.5 22.6 24.2 28.9 24.9 9.7 32.4 49.7 27.3 20.1 14.9 21.1 19.2 14.9 26.0 33.5 15.2 17.2 21.2 26.2 19.8 20.2 22.9 20.2 20.0 25.6 18.5 22.8 38.9 18.1 20.4 21.8 26.3 18.0 19.9 13.6 57.8 20.5 16.9 25.7 42.1 15.7 17.3 19.6 22.1 13.7 17.0 18.2 31.2 19.5 10.5 18.5 17.7 18.1 9.5 7.5 8.3 6.6 14.1 18.1 7.9 10.9 4.0 16.0 12.4 15.4 19.2 15.3 6.8 7.5 9.9 6.1 9.5 17.7 16.5 12.1 8.1 13.6 8.7 11.0 13.4 3.5 11.9 7.9 18.0 15.8 13.0 8.2 12.2 27.1 15.3 5.2 9.1 14.4 14.6 14.9 8.1 7.1 18.8 27.2 11.7 17.0 15.8 6.3 19.6 15.1 12.7 25.4 30.0 13.0 15.0 17.6 16.0 16.5 10.4 14.9 5.3 9.5 5.4 18.1 14.6 15.9 9.9 8.7 8.7 7.6 6.6 7.6 8.4 4.5 10.0 8.9 12.5 9.5 7.5 9.5 17.7 12.7 8.3 14.1 4.1 4.7 18.1 7.9 24.2 24.9 49.7 27.3 19.8 20.2 18.5 22.8 18.0 18.2 PDCL3 VIAF1 ENSG00000115539 "Phosducin like 3" Q9H2J4 2 100562690-100576735 "Predicted intracellular proteins" "Angiogenesis, Apoptosis" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018469, HPA027094" Approved Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018469: AB_1855116, HPA027094: AB_10601387" "unprognostic (1.34e-1)" "unprognostic (8.30e-2)" "unprognostic (2.20e-1)" "unprognostic (3.32e-2)" "unprognostic (5.07e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (6.07e-5)" "unprognostic (1.44e-1)" "unprognostic (5.46e-2)" "unprognostic (1.66e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (2.55e-5)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (8.22e-2)" "prognostic favourable (4.23e-4)" 12.9 15.9 14.7 16.4 16.2 12.0 18.0 10.7 16.5 12.7 18.8 14.3 15.3 10.5 20.1 23.5 22.5 14.9 13.1 17.6 14.6 15.8 20.9 12.2 13.5 14.0 24.4 15.9 15.4 10.4 10.8 11.4 17.1 17.4 19.6 17.9 10.2 12.0 15.4 35.7 22.0 12.1 49.6 18.3 14.5 13.3 14.0 14.5 13.4 13.0 18.8 19.6 29.9 16.8 26.5 33.4 22.2 43.6 25.6 31.4 23.3 13.2 18.5 19.5 16.9 6.3 8.8 21.8 16.5 10.2 29.8 18.6 23.2 8.2 21.3 25.1 19.3 11.1 24.1 15.9 23.7 34.2 20.8 22.5 10.0 27.2 16.7 23.8 24.1 9.8 29.1 26.4 16.9 18.3 18.7 14.5 22.1 22.5 23.8 36.5 25.6 27.3 23.3 20.9 14.9 18.3 30.7 18.4 16.1 12.9 17.7 18.1 13.9 16.5 14.3 18.8 19.9 14.5 22.6 8.8 16.3 22.4 11.6 27.8 14.7 18.6 19.3 22.2 19.4 34.9 22.1 26.5 29.7 21.5 33.4 20.8 31.0 23.8 2.1 25.6 43.6 18.4 31.4 23.3 14.7 16.2 10.7 16.5 14.6 15.8 24.4 15.9 17.4 14.5 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.7 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.1 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.1 3.1 19.5 5.3 17.0 12.8 19.0 0.1 11.0 15.1 10.9 11.5 28.7 7.3 17.0 5.6 13.4 12.4 13.2 6.5 7.0 2.6 8.8 20.5 8.3 11.5 15.3 11.4 23.8 24.2 6.9 20.5 9.5 22.6 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavourable (2.57e-4)" "prognostic unfavourable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 17.3 12.6 11.1 14.3 18.8 8.6 18.0 14.6 15.6 12.9 13.0 17.6 12.8 17.1 19.8 20.2 12.6 13.1 12.7 8.8 8.5 7.5 11.2 18.5 12.5 12.0 14.5 10.7 16.5 16.5 11.9 18.1 10.3 13.6 14.0 14.4 15.5 14.8 16.3 13.4 20.0 15.8 10.1 9.7 12.3 14.8 11.1 13.6 13.7 15.7 11.1 20.4 10.9 12.3 5.2 7.4 5.5 3.7 5.4 9.3 3.3 8.2 11.8 8.0 6.6 11.5 10.8 3.3 4.6 5.5 7.7 13.8 12.0 10.6 4.0 9.4 4.4 12.1 9.8 5.8 11.1 8.6 25.7 8.0 8.2 14.3 12.3 3.4 5.2 9.1 15.2 13.5 15.4 8.8 9.5 5.1 6.1 8.2 6.2 8.0 3.1 6.1 6.1 6.7 11.6 8.7 4.5 4.2 6.0 4.8 3.4 9.4 3.7 3.1 5.7 7.0 4.3 4.6 13.0 3.6 0.1 6.5 8.8 8.5 4.4 0.0 3.7 5.5 6.5 3.2 5.6 5.2 8.5 5.0 2.7 4.4 9.3 7.5 0.0 5.4 2.4 7.4 6.7 3.3 11.1 18.8 14.6 15.6 8.5 7.5 14.5 10.7 13.6 13.6 PKLR ENSG00000143627 "Pyruvate kinase L/R" P30613 1 155289293-155301434 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.2;kidney: 12.4;liver: 47.8" "Cell line enriched" "Detected in some" 9 "K-562: 47.4" "Cancer enriched" "Detected in some" 9 "liver cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.7" "Low region specificity" "Detected in some" "HPA006653, CAB034376, CAB034378" Enhanced Approved "Golgi apparatus,Cytosol" 2900000 "Golgi apparatus, Cytosol" "CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: " "unprognostic (9.16e-2)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (2.62e-1)" "unprognostic (7.86e-4)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (8.79e-2)" "unprognostic (1.89e-1)" "unprognostic (4.07e-1)" "unprognostic (4.53e-2)" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (6.21e-3)" 0.1 0.0 0.1 0.3 0.1 7.2 0.1 0.9 0.2 0.1 4.9 0.1 0.1 5.8 0.1 1.3 0.1 0.0 0.7 0.1 0.1 0.4 12.4 47.8 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 17.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 42.9;T-47d: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 22.9 20.7 7.2 0.5 3.8 6.2 2.8 4.9 8.2 16.3 9.5 1.5 20.3 0.0 32.3 17.6 28.8 0.3 11.3 14.9 0.0 0.6 0.0 9.3 1.7 20.7 0.1 0.6 3.6 15.7 6.3 17.6 32.8 0.0 0.8 32.2 8.3 0.0 0.0 1.3 3.4 1.1 20.0 0.0 42.9 4.6 0.4 0.9 15.1 3.0 13.2 72.3 0.3 41.8 4.5 12.2 2.0 39.1 0.0 0.0 0.0 3.5 0.0 20.0 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 PMS1 "MLH2, PMSL1" ENSG00000064933 "PMS1 homolog 1, mismatch repair system component" P54277 2 189784085-189877629 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031013 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA031013: " "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (9.31e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-3)" "unprognostic (1.49e-2)" "prognostic unfavourable (2.38e-6)" "unprognostic (5.31e-2)" "unprognostic (1.60e-2)" "unprognostic (7.29e-3)" "unprognostic (3.55e-1)" "unprognostic (2.30e-1)" "prognostic unfavourable (1.86e-6)" "unprognostic (1.29e-1)" "unprognostic (3.77e-2)" "unprognostic (1.92e-2)" "prognostic favourable (3.73e-4)" 9.8 8.2 9.6 9.8 12.4 9.9 10.1 14.6 13.2 10.6 7.5 6.9 17.3 6.6 11.8 14.5 7.3 11.4 7.5 7.1 9.7 8.0 6.3 8.6 7.1 11.1 10.1 9.9 12.2 9.8 7.6 18.2 7.6 14.2 8.9 8.2 6.7 8.4 15.0 8.4 9.9 8.5 9.6 10.7 11.1 11.5 38.8 10.9 9.6 9.6 7.3 9.2 8.2 8.4 14.0 8.1 2.9 5.5 9.0 13.2 3.7 7.9 7.2 18.4 14.5 10.1 15.3 16.2 15.2 7.5 12.9 15.7 11.8 10.9 23.7 8.7 6.3 11.8 17.9 11.2 18.4 17.7 10.4 23.6 13.1 17.6 14.0 13.6 10.7 9.8 11.4 12.0 24.6 13.4 19.6 12.9 15.9 5.5 16.1 19.1 18.2 16.6 18.7 12.6 22.7 12.4 11.7 17.2 12.0 11.3 7.1 10.8 8.1 11.2 10.4 14.1 9.7 8.8 13.4 10.3 12.6 20.5 8.2 12.1 8.9 2.2 5.5 2.9 12.0 3.3 11.2 11.7 8.8 13.2 5.0 14.0 8.9 11.4 2.8 9.0 4.1 8.1 8.2 3.7 9.6 12.4 14.6 13.2 9.7 8.0 10.1 9.9 14.2 10.9 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818902-825573 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 158.1;breast: 155.2" "Cell line enhanced" "Detected in all" "ASC diff: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" "Lipid droplets" Nucleoplasm "HPA055173: , HPA062602: , HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 158.1 7.2 1.6 9.4 1.8 11.2 155.2 2.7 2.3 4.1 35.9 1.5 3.8 5.6 4.5 7.8 8.6 4.3 7.2 12.6 1.7 1.1 15.6 7.4 11.3 4.5 1.6 1.6 4.9 11.8 2.5 4.2 11.6 1.8 5.2 1.5 1.9 8.1 8.1 25.0 6.1 23.1 3.0 2.1 4.9 8.2 4.0 1.5 1.5 11.3 4.8 5.1 13.0 18.6 4.2 6.5 18.7 8.5 3.6 5.3 3.6 10.4 8.2 1.7 4.4 64.1 5.7 11.0 11.1 9.0 7.0 6.2 6.9 10.5 6.2 6.6 8.3 9.4 2.5 4.6 2.1 7.9 22.7 8.5 3.6 11.1 21.0 5.8 10.8 11.2 6.0 4.7 5.4 5.7 7.2 6.3 6.2 6.1 7.8 12.9 4.9 17.6 7.6 3.7 13.8 6.8 2.4 6.3 8.4 20.6 17.6 6.4 7.5 6.8 10.2 6.3 4.9 4.1 5.0 24.3 15.0 5.2 15.8 8.4 4.4 9.3 8.5 18.7 3.6 5.5 3.5 4.2 4.6 5.2 5.7 3.6 5.3 4.3 7.7 3.6 6.0 6.5 3.9 3.6 1.6 1.8 2.7 1.9 1.7 1.1 1.6 1.6 1.8 1.5 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 17.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 3.3 2.2 1.5 11.6 2.8 17.6 3.4 1.7 1.6 4.4 4.2 1.1 1.5 2.6 2.8 3.5 9.0 2.4 2.3 1.6 1.0 1.2 2.5 5.1 2.2 5.3 1.1 0.3 2.7 5.0 1.4 2.5 4.1 1.4 2.1 5.2 2.6 2.6 0.7 1.1 3.7 7.7 2.9 2.7 5.4 3.0 5.3 2.4 17.6 1.6 10.3 8.4 2.1 4.2 1.2 0.9 0.7 0.0 3.2 2.7 0.5 17.1 8.8 16.7 7.7 0.8 4.9 8.5 9.8 5.0 15.6 18.1 8.8 13.5 10.7 5.6 5.5 10.6 16.7 6.0 18.5 12.5 9.2 15.9 9.7 10.9 0.4 18.9 6.9 1.4 0.4 8.5 1.4 9.0 13.9 6.9 15.6 15.0 19.2 12.4 9.8 20.6 16.4 15.4 9.7 5.6 9.7 12.0 6.9 9.9 5.8 3.1 11.7 6.7 3.2 2.5 18.6 10.4 7.7 5.0 10.2 24.7 4.7 14.0 10.0 0.0 0.0 0.7 0.9 0.0 0.7 1.2 0.9 1.7 0.6 1.2 0.1 0.8 0.0 3.2 0.0 0.9 2.7 0.5 1.5 2.8 1.7 1.6 1.0 1.2 1.1 0.3 1.4 2.4 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: , HPA059859: " "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.8 2.5 0.0 0.0 18.3 26.6 8.8 0.0 0.4 0.0 0.1 11.3 17.4 0.1 4.0 0.3 55.8 0.3 6.7 0.0 0.0 0.3 0.0 13.5 2.0 1.1 0.0 0.0 1.3 6.2 0.0 2.1 0.0 0.0 0.0 0.0 20.4 0.0 0.0 1.7 5.3 0.0 0.0 8.6 13.3 10.9 9.2 0.1 29.9 10.0 0.1 5.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: " "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 14.5 12.5 19.1 15.5 23.8 26.4 12.2 17.9 22.1 12.9 13.8 11.4 9.5 14.1 10.9 11.0 8.9 10.0 12.5 14.8 17.9 11.4 10.1 10.5 12.1 18.9 28.4 17.2 12.6 9.5 11.3 30.8 12.7 20.6 11.8 14.7 6.8 10.2 9.7 20.0 6.5 15.3 14.5 22.8 21.5 13.1 46.8 24.1 18.9 8.7 7.5 16.4 14.7 10.4 12.2 12.7 32.1 19.2 13.9 14.7 11.4 15.5 8.5 14.8 13.2 9.8 19.7 11.1 12.6 10.7 14.8 18.2 6.7 11.3 16.7 5.0 12.0 6.7 6.7 4.8 22.1 18.3 7.8 9.3 4.6 24.8 14.3 17.3 18.4 15.1 4.5 11.1 6.9 20.1 9.8 17.0 21.3 11.3 18.2 16.2 13.5 9.9 18.1 11.4 13.7 5.2 9.1 16.0 13.9 15.4 11.1 20.2 7.4 20.7 17.0 16.2 6.9 13.6 14.4 15.2 20.0 34.0 8.2 16.6 18.4 20.0 15.0 32.1 10.7 19.2 11.7 12.2 10.8 13.8 12.7 11.0 9.6 11.7 28.1 13.9 16.4 8.1 14.7 11.4 19.1 23.8 17.9 22.1 17.9 11.4 28.4 17.2 20.6 24.1 PRMT7 "FLJ10640, KIAA1933" ENSG00000132600 "Protein arginine methyltransferase 7" Q9NVM4 16 68310974-68358563 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044241 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA044241: " "unprognostic (9.33e-2)" "unprognostic (5.33e-2)" "unprognostic (1.52e-1)" "prognostic favourable (2.31e-5)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (4.12e-2)" "unprognostic (1.22e-1)" "unprognostic (3.74e-1)" "unprognostic (1.19e-1)" "unprognostic (4.74e-3)" "unprognostic (3.09e-2)" "unprognostic (7.72e-2)" "unprognostic (1.75e-1)" "unprognostic (9.23e-2)" "unprognostic (3.57e-1)" "unprognostic (1.31e-1)" 14.8 14.4 15.6 12.7 22.0 11.1 12.9 29.4 20.5 11.4 11.7 20.2 13.9 7.0 18.9 11.9 12.7 18.1 9.3 23.1 14.4 13.1 9.5 12.2 9.7 17.0 11.2 18.7 21.9 14.8 12.0 14.0 11.4 13.3 12.8 7.6 20.8 17.3 16.2 34.0 16.9 9.9 18.5 11.6 12.4 9.9 17.0 13.1 24.4 11.1 12.0 14.9 13.3 10.4 10.8 26.2 9.9 8.5 18.6 18.1 11.5 10.1 16.5 7.8 19.7 7.5 7.1 26.3 10.2 5.5 12.9 10.7 41.6 10.2 21.6 17.1 8.6 13.2 11.1 10.3 7.1 7.7 16.7 6.4 18.5 18.8 5.5 11.8 10.0 7.8 4.4 10.6 10.0 7.7 15.1 1.2 7.0 17.0 14.5 18.2 12.9 11.2 19.5 11.5 14.6 6.0 9.3 10.8 8.4 34.0 8.6 6.9 14.3 11.7 9.2 9.2 8.1 10.9 9.0 6.6 12.3 22.1 11.6 12.6 9.4 9.9 7.0 5.9 15.8 8.5 18.1 10.1 10.6 13.9 10.2 10.8 16.1 14.1 0.8 18.6 7.7 26.2 11.7 11.5 15.6 22.0 29.4 20.5 14.4 13.1 11.2 18.7 13.3 13.1 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell line enhanced" "Detected in some" "REH: 21.8;SCLC-21H: 6.3;SH-SY5Y: 14.2;T-47d: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062741: " "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favourable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 5.2 4.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 2.3 0.0 1.5 0.0 0.1 4.0 0.0 0.0 0.0 5.0 0.0 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.4 21.8 0.0 0.2 2.9 4.2 6.3 14.2 0.0 0.2 0.0 7.1 0.0 0.0 0.0 2.6 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome subunit alpha 4" P25789 15 78540405-78552419 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol 12000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: , HPA060613: " "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 41.2 38.8 24.9 36.7 25.8 33.4 33.0 25.3 37.5 32.4 38.0 17.9 23.7 39.4 35.3 32.5 49.9 27.1 24.4 37.7 29.8 27.6 55.7 76.3 37.4 45.1 25.5 26.9 31.2 24.4 20.2 25.9 55.4 33.8 35.3 41.3 19.1 26.0 25.0 60.3 26.3 49.1 36.6 28.1 45.5 31.5 36.5 21.4 61.6 42.6 75.0 44.8 41.3 28.3 29.4 61.9 31.4 75.6 37.7 40.0 61.4 40.1 58.2 50.4 44.4 31.8 30.1 39.5 37.8 30.4 46.6 50.0 60.5 58.7 87.7 55.9 34.8 55.0 101.6 41.0 45.1 35.9 70.8 73.6 43.6 48.7 51.6 74.8 45.5 24.3 25.7 39.2 39.1 50.2 78.9 34.4 38.0 57.8 50.4 70.2 47.4 34.2 43.9 66.7 29.4 47.2 70.4 44.5 32.5 60.6 44.3 46.1 40.9 61.6 39.9 34.8 46.5 38.3 64.3 31.5 74.2 82.7 32.6 112.5 38.3 18.8 47.4 31.4 27.8 75.6 28.5 29.4 29.2 29.0 61.9 22.9 23.3 28.3 21.7 37.7 69.7 35.3 40.0 61.4 24.9 25.8 25.3 37.5 29.8 27.6 25.5 26.9 33.8 21.4 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: " "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 46.5 30.2 36.4 26.9 25.4 26.6 39.3 36.7 35.3 59.7 45.0 37.8 38.3 40.6 46.0 31.8 35.6 46.2 32.1 62.8 38.9 20.1 29.7 24.8 40.3 30.8 42.1 28.9 19.7 32.2 30.1 30.5 37.4 44.1 17.6 43.4 42.7 32.8 29.2 29.3 41.6 28.0 63.8 18.1 39.3 47.5 26.2 19.4 32.6 20.5 31.3 42.1 30.8 28.6 33.3 46.7 25.7 37.6 12.5 31.6 45.4 21.5 28.9 30.1 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842984 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol 12000000 Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 14.1 20.1 10.2 12.2 16.2 14.7 32.5 20.7 21.8 14.6 12.9 10.2 12.3 10.3 14.8 14.1 17.3 13.8 10.6 12.7 11.7 12.3 11.5 21.0 34.8 23.6 9.8 14.1 16.7 32.2 13.3 11.7 10.5 14.5 16.1 12.5 8.8 15.1 15.7 10.0 16.7 11.2 24.5 9.9 12.3 14.4 11.3 8.1 13.0 12.6 9.2 15.5 14.9 13.5 17.5 14.4 15.2 17.9 14.2 25.2 14.2 13.2 17.3 8.4 15.6 18.8 18.7 9.9 19.7 15.5 18.7 17.1 15.3 8.8 13.6 9.0 20.0 19.9 0.0 19.4 21.8 12.4 1.9 11.3 24.0 8.5 14.2 3.9 4.3 15.6 12.6 18.1 19.4 10.8 41.4 9.1 17.4 16.5 12.1 8.2 12.4 12.4 11.1 18.3 10.7 17.2 11.7 11.5 7.4 23.8 20.3 9.4 24.3 9.7 16.7 0.0 10.1 7.8 17.4 5.5 5.5 14.9 11.6 13.1 16.4 15.2 14.9 12.3 17.1 16.5 18.6 17.5 19.9 20.5 14.4 13.2 19.4 15.1 8.1 14.2 17.9 10.5 25.2 14.2 10.2 16.2 20.7 21.8 11.7 12.3 9.8 14.1 14.5 8.1 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell line enhanced" "Detected in many" "HEL: 37.1;HMC-1: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.8 5.5 2.7 2.0 1.7 4.2 1.5 0.0 0.3 1.8 13.5 7.6 10.4 2.5 0.0 1.2 37.1 1.8 0.0 2.2 2.1 41.2 1.9 13.0 1.9 6.2 3.9 8.8 0.0 8.6 1.3 0.3 0.0 0.8 0.0 0.0 2.8 1.8 4.2 13.6 0.1 0.8 0.9 3.8 0.1 12.2 4.3 2.8 0.2 3.1 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" HPA038186 Approved Approved Nucleoplasm,Nucleoli 31000 Nucleoli Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.0 26.9 46.2 43.3 25.0 21.0 16.7 26.5 29.7 24.2 20.8 17.0 24.9 2.3 19.9 48.1 12.7 26.8 24.6 9.6 83.3 36.4 2.9 15.8 5.8 28.3 0.7 7.1 19.9 10.0 17.4 35.8 27.0 21.1 6.1 22.0 15.3 1.1 4.9 44.0 29.1 0.5 12.1 5.0 19.0 1.2 14.2 46.0 29.0 10.9 22.7 9.9 3.0 36.6 33.3 46.3 4.6 24.1 5.3 2.5 3.1 25.9 2.0 24.2 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2, small subunit processome component" Q15269 21 44107290-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 30.5;Daudi: 26.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA024573 Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 6.1 6.1 11.3 7.7 14.6 3.6 6.3 9.7 12.8 4.0 9.0 9.6 2.4 4.4 7.8 9.2 8.2 5.9 4.8 4.6 6.8 4.8 6.9 8.7 5.0 7.9 15.4 5.7 5.0 12.8 1.4 4.0 7.6 8.9 8.1 1.8 4.9 8.2 5.2 8.0 14.7 5.6 2.2 6.4 8.8 10.6 5.3 17.2 3.6 4.8 8.6 16.8 5.0 5.7 6.8 2.6 2.9 4.3 3.4 6.9 5.0 1.1 0.4 0.3 1.2 3.5 3.6 9.2 11.8 6.2 15.7 10.6 30.5 0.5 26.4 0.4 0.0 1.3 0.5 8.9 9.1 6.4 19.0 3.1 5.5 7.0 2.3 2.3 0.9 0.2 0.0 10.9 0.0 0.5 10.1 10.6 5.2 0.3 0.1 0.7 0.3 1.1 1.5 0.1 13.6 0.0 0.4 9.2 1.6 0.6 1.0 7.4 0.0 1.0 6.0 6.4 1.1 14.2 1.4 14.3 17.0 1.2 0.4 2.8 9.1 0.2 2.2 2.9 6.0 3.1 6.6 6.8 4.9 6.9 1.6 4.1 4.9 6.1 1.2 3.4 4.3 2.6 3.5 5.0 11.3 14.6 9.7 12.8 6.8 4.8 15.4 5.7 8.9 17.2 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: " "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavourable (1.74e-5)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 73.9 33.6 34.7 37.7 41.2 52.7 20.7 41.7 51.3 55.7 56.8 32.9 70.0 20.9 27.1 58.2 52.8 37.0 50.6 71.4 9.7 30.7 21.0 27.2 23.8 49.6 18.9 17.2 35.1 45.3 40.1 45.0 49.0 37.4 16.5 60.0 53.9 10.4 44.4 62.2 40.3 18.4 35.3 30.6 71.6 46.9 26.3 44.3 29.4 107.9 33.5 60.8 56.9 51.4 36.6 55.1 44.8 48.1 12.6 13.8 19.6 33.7 36.1 69.3 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 RAD23B "HHR23B, HR23B, P58" ENSG00000119318 "RAD23 homolog B, nucleotide excision repair protein" P54727 9 107283137-107332194 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029718, HPA029720, CAB033868" Enhanced Supported Nucleoplasm,Cytosol 8200000 "Nucleoplasm, Cytosol" "CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008" "unprognostic (3.95e-3)" "unprognostic (1.01e-2)" "unprognostic (2.28e-2)" "unprognostic (8.14e-2)" "unprognostic (4.71e-2)" "prognostic unfavourable (2.58e-4)" "unprognostic (2.94e-1)" "prognostic unfavourable (6.71e-4)" "unprognostic (1.34e-1)" "unprognostic (3.72e-1)" "unprognostic (3.31e-2)" "unprognostic (1.20e-1)" "unprognostic (2.94e-3)" "unprognostic (2.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" 41.0 30.1 21.9 23.5 24.5 37.0 28.9 33.3 28.1 28.9 31.4 18.4 28.2 21.8 27.0 38.0 45.3 22.6 24.1 45.5 22.2 23.0 29.7 82.0 27.7 20.7 20.8 23.3 31.6 45.9 21.0 24.8 66.1 25.6 31.1 25.9 17.3 28.7 25.8 98.2 38.2 29.1 29.4 22.6 29.8 23.0 38.5 18.6 32.8 30.4 34.0 27.1 42.1 32.6 5.2 2.5 7.1 2.7 5.0 4.9 1.2 33.3 29.7 42.1 27.0 29.0 46.0 47.5 51.8 42.7 46.2 31.8 49.2 36.6 46.9 21.0 56.6 47.0 58.0 46.1 46.7 31.8 19.0 24.4 31.3 37.5 38.6 43.6 21.0 38.5 43.1 44.1 66.6 32.1 39.3 35.3 41.6 54.5 42.4 22.2 44.8 34.7 31.7 55.3 22.2 39.7 31.6 38.5 26.1 35.8 50.7 31.9 51.7 17.9 29.4 34.5 33.9 42.5 38.7 24.3 44.4 25.3 36.8 26.0 36.1 1.7 2.7 2.3 4.4 2.7 4.9 4.0 2.6 3.7 2.2 5.2 4.4 3.5 7.1 5.0 1.7 2.5 4.6 1.2 21.9 24.5 33.3 27.4 22.2 23.0 20.8 23.3 25.6 18.6 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.4 4.5 1.5 0.5 3.4 3.9 1.8 2.8 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 1.7 5.7 0.0 4.3 1.1 2.1 0.0 1.5 0.0 0.0 4.4 0.3 0.3 0.0 2.6 0.4 0.0 1.6 2.7 0.0 0.0 0.4 0.5 0.0 3.5 0.0 0.9 1.4 0.3 2.0 0.0 5.4 2.8 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 RANBP9 RanBPM ENSG00000010017 "RAN binding protein 9" Q96S59 6 13621498-13711564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033767, HPA050007" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB033767: AB_2176959, HPA050007: " "unprognostic (3.59e-2)" "unprognostic (6.57e-2)" "unprognostic (4.37e-2)" "unprognostic (2.67e-1)" "unprognostic (1.78e-1)" "prognostic favourable (9.97e-4)" "unprognostic (1.30e-1)" "unprognostic (4.61e-2)" "unprognostic (5.87e-3)" "prognostic favourable (2.47e-4)" "unprognostic (1.61e-1)" "unprognostic (6.74e-2)" "unprognostic (3.51e-1)" "unprognostic (7.19e-3)" "unprognostic (1.52e-1)" "unprognostic (3.49e-1)" "unprognostic (3.09e-1)" 12.4 12.7 15.1 14.0 13.6 30.1 24.8 13.1 24.0 14.5 14.4 9.8 9.8 8.3 13.2 14.3 40.8 9.7 15.5 12.2 15.0 16.0 11.8 16.0 17.9 10.5 18.0 14.3 12.4 11.9 14.7 10.6 15.7 13.7 13.9 11.4 8.3 14.4 11.4 31.8 16.9 9.1 14.7 12.4 9.5 11.0 60.1 12.6 20.9 10.7 20.0 18.0 14.4 21.0 2.0 2.3 3.8 2.0 2.7 8.1 1.2 16.4 7.2 17.5 17.6 23.8 22.1 18.5 20.2 22.8 21.2 22.4 11.0 9.8 14.6 33.0 23.5 9.0 13.4 11.7 29.3 24.5 12.5 14.7 14.3 20.3 32.9 22.9 11.0 22.3 15.2 25.1 20.8 17.2 31.0 11.7 23.5 16.6 26.1 19.1 7.7 10.2 21.0 13.7 20.7 16.8 19.1 22.1 15.5 16.3 30.3 29.9 16.1 19.5 16.9 19.4 13.7 15.8 20.7 28.2 34.3 19.8 8.9 14.6 35.7 0.8 1.3 3.8 1.9 1.8 3.8 2.0 4.0 2.0 1.4 1.7 3.8 2.6 1.8 2.7 2.0 2.3 8.1 1.2 15.1 13.6 13.1 24.0 15.0 16.0 18.0 14.3 13.7 12.6 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell line enriched" "Detected in some" 15 "RH-30: 24.5" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 24.5 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favourable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.5 10.6 30.2 29.2 5.4 9.3 13.3 11.6 4.0 5.6 15.9 18.5 14.1 15.7 15.9 8.6 14.4 18.5 6.6 11.9 8.3 8.7 10.4 13.0 11.5 26.1 18.5 17.7 7.9 11.3 17.9 6.7 11.6 12.9 3.7 22.9 15.5 4.7 7.8 16.7 21.0 21.2 11.4 12.9 9.4 7.8 21.1 9.3 9.1 12.0 15.2 14.8 14.4 7.7 11.9 6.9 17.9 10.5 21.7 18.0 14.4 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818049-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 8.0 17.7 5.7 19.1 7.2 14.4 10.9 19.9 10.2 7.9 7.5 5.6 5.9 6.9 11.6 8.9 10.3 7.0 6.5 6.2 5.2 5.5 5.4 6.2 6.6 19.1 4.7 5.6 9.6 7.6 3.7 5.9 14.2 8.6 5.7 10.3 7.0 7.8 4.6 6.1 7.5 7.0 6.6 5.6 11.8 6.3 17.8 3.7 34.7 6.1 9.7 19.2 5.2 7.0 8.2 7.9 8.5 7.5 3.3 8.3 4.1 11.4 11.5 22.0 17.7 1.7 2.7 11.9 16.0 7.4 21.5 18.7 15.1 17.8 43.1 6.7 6.2 17.7 27.7 11.3 29.1 16.5 16.6 24.9 13.4 16.3 1.9 30.1 12.0 2.5 1.5 18.5 12.8 7.1 17.3 10.9 12.9 13.4 25.4 14.4 25.8 10.0 9.5 25.6 9.9 6.4 10.3 11.4 20.1 12.0 16.2 8.4 13.0 16.7 3.7 11.4 12.7 14.4 17.0 6.1 8.3 69.1 8.2 17.9 21.7 1.6 5.7 8.5 4.5 7.5 4.9 8.2 5.5 4.7 7.9 7.8 7.4 6.3 1.3 3.3 6.5 3.3 8.3 4.1 5.7 7.2 19.9 10.2 5.2 5.5 4.7 5.6 8.6 3.7 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457559-41470882 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.9;lung: 120.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.0;BJ hTERT+: 78.9;Daudi: 25.7;U-698: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 46.2" "Lineage enriched" "Detected in many" 26 "T-cells: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" 390000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: " "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavourable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 58.6 6.7 26.7 8.8 33.1 109.9 27.7 21.6 22.7 12.8 5.6 36.1 4.2 5.7 8.7 3.1 5.4 7.6 14.3 15.1 32.1 16.8 11.0 8.3 120.1 10.8 41.7 15.2 1.8 13.4 8.7 7.1 70.6 21.1 10.7 3.6 16.1 33.2 6.8 12.7 10.8 4.9 11.3 22.2 7.3 8.0 7.1 34.8 15.2 26.9 5.8 6.9 9.5 8.7 1.7 1.7 0.2 0.2 0.1 46.2 2.8 0.2 0.1 8.8 0.0 1.7 15.0 0.3 0.2 78.9 0.0 0.3 10.9 0.1 25.7 0.2 1.0 0.2 0.3 0.5 0.1 2.6 1.2 0.0 1.9 0.8 0.8 0.9 0.3 1.1 1.7 0.3 11.0 9.0 1.9 0.0 0.2 0.0 5.7 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.2 4.9 6.0 0.0 0.9 0.5 0.1 0.0 0.0 27.0 0.0 0.6 0.2 0.0 0.2 0.0 1.6 0.1 1.6 1.2 13.8 4.4 1.7 1.7 46.2 10.5 0.2 0.1 0.0 0.5 23.1 2.8 26.7 33.1 21.6 21.7 32.1 16.8 41.7 15.2 21.1 34.8 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: , HPA036888: " "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 13.7 9.0 12.1 11.7 18.2 31.1 16.6 23.6 17.1 12.7 10.9 12.4 8.7 7.2 15.5 7.3 10.2 11.5 9.8 8.5 11.7 8.5 9.8 11.2 10.9 13.0 15.7 11.6 19.4 12.1 16.3 17.3 13.4 13.6 10.8 10.6 9.6 12.0 9.3 18.3 13.9 10.4 13.5 11.6 10.2 10.1 17.8 15.9 18.4 15.5 9.4 12.9 11.6 11.9 6.2 2.6 7.9 4.7 10.7 7.8 2.3 9.8 8.4 13.2 10.0 5.5 6.9 12.7 12.0 8.9 10.9 13.1 13.7 8.1 18.9 10.9 8.4 10.2 20.2 8.5 18.5 13.2 9.6 30.1 10.3 9.8 5.7 30.2 10.0 5.2 5.5 19.5 14.9 10.5 24.3 16.1 11.1 6.6 17.8 10.5 21.0 11.5 18.3 20.9 12.3 5.6 12.2 12.0 9.2 15.6 7.2 8.1 6.3 11.0 13.0 16.5 11.6 10.0 12.7 7.9 13.7 27.6 7.6 12.2 10.9 7.9 3.6 4.3 6.8 2.5 7.8 6.2 5.8 4.9 2.6 5.2 7.7 5.9 4.2 10.7 4.7 2.4 4.0 2.3 12.1 18.2 23.6 17.1 11.7 8.5 15.7 11.6 13.6 15.9 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806556-12815201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favourable (1.18e-4)" "prognostic favourable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favourable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavourable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 6.5 5.5 6.4 11.4 10.6 21.9 6.6 11.0 7.5 6.8 6.6 9.2 1.6 8.6 6.8 4.4 14.1 6.0 5.7 5.1 6.7 4.8 8.7 5.9 5.5 9.2 10.6 5.8 7.3 7.0 6.2 4.1 11.8 6.1 5.3 5.7 5.5 8.8 4.3 7.1 13.4 7.1 4.4 7.8 12.0 7.4 14.1 8.4 44.8 8.6 13.4 17.4 6.0 8.0 11.3 7.8 7.1 6.8 12.9 8.6 5.0 14.8 11.2 6.8 6.8 1.0 1.9 8.4 6.9 2.9 10.4 12.1 8.8 5.7 15.9 10.5 1.6 8.9 5.5 6.8 5.7 8.6 15.0 7.6 11.9 6.8 0.7 7.0 7.1 1.0 1.7 8.8 3.2 4.0 10.5 4.7 4.9 25.5 12.8 6.9 6.7 19.6 13.8 9.8 11.4 2.6 5.9 14.1 8.2 7.5 2.7 3.1 7.4 4.3 3.8 12.4 6.2 17.6 11.4 11.5 12.7 12.6 7.3 11.2 10.0 7.1 6.8 6.4 8.6 6.6 7.0 9.8 7.0 6.1 4.2 11.3 6.6 6.5 6.8 12.9 5.9 7.8 5.5 5.0 6.4 10.6 11.0 7.5 6.7 4.8 10.6 5.8 6.1 8.4 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487061-228495766 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 15.7 30.3 25.6 12.5 28.1 12.3 10.3 33.2 54.7 11.4 10.7 15.5 12.5 14.7 12.9 12.2 18.0 14.2 14.5 17.7 25.2 24.9 16.2 20.4 11.5 9.8 20.2 29.3 20.2 19.4 22.3 16.4 8.8 22.7 15.0 6.6 12.3 30.3 12.6 55.5 15.5 13.2 8.6 16.3 19.0 14.2 9.5 11.4 11.1 27.9 19.4 11.2 10.0 13.1 2.0 1.7 8.7 2.1 1.0 2.3 0.6 9.3 7.0 4.9 10.3 5.4 3.5 9.5 7.8 4.8 4.9 3.7 3.6 6.5 21.2 16.3 8.9 7.4 6.2 6.6 1.8 9.6 8.0 6.4 5.2 4.6 14.7 7.3 12.6 6.1 11.8 3.8 5.1 4.3 10.2 41.5 3.5 5.2 11.6 6.5 11.0 7.2 9.9 4.5 20.0 3.5 5.9 10.9 11.0 7.9 16.5 21.0 11.6 17.5 9.9 6.1 6.3 6.6 7.4 75.5 22.6 11.6 16.4 7.7 10.2 0.0 1.1 8.7 1.3 2.1 1.5 1.2 1.5 2.3 1.4 2.0 1.4 1.2 0.3 1.0 1.4 1.7 1.3 0.6 25.6 28.1 33.2 47.3 25.2 24.9 20.2 29.3 22.7 11.4 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell line enhanced" "Detected in many" "AN3-CA: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064161: " "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.0 4.7 15.3 0.2 0.0 7.9 0.6 0.7 1.9 1.7 3.6 1.7 7.9 2.2 0.1 1.9 10.0 0.7 1.8 7.5 5.0 1.5 7.3 4.8 2.0 0.6 4.6 0.2 0.2 3.1 1.0 0.3 6.0 2.9 0.2 7.6 7.7 1.9 4.7 1.8 5.0 2.7 4.1 3.7 1.8 7.3 6.6 2.2 1.2 2.2 7.2 1.7 0.5 1.3 5.2 3.1 3.1 3.6 12.0 8.3 5.7 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell line enhanced" "Detected in many" "HSkMC: 17.8;U-266/84: 18.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028910 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA028910: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favourable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavourable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.6 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 2.7 1.0 2.8 0.8 3.6 1.8 1.8 5.3 2.5 9.2 0.7 0.6 17.8 4.1 3.1 6.4 4.7 2.6 4.6 6.2 5.3 1.1 1.5 0.5 3.2 1.1 1.8 12.7 3.4 1.2 2.3 3.3 3.5 4.0 1.6 5.6 0.9 5.4 5.1 1.9 5.9 1.6 2.0 18.7 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859876-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 430.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA055259: " "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavourable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 48.8 33.8 24.9 42.2 43.0 85.7 53.6 27.8 61.1 49.9 46.0 26.5 28.1 40.4 47.8 36.4 65.5 56.5 38.9 31.5 22.6 16.2 50.0 85.9 34.8 83.7 22.3 26.1 109.2 106.6 9.3 30.5 46.9 30.9 41.8 26.8 30.4 99.8 31.6 157.7 90.1 43.3 36.6 21.9 57.6 50.1 67.3 17.6 59.5 65.3 107.9 54.0 45.0 57.1 395.8 193.6 24.8 110.7 126.0 278.4 430.5 126.2 98.4 65.8 92.7 98.8 162.8 166.6 77.5 98.6 102.7 97.9 135.8 127.2 191.2 179.9 66.7 95.2 77.5 165.1 35.9 97.7 208.8 89.3 94.7 154.6 171.1 128.4 97.8 203.2 217.7 56.8 122.4 112.2 113.4 124.0 64.8 197.0 173.7 169.6 154.7 151.8 156.3 69.8 226.6 93.7 120.2 95.3 143.0 27.5 192.2 240.0 91.2 249.6 86.0 63.6 74.1 127.0 130.0 166.3 151.2 123.4 83.6 205.6 78.9 24.8 110.4 16.5 134.8 110.7 234.6 368.3 232.2 167.1 166.6 395.8 278.4 212.5 11.3 126.0 85.6 193.6 195.9 430.5 24.9 43.0 27.8 61.1 22.6 16.2 22.3 26.1 30.9 17.6 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Supported "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" 830000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 63.6 33.4 37.0 59.0 40.4 70.6 88.2 34.5 42.2 73.6 60.5 33.5 42.3 18.8 67.3 49.8 81.3 65.7 39.4 38.8 31.7 26.4 53.2 84.5 46.1 103.9 35.1 26.3 139.1 159.9 33.1 42.0 52.0 34.1 67.6 50.9 35.9 66.2 51.0 87.2 77.1 36.4 67.3 47.9 60.3 46.3 42.8 20.0 81.3 66.1 91.7 102.8 74.2 55.9 72.5 58.7 5.9 40.9 45.0 97.0 135.7 44.2 89.4 37.8 63.7 170.4 309.9 66.8 54.1 111.7 83.8 65.1 98.8 77.7 175.4 61.7 128.8 80.6 270.2 209.1 92.7 48.4 162.0 107.5 80.1 82.0 240.2 112.6 53.9 304.0 272.6 91.0 363.9 133.9 98.4 69.0 125.2 73.0 75.0 50.1 82.7 64.0 84.1 86.3 170.2 115.1 87.9 67.3 70.4 33.3 94.9 133.6 70.1 162.8 78.4 43.8 66.2 40.7 85.9 67.9 105.2 117.3 53.9 151.6 49.3 3.5 40.9 5.9 38.2 36.2 71.1 72.5 74.6 53.7 58.7 60.5 97.0 75.7 2.7 45.0 33.5 37.4 57.0 135.7 37.0 40.4 34.5 42.2 31.7 26.4 35.1 26.3 34.1 20.0 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 21.2 26.3 12.6 17.8 14.2 9.3 26.6 24.4 19.9 21.4 17.0 29.0 14.0 26.6 25.5 14.4 17.2 19.9 25.0 7.4 38.2 63.5 25.5 22.3 25.6 20.9 37.3 33.3 13.9 18.9 18.3 22.5 14.5 28.5 19.2 13.5 23.5 17.8 37.2 22.0 50.3 28.4 16.5 39.9 22.3 21.0 28.2 15.8 19.8 31.5 43.8 22.7 30.2 17.2 17.8 40.7 19.9 31.8 33.5 30.7 41.2 24.2 25.9 41.6 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor-like tyrosine kinase" 3 134065303-134250744 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: , HPA075430: " "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 23.8 13.2 8.5 12.1 9.3 6.3 27.5 10.6 9.5 26.5 19.3 12.7 18.2 8.8 25.8 19.1 21.1 16.7 15.8 17.1 8.1 6.7 12.9 12.7 12.4 9.1 10.8 7.3 39.7 17.7 14.1 17.9 18.8 8.6 26.9 12.1 16.4 15.2 21.5 15.3 15.5 13.3 28.6 8.4 13.8 14.3 20.3 10.0 13.6 23.2 11.4 15.2 27.5 31.9 2.8 0.7 6.7 1.6 3.1 4.3 1.1 25.6 6.8 21.6 16.5 27.9 29.7 16.7 17.0 39.7 22.8 25.7 21.6 19.7 5.0 28.4 21.0 24.1 15.3 21.5 32.7 8.4 6.9 13.3 7.4 13.9 21.8 6.5 11.8 19.6 25.3 14.1 28.4 19.0 4.6 2.5 22.3 12.2 9.0 8.4 18.2 8.2 4.4 16.6 10.5 18.7 19.0 10.6 15.7 20.7 15.1 25.8 18.9 11.8 14.0 18.9 17.2 19.7 13.7 1.1 1.3 2.7 12.0 10.9 13.3 6.7 1.6 3.1 2.5 1.6 2.9 1.5 4.2 3.0 0.7 2.8 4.3 3.4 0.6 3.1 1.6 0.0 1.0 1.1 8.5 9.3 10.6 9.5 8.1 6.7 10.8 7.3 8.6 10.0 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Group enriched" "Detected in some" 5 "HBEC3-KT: 656.0;RT4: 256.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: " "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavourable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 24.8 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.2 0.5 61.7 0.0 656.0 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 87.4 0.7 99.7 0.4 0.0 0.0 1.4 0.1 0.0 0.0 0.0 4.8 0.0 15.6 0.0 15.5 256.5 0.5 0.0 1.0 0.1 0.2 0.1 0.1 0.1 0.3 21.7 2.9 8.4 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell line enhanced" "Detected in all" "AF22: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: , HPA070248: " "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavourable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 7.1 3.6 53.9 11.5 21.0 18.2 7.6 8.0 15.1 5.4 9.6 22.5 26.6 6.7 25.4 8.7 26.7 16.8 20.3 5.3 3.3 22.9 10.0 23.5 17.9 17.1 6.3 3.4 14.9 16.7 17.1 17.6 8.2 6.5 9.8 24.9 7.4 2.5 8.2 16.8 11.4 3.5 13.6 5.7 38.0 32.0 14.2 8.0 18.4 4.2 10.5 16.8 10.9 15.5 5.2 8.4 9.2 3.7 1.8 3.1 9.0 2.0 13.9 9.0 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell line enhanced" "Detected in many" "AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.3 1.0 11.8 0.1 1.6 12.4 0.2 6.7 11.0 7.7 7.2 1.9 1.3 0.3 1.5 8.7 0.0 1.9 0.0 9.1 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.1 1.1 8.2 0.1 0.1 4.8 0.8 1.9 0.1 4.0 3.8 0.0 0.6 0.0 0.0 0.4 4.7 1.9 3.4 1.7 0.2 0.3 0.1 2.2 7.5 5.0 2.7 4.2 0.1 0.1 0.0 1.5 1.6 10.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA048362: " "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favourable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 27.5 49.3 34.8 35.6 49.9 36.2 30.4 17.0 52.5 23.6 30.6 14.8 23.3 38.5 22.1 38.1 36.3 26.9 28.7 32.7 29.7 31.9 33.8 49.5 26.4 40.1 29.3 40.0 28.4 41.5 9.7 30.7 28.9 22.2 32.8 16.2 22.8 48.2 26.0 52.7 21.1 37.8 15.5 19.5 49.3 36.8 30.8 18.7 44.4 43.2 25.4 35.5 21.6 23.3 61.7 83.7 39.6 71.7 29.9 53.1 71.6 31.8 23.3 25.2 14.5 3.8 12.3 4.6 12.9 10.9 11.0 6.5 6.3 16.2 15.4 36.0 7.1 14.2 11.7 15.6 7.4 22.3 25.3 20.3 14.8 15.3 22.6 30.0 39.9 12.9 13.3 13.0 12.2 19.1 19.4 14.5 13.1 30.6 25.9 46.1 44.6 30.6 33.0 24.3 29.2 10.5 14.8 13.5 27.7 11.3 10.6 33.0 29.2 22.5 19.1 12.5 27.5 24.6 18.5 73.1 52.4 10.1 26.9 23.9 29.6 39.6 71.7 34.5 29.9 71.0 28.2 59.7 39.7 31.3 71.2 61.7 53.1 37.6 5.4 29.9 65.4 83.7 29.4 71.6 34.8 49.9 17.0 52.5 29.7 31.9 29.3 40.0 22.2 18.7 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: " "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavourable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 16.9 15.4 9.5 21.2 15.9 16.9 17.7 21.6 18.2 18.6 15.4 25.2 18.6 13.0 22.8 18.9 15.6 16.8 14.0 10.9 9.6 8.5 13.3 12.7 15.6 20.7 15.3 13.2 23.9 17.6 21.0 15.4 18.4 13.7 14.9 16.8 20.6 16.1 18.5 20.0 18.0 17.1 17.9 13.7 21.9 15.0 33.5 14.2 24.5 18.6 12.0 20.7 18.6 16.3 11.2 12.8 6.9 14.9 7.6 9.1 5.3 5.7 6.7 9.8 6.4 4.7 6.3 16.3 4.8 5.5 6.9 5.9 4.5 8.0 11.4 6.6 5.3 7.3 9.1 5.1 5.5 5.5 11.3 6.4 6.9 5.2 6.7 11.3 6.1 8.2 5.8 5.7 9.2 8.1 10.8 9.3 4.9 11.1 7.8 6.6 13.4 5.4 9.1 6.3 8.4 5.3 6.6 7.1 13.0 7.3 8.6 5.8 9.3 15.4 5.4 4.0 4.2 4.4 6.7 9.7 10.4 88.6 4.2 4.0 3.9 6.8 10.7 6.9 8.3 14.9 8.7 8.7 7.4 9.1 12.8 11.2 8.3 8.3 6.5 7.6 10.6 8.6 4.7 5.3 9.5 15.9 21.6 18.2 9.6 8.5 15.3 13.2 13.7 14.2 SGSM2 "KIAA0397, RUTBC1" ENSG00000141258 "Small G protein signaling modulator 2" O43147 17 2337498-2381058 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 8.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021641, HPA024553" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021641: AB_2188702, HPA024553: AB_1856512" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-2)" "unprognostic (4.88e-2)" "prognostic favourable (3.11e-4)" "unprognostic (1.49e-1)" "unprognostic (7.84e-2)" "unprognostic (7.63e-2)" "unprognostic (1.90e-1)" "prognostic favourable (9.00e-6)" "unprognostic (2.78e-2)" "unprognostic (8.27e-2)" "unprognostic (1.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-2)" 11.1 15.3 51.8 13.3 45.8 17.3 15.9 14.4 43.7 11.6 12.1 12.6 14.9 10.8 13.3 38.6 16.5 12.7 15.1 12.3 43.2 24.9 12.6 6.6 14.7 15.4 13.9 34.8 11.3 14.8 25.4 30.7 11.1 18.9 20.6 7.4 13.6 23.0 18.1 13.4 23.0 13.0 14.2 13.7 16.6 14.2 10.0 17.6 9.4 15.7 6.0 10.8 16.1 10.9 0.6 0.9 8.6 0.4 1.3 2.1 0.7 10.1 15.7 14.4 20.0 8.2 9.9 21.4 8.8 10.4 12.3 12.5 15.8 19.6 4.9 9.6 12.8 14.4 8.8 10.4 4.3 7.2 18.0 8.6 23.8 16.7 7.0 5.1 13.0 10.6 6.9 12.4 7.2 12.7 5.1 7.4 7.3 21.6 10.9 6.9 7.0 6.9 24.0 7.3 3.9 15.8 21.4 7.0 16.6 11.0 8.3 6.6 21.5 6.2 14.8 9.9 11.3 14.5 11.6 6.1 0.9 4.5 8.6 6.8 8.7 8.6 0.4 2.1 1.7 0.3 1.5 0.1 0.7 1.0 0.7 0.6 2.1 1.1 0.2 1.3 0.0 0.9 1.0 0.7 51.8 45.8 14.4 43.7 43.2 24.9 13.9 34.8 18.9 17.6 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.1;RT4: 9.7;SK-MEL-30: 8.7;WM-115: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037683: , HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.2 0.5 0.2 6.1 5.0 0.0 5.5 0.3 4.2 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 5.5 0.0 3.8 0.0 2.0 9.7 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.2 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 SKP1 "EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L" ENSG00000113558 "S-phase kinase associated protein 1" P63208 5 134148935-134177038 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB012982, HPA053745, HPA058134" Approved Supported Nucleoplasm,Cytosol 600000 Nucleoplasm Cytosol "CAB012982: AB_2533076, HPA053745: , HPA058134: " "prognostic unfavourable (7.53e-4)" "unprognostic (1.97e-1)" "unprognostic (9.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (5.72e-4)" "unprognostic (4.47e-2)" "unprognostic (1.33e-1)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (3.07e-1)" "prognostic favourable (5.20e-4)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (8.26e-2)" "unprognostic (2.40e-1)" 63.7 90.2 101.8 35.1 113.6 59.2 110.3 109.3 152.1 94.0 70.5 78.8 55.7 43.6 73.9 99.3 72.9 84.5 64.4 116.0 112.7 100.7 113.8 83.5 52.8 52.3 109.9 121.7 98.4 44.6 116.8 81.4 83.1 114.2 84.8 69.1 68.5 54.7 113.4 141.7 59.9 55.2 82.3 106.3 47.0 58.8 69.3 79.7 57.5 108.0 82.1 60.9 71.8 58.2 113.5 78.4 136.3 90.7 96.4 157.1 209.1 67.4 52.7 78.6 105.7 121.8 99.5 56.1 78.7 100.1 92.5 95.8 80.9 65.8 50.0 118.2 106.1 37.8 78.5 118.9 107.8 45.7 55.5 39.4 82.8 57.5 57.5 30.2 49.0 85.1 95.9 81.0 64.2 98.8 47.5 44.2 138.2 53.3 65.1 32.5 45.6 56.8 36.0 84.1 61.2 103.3 76.0 64.4 50.5 106.7 27.3 71.8 79.1 47.4 74.2 59.8 37.1 62.4 79.7 27.5 45.8 74.3 83.2 58.0 64.7 132.3 83.2 136.3 91.3 78.3 102.0 113.5 131.3 111.8 78.4 99.8 157.1 123.5 78.0 96.4 90.7 69.6 130.2 209.1 101.8 113.6 109.3 152.1 112.7 100.7 109.9 121.7 114.2 79.7 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051720 Uncertain Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA051720: " "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favourable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favourable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favourable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.4 12.3 2.1 9.2 7.1 2.8 5.1 2.9 2.6 3.2 3.6 1.4 11.5 5.1 3.0 3.4 10.0 2.6 3.5 1.7 2.7 3.2 4.3 9.1 1.7 2.6 0.5 11.7 5.8 2.0 6.1 1.1 5.1 1.2 1.8 2.6 2.4 4.6 2.4 0.7 4.1 5.0 1.5 2.2 2.5 11.4 1.1 2.7 8.5 5.1 3.6 11.4 3.3 6.6 2.2 1.7 5.2 2.5 3.9 2.3 1.7 5.6 7.6 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 23.8;hTCEpi: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favourable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.3 3.2 1.5 23.8 10.8 10.3 5.4 14.5 1.6 3.5 1.7 1.4 0.0 0.8 3.4 2.5 0.9 2.7 1.3 0.0 2.8 1.2 5.4 4.5 15.3 0.0 0.1 13.1 19.5 1.5 2.8 2.8 1.9 0.0 6.6 4.7 0.0 0.1 0.5 4.2 0.0 5.7 0.2 7.9 2.1 2.4 0.0 0.7 9.7 13.6 1.6 0.7 5.6 3.2 1.9 0.3 3.5 0.0 0.0 0.0 4.6 2.5 7.1 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 SNAPC4 "FLJ13451, PTFalpha, SNAP190" ENSG00000165684 "Small nuclear RNA activating complex polypeptide 4" Q5SXM2 9 136375577-136400168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046627, HPA073243" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA046627: AB_10961152, HPA073243: " "unprognostic (3.34e-2)" "unprognostic (2.12e-1)" "unprognostic (5.26e-2)" "unprognostic (1.75e-2)" "unprognostic (3.17e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (2.40e-1)" "prognostic favourable (4.52e-5)" "unprognostic (3.15e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (6.41e-2)" 6.8 5.8 7.6 9.5 15.4 12.7 7.6 20.1 19.4 8.0 6.6 10.9 8.7 9.5 9.9 10.1 6.6 14.5 9.2 6.3 10.1 8.0 8.6 11.5 8.0 10.8 7.7 10.1 11.2 17.8 13.4 13.3 6.7 10.4 9.1 7.2 11.8 10.8 8.5 7.2 13.5 7.8 8.0 8.2 11.7 8.1 20.0 10.2 11.2 10.0 5.7 10.2 9.4 7.1 3.4 1.7 3.7 1.6 2.3 2.6 0.6 6.0 7.1 7.3 10.1 4.7 9.2 13.4 7.9 5.3 8.3 6.7 16.2 5.6 9.3 5.7 6.2 19.7 8.8 10.2 5.0 13.1 13.8 6.3 18.0 7.7 4.2 13.2 7.5 7.3 8.6 7.2 6.9 7.3 12.9 6.9 5.8 13.6 7.6 15.0 15.1 9.3 12.6 7.4 13.2 4.8 11.0 21.1 14.7 7.9 13.2 4.2 13.5 7.7 10.4 8.6 7.9 15.4 11.2 4.3 5.1 7.6 6.0 6.2 5.0 0.0 1.6 1.3 2.6 1.3 1.2 2.0 1.1 1.1 0.6 3.4 0.9 0.7 3.7 2.3 0.5 1.7 0.9 0.6 7.6 15.4 20.1 19.4 10.1 8.0 7.7 10.1 10.4 10.2 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 44.9;fHDF/TERT166: 43.7;U-138 MG: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavourable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.1 3.9 3.4 5.0 11.0 15.9 4.2 24.2 44.9 11.9 7.0 3.7 2.5 2.6 4.7 43.7 2.5 3.7 3.8 15.2 2.6 3.4 4.1 3.7 4.4 6.8 2.4 4.6 12.6 5.8 10.1 4.0 4.0 3.6 2.9 7.5 1.8 2.1 3.9 3.8 3.2 2.7 5.8 3.3 4.8 3.9 2.7 7.4 5.9 3.9 4.6 1.6 3.4 4.5 29.7 6.6 9.8 4.7 3.6 2.2 2.2 13.5 4.7 9.2 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 SRI ENSG00000075142 Sorcin P30626 7 88205118-88226993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 140.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019004, HPA073666" Enhanced Supported Nucleoplasm,Cytosol 1400000 "Nucleoplasm, Cytosol" "HPA019004: AB_2670006, HPA073666: AB_2686623" "unprognostic (1.86e-2)" "unprognostic (2.31e-3)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-3)" "unprognostic (1.24e-3)" "prognostic favourable (3.08e-4)" "unprognostic (9.87e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.36e-1)" "unprognostic (2.10e-2)" "unprognostic (1.29e-2)" "unprognostic (9.87e-2)" "unprognostic (8.44e-2)" "unprognostic (3.14e-3)" 20.6 22.0 47.7 24.6 53.5 18.7 22.4 18.9 43.6 24.1 140.7 32.5 7.0 45.3 18.1 33.1 15.6 39.4 14.2 19.4 35.9 40.2 21.7 14.6 21.9 16.6 45.0 44.8 23.3 18.4 12.1 18.3 21.2 36.9 19.5 115.0 11.1 17.7 18.4 8.7 11.1 62.8 25.2 41.9 14.6 16.2 10.0 28.0 9.2 19.7 9.4 19.4 27.0 18.7 29.7 34.5 95.4 42.1 36.3 36.4 32.7 34.1 13.1 35.5 36.5 57.6 48.6 17.8 20.5 33.3 23.2 27.6 12.2 77.6 38.0 21.7 31.1 34.6 44.6 46.5 30.4 30.6 20.0 19.7 36.2 0.0 34.9 26.2 21.1 49.7 42.6 24.5 35.7 69.5 17.4 33.0 31.8 21.6 38.2 18.0 31.2 26.5 15.9 50.3 21.0 43.2 34.2 25.7 30.5 62.6 36.0 28.6 17.0 11.7 43.4 43.5 36.5 39.9 36.5 30.9 14.3 40.7 42.7 25.1 73.7 86.5 26.1 95.4 31.0 36.5 36.4 29.7 34.5 35.2 34.5 24.9 25.8 29.8 16.3 36.3 42.1 27.5 34.7 32.7 47.7 53.5 18.9 43.6 35.9 40.2 45.0 44.8 36.9 28.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell line enhanced" "Detected in some" "CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047014 Approved Nucleoplasm,Vesicles 220000 "Nucleoplasm, Vesicles" "HPA047014: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favourable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.2 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.0 0.0 0.0 35.7 72.1 26.0 2.7 0.0 50.5 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.2 0.1 0.0 0.0 47.3 4.7 21.5 2.9 0.0 0.2 33.4 0.0 50.5 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.4 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 STRADA "LYK5, NY-BR-96, Stlk, STRAD" ENSG00000266173 "STE20-related kinase adaptor alpha" Q7RTN6 17 63682336-63741986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031637 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA031637: AB_10601718" "unprognostic (1.59e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-3)" "unprognostic (5.52e-2)" "unprognostic (8.91e-2)" "unprognostic (7.56e-5)" "unprognostic (6.79e-4)" "unprognostic (3.68e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "prognostic favourable (5.34e-5)" "unprognostic (7.29e-2)" "prognostic unfavourable (6.08e-7)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "prognostic favourable (6.43e-4)" 13.3 17.7 19.4 14.6 23.7 17.5 13.0 25.0 28.4 15.2 13.2 27.1 8.7 9.5 16.1 20.6 14.3 20.9 14.5 15.1 18.9 20.2 14.7 13.0 13.9 19.6 20.9 21.7 18.5 12.5 21.9 17.5 14.4 26.0 13.8 13.1 22.2 12.6 16.7 10.3 20.1 12.0 19.1 19.4 20.7 12.6 55.4 21.4 16.2 13.3 8.9 21.3 12.9 12.8 11.2 16.2 18.6 10.0 15.6 11.7 7.5 7.2 21.7 18.9 19.0 18.6 13.9 7.4 13.8 12.7 19.9 17.8 5.6 8.4 11.0 8.6 11.7 6.0 12.5 13.3 19.8 12.2 12.1 21.8 15.2 13.4 13.2 20.6 15.7 14.5 11.5 22.6 13.0 22.0 13.9 11.8 18.8 13.4 24.2 14.1 9.4 12.3 15.8 30.1 13.5 17.8 14.3 20.7 23.2 9.4 15.5 15.1 11.4 15.0 17.6 19.0 13.5 15.3 11.4 11.8 12.5 13.9 14.1 12.5 14.9 18.6 9.5 8.6 10.5 7.1 9.7 11.2 9.7 11.7 16.2 9.0 9.6 8.5 11.4 15.6 10.0 13.7 7.2 7.5 19.4 23.7 25.0 28.4 18.9 20.2 20.9 21.7 26.0 21.4 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937018-32001045 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli, Nuclear bodies" "HPA057436: " "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 10.1 10.8 13.4 15.4 10.4 25.5 33.5 16.0 13.8 11.2 11.4 7.5 13.6 10.1 12.5 8.1 12.3 9.8 7.7 9.7 9.1 7.6 10.9 11.5 10.6 19.9 9.3 9.9 10.0 10.1 15.5 10.4 15.3 9.5 10.7 10.9 6.9 10.1 9.6 8.7 9.9 12.2 9.6 7.7 15.2 10.7 17.1 12.5 31.8 12.0 6.5 18.9 10.8 19.5 5.5 4.6 4.1 2.6 4.4 5.5 1.2 14.0 12.5 11.8 13.5 6.8 8.8 12.1 13.7 12.1 16.9 20.5 9.4 7.9 30.8 10.6 8.5 12.5 17.5 7.9 27.5 10.8 17.0 21.3 10.6 6.8 8.0 33.5 21.9 6.1 8.9 16.8 12.9 10.3 20.5 42.8 14.5 4.9 39.8 19.5 6.7 7.6 23.8 30.2 24.9 9.9 13.8 15.1 11.8 22.1 7.2 13.2 20.8 28.0 7.6 13.4 12.2 16.1 21.1 23.4 29.1 38.1 9.8 20.7 12.1 1.4 1.9 3.8 3.8 2.6 3.0 5.5 4.1 4.0 1.4 4.4 3.9 5.5 4.1 4.4 1.8 4.6 4.2 1.2 13.4 10.4 16.0 13.8 9.1 7.6 9.3 9.9 9.5 12.5 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 38.7 1.1 0.0 6.0 0.8 3.2 0.0 0.0 5.3 22.3 0.0 0.0 0.0 30.8 20.5 0.0 4.4 0.0 0.4 0.0 0.6 3.1 0.0 4.7 0.0 13.5 0.2 0.0 25.8 0.0 10.6 0.8 5.8 2.0 1.8 0.0 2.7 0.0 2.5 23.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.3 0.0 21.7 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.0 18.5 20.3 19.6 10.6 7.1 24.2 5.0 9.8 3.5 4.3 12.2 21.5 0.0 5.7 9.4 5.0 6.9 8.7 4.5 0.8 6.4 5.0 12.3 11.3 11.3 1.9 1.8 12.5 3.2 5.5 9.3 5.9 5.1 0.3 4.1 13.8 3.1 1.2 14.6 10.7 8.9 14.9 3.2 7.6 9.9 0.4 6.2 7.6 7.6 8.1 4.9 1.0 13.6 3.3 9.6 8.4 10.3 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295069 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: , HPA065897: " "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 7.1 0.9 3.4 0.0 0.0 0.2 0.1 1.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.4 5.0 0.0 12.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 30.6 61.2 0.5 0.0 23.3 4.2 7.9 0.1 0.1 0.7 0.0 58.1 0.0 0.2 118.1 5.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.0 3.0 74.6 0.8 0.2 0.6 0.1 33.7 0.0 0.2 1.6 0.4 0.2 0.8 0.0 0.8 3.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 96.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362842-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: " "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favourable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 17.4 17.2 13.3 12.9 14.8 22.2 14.2 13.4 19.6 15.2 14.4 13.8 12.5 12.8 14.0 15.8 16.5 12.3 10.9 19.3 12.3 13.9 20.7 23.9 11.1 13.5 18.3 11.0 14.3 14.8 22.2 27.8 14.4 23.2 15.9 15.1 14.0 16.1 14.9 29.4 13.4 14.9 12.3 15.8 14.5 12.5 42.8 14.8 22.3 18.2 17.5 13.2 16.2 11.7 13.9 15.4 12.5 19.3 11.7 22.3 10.1 12.5 17.2 12.0 6.2 15.9 15.3 48.4 15.4 12.7 15.7 12.0 12.9 13.4 12.9 12.1 13.9 8.3 21.9 15.8 16.0 14.4 12.7 16.3 17.4 11.2 15.5 20.7 11.7 12.2 17.8 18.6 19.4 10.3 25.4 18.9 20.7 17.9 24.3 8.9 23.1 16.7 15.5 20.6 18.5 10.4 19.1 5.0 16.2 12.8 9.2 13.7 14.9 13.4 7.3 15.1 13.1 18.2 16.9 24.1 56.2 41.7 18.3 19.4 21.7 10.6 13.2 12.5 16.2 17.4 21.1 12.3 14.1 16.8 15.0 13.9 22.3 16.8 2.7 11.7 19.3 15.4 13.2 10.1 13.3 14.8 13.4 19.6 12.3 13.9 18.3 11.0 23.2 14.8 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Cell line enhanced" "Detected in some" "HSkMC: 7.4;hTCEpi: 7.4;RPTEC TERT1: 7.6;RT4: 9.3;THP-1: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 3.9 0.0 0.1 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 3.5 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.5 7.4 7.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.4 1.5 0.1 0.0 0.0 7.6 9.3 0.0 0.2 0.4 0.0 1.8 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274192-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles Vesicles "HPA012093: AB_1858056, HPA070824: " "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favourable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 64.3 34.6 26.5 22.1 45.0 23.0 84.3 11.0 38.3 35.7 42.2 43.1 33.7 41.8 35.0 30.0 86.8 25.1 50.3 34.6 21.0 17.2 50.7 69.3 46.7 34.3 37.5 13.7 27.9 87.6 31.3 15.0 92.7 40.9 31.6 40.1 23.9 40.1 43.7 53.2 49.5 70.6 41.2 50.3 22.7 57.8 13.2 32.5 9.4 66.4 42.1 36.3 57.7 54.5 17.0 19.6 60.3 43.5 13.0 24.0 33.6 26.8 9.7 0.5 7.1 62.9 26.6 29.0 26.4 32.6 15.6 18.0 24.8 66.7 6.1 19.3 38.8 46.0 9.0 59.2 15.4 22.1 3.7 38.9 6.7 29.7 28.5 0.5 38.5 25.1 55.7 32.0 40.9 16.6 24.2 11.5 27.3 1.1 0.4 6.7 0.4 8.7 0.9 4.3 4.8 21.0 84.8 0.5 0.5 8.7 32.4 18.3 8.7 5.9 25.1 28.2 7.8 13.0 9.5 5.6 6.5 2.7 27.7 6.1 15.9 60.3 27.7 59.9 24.0 36.2 20.5 17.0 22.0 19.5 19.6 14.0 14.7 15.8 35.5 13.0 43.5 5.3 23.5 33.6 26.5 45.0 11.0 38.3 21.0 17.2 37.5 13.7 40.9 32.5 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Group enriched" "Detected in some" 6 "NTERA-2: 6.4;SH-SY5Y: 1.9" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: , HPA063207: " "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273474-97277964 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell line enhanced" "Detected in some" "K-562: 13.7;SCLC-21H: 29.2;SH-SY5Y: 22.6;U-2 OS: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favourable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favourable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 5.5 8.3 9.0 4.0 19.7 1.3 11.3 8.4 24.0 11.5 8.0 9.3 20.1 1.9 14.2 14.9 4.5 11.9 6.3 11.1 9.1 15.0 8.5 1.9 6.6 5.5 8.6 9.1 23.9 8.0 5.5 12.8 4.1 17.4 14.6 3.4 7.1 8.7 17.7 10.5 3.8 3.7 13.3 7.1 6.4 7.4 46.4 5.2 6.3 7.9 4.4 6.6 9.8 4.6 1.5 2.3 0.7 0.5 1.0 1.3 0.4 0.0 7.4 0.0 0.0 0.2 0.2 0.0 5.8 0.0 5.8 3.8 0.0 0.2 0.0 8.1 6.9 2.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 9.4 0.0 8.2 0.0 0.0 13.7 0.0 0.2 10.7 0.0 0.0 0.0 0.1 10.5 0.0 0.0 4.9 0.0 29.2 22.6 0.0 1.9 0.0 0.0 0.9 0.0 0.0 12.7 0.0 0.0 6.9 10.3 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.5 0.0 0.7 0.5 0.1 2.3 1.5 1.3 0.5 0.0 1.0 0.2 2.2 1.1 0.4 9.0 19.7 8.4 24.0 9.1 15.0 8.6 9.1 17.4 5.2 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243811-110256640 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 447.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 127.1;granulocytes: 104.5" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" 25000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favourable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 23.6 16.7 26.6 18.2 16.9 35.8 25.9 10.8 19.7 30.8 57.9 7.7 17.5 40.7 15.5 20.4 162.3 27.5 22.2 11.7 20.9 19.0 65.8 69.4 39.0 19.4 21.3 14.1 18.2 22.0 5.3 8.0 41.2 28.7 15.5 50.6 8.0 50.2 16.3 16.0 26.3 58.9 21.9 17.6 19.8 26.3 9.2 7.0 40.0 18.9 447.3 82.0 31.3 27.1 12.8 127.1 104.5 25.1 14.2 26.0 18.8 61.9 85.2 23.1 25.5 58.3 76.0 34.0 75.5 70.5 52.6 40.1 55.3 74.8 55.3 32.5 69.7 140.2 32.9 100.6 51.7 81.9 73.0 27.7 79.9 95.6 66.7 68.7 84.6 53.9 66.4 77.0 58.3 46.2 46.5 53.3 71.9 50.2 57.2 103.1 49.1 104.0 24.0 78.3 64.4 67.3 44.0 50.3 18.0 81.4 66.2 51.2 63.5 47.6 55.4 54.3 35.1 101.8 93.5 27.0 76.2 47.0 78.8 60.0 75.3 32.2 25.1 104.5 14.5 15.1 13.9 12.8 20.5 17.4 37.1 5.6 7.7 11.5 99.7 14.2 9.6 127.1 26.0 18.8 26.6 16.9 10.8 19.7 20.9 19.0 21.3 14.1 28.7 7.0 UBA1 "A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X" ENSG00000130985 "Ubiquitin like modifier activating enzyme 1" P22314 X 47190861-47215128 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000289, HPA001506, CAB019435, CAB073410" Approved Enhanced Nucleoplasm 16000000 Nucleoplasm "CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305" "unprognostic (7.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" "unprognostic (2.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (6.10e-5)" "unprognostic (7.22e-2)" "unprognostic (2.42e-3)" "unprognostic (3.43e-2)" "unprognostic (8.50e-3)" "unprognostic (2.17e-3)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (5.38e-2)" "prognostic favourable (1.78e-4)" "unprognostic (1.21e-2)" 45.6 63.0 56.0 47.2 50.6 42.0 38.3 58.1 75.7 48.0 39.3 55.9 44.9 36.3 52.9 34.1 59.4 56.0 39.9 48.7 49.5 39.9 51.1 60.0 42.0 48.2 47.7 62.3 57.6 34.9 78.8 55.5 39.1 47.6 40.2 35.5 41.0 47.5 45.7 77.7 56.1 37.9 59.4 35.5 53.4 38.7 36.0 48.6 52.7 65.0 43.9 54.0 39.2 52.7 28.9 30.6 32.6 36.0 25.6 29.0 24.1 45.8 47.6 54.5 82.8 37.3 34.0 24.1 30.5 32.5 43.9 35.8 37.8 35.0 34.2 20.3 61.0 44.3 68.3 64.9 32.3 28.3 69.4 21.4 52.8 30.3 26.3 36.0 46.2 31.9 34.0 63.8 49.8 57.5 23.2 30.8 43.5 58.1 33.9 31.9 58.0 74.4 39.5 38.0 58.2 35.1 49.4 35.3 26.5 90.9 44.2 20.2 61.5 22.5 42.0 33.0 38.3 47.5 28.4 21.1 21.9 48.8 33.9 25.8 39.4 17.4 27.0 27.4 29.0 36.0 25.4 28.9 24.0 25.9 30.6 22.0 19.1 23.4 32.6 25.6 32.8 20.8 28.2 24.1 56.0 50.6 58.1 75.7 49.5 39.9 47.7 62.3 47.6 48.6 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" 34000 Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: " "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favourable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 16.8 13.0 14.3 14.3 17.2 28.0 17.2 15.4 19.1 19.8 24.0 21.8 15.5 20.0 16.7 12.1 55.0 13.1 15.1 9.9 13.7 16.0 15.6 20.5 14.3 21.6 17.0 14.7 11.9 14.0 17.5 17.4 27.4 23.4 14.3 22.2 9.3 21.8 15.0 9.9 22.1 28.7 15.2 20.2 17.3 18.7 9.0 14.6 27.8 17.0 17.6 31.8 18.6 24.7 20.7 13.6 56.4 20.6 19.1 18.9 15.4 18.4 6.8 7.6 8.3 11.8 16.7 13.2 16.2 15.3 12.4 13.6 5.0 13.2 17.8 10.6 11.8 40.1 9.1 17.7 16.5 12.9 7.3 8.9 9.6 7.7 16.9 30.6 19.5 15.1 27.6 10.9 19.5 11.5 4.4 16.7 17.6 6.4 19.1 9.6 7.9 10.7 16.0 16.2 17.1 15.6 21.7 13.0 11.5 12.2 12.0 18.1 11.5 16.7 17.6 19.2 9.4 7.2 10.6 56.1 26.9 22.9 11.0 14.5 14.2 39.4 16.8 36.0 16.5 16.6 15.4 18.9 17.4 17.0 13.6 20.7 15.8 16.6 56.4 19.1 20.6 13.6 18.9 15.4 14.3 17.2 15.4 19.1 13.7 16.0 17.0 14.7 23.4 14.6 WBP2 "GRAMD6, WBP-2" ENSG00000132471 "WW domain binding protein 2" Q969T9 17 75845699-75856507 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065682, HPA068819" Approved Approved Nucleoplasm,Cytosol 870000 "Nucleoplasm, Cytosol" "HPA065682: , HPA068819: " "unprognostic (1.74e-1)" "unprognostic (1.71e-2)" "unprognostic (3.17e-2)" "unprognostic (2.85e-1)" "unprognostic (8.39e-2)" "unprognostic (7.12e-2)" "unprognostic (8.89e-2)" "unprognostic (3.09e-1)" "unprognostic (2.68e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-3)" "unprognostic (6.18e-2)" "unprognostic (2.21e-1)" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "unprognostic (2.13e-2)" "unprognostic (1.76e-1)" 37.4 50.4 59.5 22.8 79.8 29.9 22.6 62.5 119.3 24.3 20.4 75.2 15.0 27.0 22.9 19.7 25.7 36.6 26.4 51.6 58.7 56.4 32.0 48.7 31.9 22.3 62.1 56.2 41.8 35.7 36.8 24.5 23.0 110.8 32.2 17.2 40.3 55.5 33.6 47.1 28.2 25.9 23.0 55.6 30.5 27.4 28.5 44.3 10.6 26.8 15.7 21.5 24.5 18.3 14.9 11.1 63.5 25.5 11.2 15.1 16.8 26.5 30.9 11.7 13.8 24.0 24.0 15.3 8.6 27.2 19.9 24.8 15.4 27.2 13.8 22.1 12.2 16.0 12.2 26.1 18.4 10.1 23.5 25.4 18.8 24.9 49.5 10.4 43.5 26.5 25.0 23.5 33.1 38.6 17.0 41.8 16.0 27.1 21.6 21.6 9.9 20.5 14.9 23.3 25.6 29.0 16.5 19.6 30.6 15.1 26.3 41.9 35.4 26.2 22.1 20.4 18.0 19.7 13.6 38.7 27.7 10.3 57.1 9.8 14.4 42.8 16.7 56.0 11.6 20.5 12.9 14.9 13.0 11.7 11.1 12.0 12.6 10.3 63.5 11.2 25.5 8.6 15.1 16.8 59.5 79.8 62.5 119.3 58.7 56.4 62.1 56.2 110.8 44.3 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178783 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: , HPA069673: " "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favourable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favourable (2.46e-4)" 20.2 17.1 14.2 24.0 30.2 8.4 21.4 16.1 19.3 22.3 18.9 20.8 27.5 18.0 24.6 18.3 16.9 24.9 25.1 12.4 16.2 14.4 24.6 23.4 19.9 21.1 33.4 15.2 35.0 20.9 35.4 26.7 28.0 22.1 20.9 15.9 16.7 17.6 30.3 22.4 30.5 23.6 17.7 22.6 23.3 15.9 12.9 30.6 18.5 25.7 12.4 20.8 22.4 22.3 10.9 7.0 34.6 8.8 8.8 12.2 6.1 4.4 11.5 13.0 8.3 19.5 13.5 44.0 11.1 32.0 10.8 8.4 4.2 5.4 15.0 4.9 13.5 5.6 8.5 17.8 8.9 6.0 7.3 7.9 12.2 7.7 17.3 5.9 15.1 19.1 21.1 14.3 28.8 12.8 10.9 8.1 12.0 9.4 4.9 5.7 7.7 7.8 6.2 5.9 12.0 13.6 13.4 2.8 10.1 12.1 10.1 8.0 10.6 4.8 20.0 4.2 11.4 6.3 5.1 18.7 13.6 8.9 10.0 7.0 15.1 12.0 8.2 9.4 9.8 6.3 9.6 10.7 11.2 9.6 7.0 10.9 12.2 8.7 34.6 8.8 8.8 6.7 9.2 6.1 14.2 30.2 16.1 19.3 16.2 14.4 33.4 15.2 22.1 30.6 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282792 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 32.7 28.8 26.3 27.0 25.8 45.3 33.8 33.6 26.4 28.1 37.6 24.9 34.6 26.4 29.5 33.7 34.1 24.4 27.4 38.3 27.6 21.9 31.4 42.8 31.8 30.6 26.5 21.1 26.9 27.7 32.5 23.6 35.2 24.1 29.3 28.2 21.5 25.6 23.1 39.9 27.2 31.0 25.9 26.5 30.6 25.3 22.6 25.8 60.2 40.9 23.3 35.2 29.7 47.0 8.2 6.3 14.2 7.0 12.0 9.0 3.0 23.7 12.5 25.8 20.5 20.6 25.8 28.0 23.6 21.3 25.7 26.0 15.1 39.9 36.3 33.6 20.5 24.9 28.1 24.3 35.1 28.2 22.7 33.8 14.6 19.4 19.1 40.3 29.5 15.6 29.2 17.7 24.4 24.3 26.2 25.4 24.2 29.5 43.8 22.0 27.0 21.6 35.8 35.9 19.7 28.8 23.5 27.5 20.4 31.5 22.7 31.9 35.0 37.0 22.1 16.0 20.0 38.8 20.6 26.6 27.0 50.3 22.2 26.1 20.6 5.1 7.0 14.2 5.5 5.9 7.0 6.3 7.6 7.7 6.1 8.2 7.1 6.8 12.2 12.0 4.5 6.3 9.0 3.0 26.3 25.8 33.6 26.4 27.6 21.9 26.5 21.1 24.1 25.8 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595443 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 21.0;thyroid gland: 74.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 19.7;EFO-21: 13.7;HaCaT: 19.0;HBEC3-KT: 42.6;RPTEC TERT1: 28.4" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Region enriched" "Detected in single" 6 "basal ganglia: 1.4" "Cell type enhanced" "Detected in many" "naive B-cell: 4.0" "Group enriched" "Detected in many" 6 "B-cells: 4.0;T-cells: 2.5" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavourable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.1 0.0 0.1 0.9 1.4 0.0 0.1 0.1 0.1 3.7 0.1 0.1 0.1 0.0 0.2 0.2 8.1 11.1 0.2 0.1 0.1 0.0 0.3 0.1 5.6 3.4 0.1 0.1 1.2 0.1 0.0 0.4 4.0 0.1 0.1 0.0 0.1 1.7 0.1 0.1 1.3 0.3 0.1 0.1 0.1 0.1 0.2 0.2 21.0 74.5 7.5 7.4 0.2 6.2 4.0 0.0 0.1 0.0 0.5 2.5 0.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.1 13.7 0.0 19.0 0.0 42.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 3.6 0.6 0.3 0.0 4.0 1.9 2.5 0.1 0.5 0.0 0.0 1.1 0.3 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 ZCCHC11 "KIAA0191, PAPD3, TUT4" ENSG00000134744 "Zinc finger CCHC-type containing 11" Q5TAX3 1 52408282-52553487 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavourable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 13.8 19.1 18.4 25.6 19.0 20.5 18.7 50.9 21.3 22.4 13.3 11.8 16.1 7.7 22.1 22.0 11.5 16.8 14.0 13.5 17.8 16.5 14.2 17.7 13.3 27.4 15.4 14.6 28.3 17.6 34.4 56.0 18.8 16.3 16.1 10.5 12.1 12.6 20.6 44.6 28.1 17.1 20.3 26.6 20.9 12.3 24.9 21.1 31.9 23.9 14.6 25.1 18.3 17.0 23.2 26.0 26.7 4.3 10.3 15.0 2.2 10.4 9.9 24.4 16.5 9.6 12.3 16.9 9.3 13.6 13.6 15.7 10.2 5.5 22.3 11.0 12.9 8.7 18.3 9.8 17.3 18.2 16.7 23.5 12.8 21.2 15.9 25.4 13.4 14.5 21.9 14.5 18.0 9.4 19.1 11.2 11.3 0.1 25.3 18.2 17.7 12.6 22.5 24.8 17.4 14.6 8.6 13.1 13.0 14.3 6.1 13.9 8.5 13.4 7.9 10.6 14.3 9.7 11.3 24.5 32.1 32.1 7.0 13.9 7.6 26.7 4.3 13.8 11.8 1.7 8.8 19.1 12.4 9.5 2.1 23.2 15.0 9.9 16.2 10.3 1.4 26.0 9.3 2.2 18.4 19.0 50.9 21.3 17.8 16.5 15.4 14.6 16.3 21.1 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.1 6.7 17.8 19.5 18.4 22.5 6.7 10.2 12.5 6.1 6.2 4.0 8.7 10.3 13.1 11.4 7.6 10.2 8.8 11.8 9.9 6.2 8.3 8.2 10.4 10.4 15.9 10.0 15.0 14.2 8.3 27.8 13.5 19.2 9.0 12.1 12.1 15.1 9.5 7.2 8.4 8.9 9.1 9.2 10.3 14.4 20.8 24.8 15.9 20.9 18.0 10.6 10.6 20.2 13.5 13.2 15.6 10.3 10.5 18.2 10.7 9.2 11.4 17.6 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 ZNF383 FLJ35863 ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA063945: " "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favourable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favourable (3.71e-4)" 9.1 7.5 9.3 10.4 12.1 6.9 10.7 20.4 10.8 9.1 8.2 12.6 10.4 7.5 11.6 7.8 8.9 8.2 6.1 9.6 8.7 6.9 9.3 7.4 7.2 11.3 14.2 6.5 12.9 9.2 9.4 11.0 6.5 11.8 9.6 7.4 8.7 8.5 8.7 14.0 11.8 9.5 10.8 13.7 10.8 8.4 10.5 12.1 13.2 11.4 5.7 11.9 10.2 9.4 11.4 4.0 6.3 5.4 5.7 11.6 4.8 3.7 8.5 6.0 9.1 7.4 7.7 3.9 5.1 7.1 5.2 7.9 3.9 4.5 5.1 7.9 4.9 3.8 4.9 6.8 7.7 7.1 5.3 7.7 6.4 3.1 8.4 8.8 8.4 9.8 5.9 5.0 9.8 4.7 4.0 2.7 6.7 1.6 7.6 4.0 5.3 3.0 5.6 10.7 4.6 4.6 10.7 7.2 5.3 8.2 4.9 7.2 5.8 5.2 2.9 6.8 4.6 4.8 4.9 8.3 7.9 9.8 1.0 4.2 6.2 3.6 4.1 6.3 7.6 4.7 10.7 9.8 7.2 9.2 4.0 11.4 11.6 9.1 5.0 5.7 5.4 3.8 7.0 4.8 9.3 12.1 20.4 10.8 8.7 6.9 14.2 6.5 11.8 12.1 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA056895: , HPA065203: " "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favourable (1.87e-4)" 9.4 13.4 15.0 7.1 21.0 3.7 8.3 14.9 20.1 9.0 14.8 12.8 14.3 13.6 10.5 9.9 6.6 11.9 11.2 10.5 13.5 13.3 9.9 37.4 10.9 6.1 12.3 11.0 12.5 25.3 8.5 12.2 12.5 8.0 14.3 5.3 10.4 14.1 25.6 17.2 11.5 11.3 7.5 10.3 8.6 17.2 9.2 10.4 28.1 16.6 2.8 8.2 10.4 6.8 4.3 3.5 3.5 1.7 3.7 7.1 1.8 4.6 9.0 8.3 7.2 3.5 3.6 5.3 5.9 3.9 5.1 5.6 9.8 5.3 8.2 5.3 3.4 4.3 5.1 4.0 2.2 7.1 50.4 8.1 6.0 17.6 5.8 3.6 7.5 4.2 3.7 4.2 3.2 4.5 10.4 3.7 3.6 6.0 11.6 10.1 8.9 16.4 13.5 5.3 4.3 5.6 4.4 8.9 12.1 3.0 10.1 4.4 10.0 6.6 5.8 9.2 7.9 1.9 6.5 8.9 7.6 6.2 5.8 4.9 5.9 3.1 1.7 3.5 4.1 1.4 4.5 2.0 6.9 6.9 2.1 4.3 7.1 4.6 0.2 3.7 1.0 3.5 4.2 1.8 15.0 21.0 14.9 20.1 13.5 13.3 12.3 11.0 8.0 10.4 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Group enriched" "Detected in some" 5 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.9" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA045439: , HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.8 13.4 1.4 3.4 7.1 2.7 2.7 4.0 4.3 2.5 2.5 8.2 7.1 1.2 3.9 6.9 1.8 6.7 3.4 13.2 3.9 2.5 1.6 2.6 6.5 10.5 2.9 3.3 2.4 5.3 3.8 9.7 13.0 4.4 1.7 9.0 2.3 10.3 5.4 7.0 7.6 3.2 3.0 6.4 5.0 9.8 4.1 4.8 2.0 6.7 8.3 2.5 5.1 4.8 4.5 5.5 4.2 9.5 9.0 2.1 1.2 5.2 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407297-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 26.4;REH: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA030730: , HPA046672: , HPA059398: " "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 6.6 6.7 15.3 5.0 14.5 4.0 5.3 10.7 18.3 6.6 6.1 4.9 6.6 4.5 10.4 7.2 4.6 7.5 6.1 4.6 13.4 10.6 9.2 8.6 4.1 3.3 8.8 16.9 10.8 7.3 8.1 6.2 2.4 8.8 10.1 5.4 4.0 4.9 12.3 18.2 6.1 4.3 9.6 5.1 3.6 4.8 3.7 8.1 1.9 5.4 3.5 4.2 6.8 5.6 6.6 3.7 1.9 2.5 1.8 6.2 2.7 3.1 3.5 4.9 4.0 7.1 3.0 3.8 4.5 2.2 2.9 3.0 1.5 1.5 3.7 7.8 2.3 2.3 5.1 2.0 3.0 1.3 26.4 3.1 2.4 4.7 3.6 1.5 3.7 4.5 1.6 3.7 2.2 2.9 7.6 2.3 2.4 5.6 3.7 5.1 3.9 2.8 16.9 3.7 2.4 1.7 1.2 7.8 4.8 2.4 2.2 2.9 2.8 1.8 2.6 4.9 5.8 2.8 3.3 3.4 3.7 1.9 3.2 3.4 3.1 1.0 1.1 0.7 3.6 2.5 4.9 2.7 4.3 4.2 2.8 6.6 6.2 3.7 1.9 1.8 0.5 3.7 4.4 2.7 15.3 14.5 10.7 18.3 13.4 10.6 8.8 16.9 8.8 8.1